amending Decree No 57 / 1997 of the Ministry of Health Coll., which sets out the medicinal products fully covered by the health insurance and the level of reimbursement of individual active substances, as amended.
According to § 15 (5) of Act No. 48 / 1997 Coll., on Public Health Insurance and on the amendment and addition of certain related laws, the Ministry of Health provides for:
Decree No 57 / 1997 Coll., laying down the medicinal products fully covered by the health insurance and the amount of the reimbursement of individual active substances, as amended by Regulations No 109 / 1997 Coll., No 131 / 1997 Coll., No 220 / 1997 Coll., No 317 / 1997 Coll., No 72 / 1998 Coll., No 133 / 1998 Coll., No 209 / 1998 Coll., No 291 / 1998 Coll., No 59 / 1999 Coll. and No 117 / 1999 Coll. are amended as follows:
Section B of Annex No 2, which lists the medicinal products fully covered by the health insurance and the level of the reimbursement of each active substance, reads as follows:
"Medicinal products fully covered by health insurance and the amount of individual payments
| 1 | A01AA | léčiva k profylaxi zubního kazu (fluorid sodný) | p.o. | |
|---|
| 1.1 | A01AA01 | fluorid sodný | p.o. | 1.1 | MG | 0,88 | |
| 56281 | ZYMAFLUOR 1/4MG | 400x0,55mg | NCH | CH |
| 00211 | NATRIUM FLUORATUM SLOVAKOFARMA | tbl 250x0,55mg | SLO | SK |
| 2 | A01AB | protiinfekční léčiva pro lokální aplikaci | lok. | H |
|---|
| 2.1 | A01AB10 | natamycin | lok. | 20 | MG | 7,48 | |
| 88317 | PIMAFUCIN | gtt 1x20 ml 2,5% | YEL | NL |
| 2.2 | A01AB03 | chlorhexidin | lok. | 100 0 | ML | 178,70 | H |
| 3 | A01AC | kortikosteriody pro lokální aplikaci | lok. | L/DER,STO, ORL |
|---|
| 3.1 | A01AC01 | triamcinolon | lok. | 1 | GM | 13,69 | L/DER, STO, ORL |
| 03613 | KENALOG IN ORABASE | pst 5gm 0.1% | BMS | GB |
| 3.2 | A01AC02 | dexametason | lok. | 1 | GM | 11,68 | L/DER, STO, ORL |
| 4 | A02A | adsorbční antacida | p.o. | |
|---|
| 4.1 | A02AD | kombinace hliníku, vápníku a hořčíku (pevné lékové formy) | p.o. | 10 | DF | 7,67 | |
| 00156 | GASTROGEL SLOVAKOFARMA | tbl 50x500mg | SLOα | SK |
| 4.2 | A02AD | kombinace hliníku, vápníku a hořčíku (tekuté lékové formy) | p.o. | 50 | DF | 7,67 | |
|
| 4.3 | A02AD01 | kombinace hliníku, vápníku a hořčíku (- obvbyklé kombinace solí - pevné lékové formy) | p.o. | 10 | DF | 7,67 | |
|
| 4.4 | A02AD01 | kombinace hliníku, vápníku a hořčíku - obvyklé kombinace solí - tekuté lékové formy) | p.o. | 50 | ML | 7,67 | |
|
| 4.5 | A02AD04 | hydrotalcit - kombinace hliníku, vápníku a hořčíku (pevné lékové formy) | p.o. | 10 | DF | 7,67 | |
|
| 4.6 | A02AD04 | hydrotalcit - kombinace hliníku, vápníku a hořčíku (tekuté lékové formy) | p.o. | 50 | ML | 7,67 | |
| 5 | A02BA | antiulceróza ze skupiny H2-antagonistů | p.o. | |
|---|
| 5.1 | A02BA01 | cimetidin | p.o. | 0.80 | GM | 4,20 | |
| 87755 | CIMETIDINE CADILA | tbl obd 100x200 mg | CAD | IND |
| 5.2 | A02BA02 | ranitidin do 150 miligramů včetně v jedné tabletě | p.o. | 0.30 | GM | 4,20 | |
| 96056 | RANISAN | tbl obd 30x150mg | PMP | CZ |
| 96283 | ULCOSAN | tbl obd 30 | GNO | CZ |
| 56514 | ULRAN 150 | tbl obd 20x150mg | KRK | SLO |
| 45321 | RANISAN | tbl obd 500x150mg | PMP | CZ |
| 5.3 | A02BA02 | ranitidin nad 150 miligramů v jedné tabletě | p.o. | 0.30 | GM | 4,01 | |
| 76477 | RANITAL 300MG | tbl obd 30x300mg | LEK | SLO |
| 5.4 | A02BA03 | famotidin do 20 mg včetně v 1 tabletě | p.o. | 40 | MG | 4,20 | |
| 96193 | FAMOSAN | tbl obd 20x20 | PMP | CZ |
| 80537 | QUAMATEL 20 | tbl obd 28x20 mg | GED | H |
| 94207 | ULFAMID | tbl 20x20mg | KRK | SLO |
| 75832 | APO-FAMOTIDINE 20MG (LEKOVKA) | tbl obd 100x20mg | APT | CND |
| 5.5 | A02BA03 | famotidin nad 20 mg v 1 tabletě | p.o. | 40 | MG | 4,01 | |
| 67539 | ULCERAN 40 | tab. obd 500x40 mg | MOE | CY |
| 67537 | ULCERAN 40 | tab. obd 30x40 mg | MOE | CY |
| 67536 | ULCERAN 40 | tab. obd 10x40 mg | MOE | CY |
| 5.6 | A02BA04 | nizatidin | p.o. | 0.30 | GM | 4,20 | |
| |
| 5.7 | A02BA06 | roxatidin | p.o. | 0.15 | GM | 4,20 | |
| |
| 5.8 | A02BA07 | ranitidin bismut citrát | p.o. | 0.8 | GM | 30,01 | |
| 6 | A02BA | antiulceróza ze skupiny H2-antagonistů | parent. | H |
|---|
| 6.1 | A02BA01 | cimetidin | parent. | 0.80 | GM | 32,06 | H |
| 91782 | LOCK - 2E | inj. 5x2 ml | CAD | IND |
| 6.2 | A02BA02 | ranitidin | parent. | 0.30 | GM | 68,43 | H |
|
| 6.3 | A02BA03 | famotidin | parent. | 40 | MG | 68,43 | H |
| 7 | A02BB | antiulceróza ze skupiny prostaglandinů | p.o. | Z |
|---|
| 7.1 | A02BB01 | misoprostol | p.o. | 0.80 | MG | 51,86 | Z |
| 97404 | CYTOTEC | tbl 50x200rg | SEA | GB |
| 8 | A02BC | antiulceróza ze skupiny inhibitorů protonové pumpy | p.o. | L/GIT,INT |
|---|
| 8.1 | A02BC01 | omeprazol (do 10 mg v jedné dávce včetně) | p.o. | 20 | MG | 25,22 | L/GIT,INT |
|
| 8.2 | A02BC01 | omeprazol (nad 10 mg v jedné dávce) | p.o. | 20 | MG | 17,20 | L/GIT,INT |
| 12507 | GASEC-20 | cps 14x20mg | MHA | CH |
| 53346 | GASEC-20 | cps 28x20mg | MHA | CH |
| 56500 | HELICID | cps 14x20 | LEX | CZ |
| 8.3 | A02BC02 | pantoprazol | p.o. | 40 | MG | 17,20 | L/GIT,INT |
|
| 8.4 | A02BC03 | lansoprazol | p.o. | 30 | MG | 17,20 | L/GIT,INT |
| 9 | A02BC | antiulceróza ze skupiny inhibitorů protonové pumpy | parent. | H |
|---|
| 9.1 | A02BC01 | omeprazol | parent. | 20 | MG | 185,06 | H |
| 76644 | LOSEC 40 MG PRO INFUS. | inj sic 5x40 mg | AST | S |
| 10 | A02BX | ostatní léčiva peptického vředu | p.o. | |
|---|
| 10.1 | A02BX | ostatní léčiva peptického vředu (bismut subsalicylat) | p.o. | 3 | DF | 22,29 | |
|
| 10.2 | A02BX02 | sukralfát | p.o. | 4 | GM | 10,46 | |
| 91217 | VENTER | tbl 50x1 gm | KRK | SLO |
| 93131 | VENTER | gra 50x2gm | KRK | SLO |
| 10.3 | A02BX03 | pirenzepin | p.o. | 0.1 | GM | 8,55 | |
| 91602 | GASTROZEPIN | tbl 50 (5x10) x 25 mg | SLO | SK |
| 10.4 | A02BX05 | zásaditý citronan bismutitý | p.o. | 0.48 | GM | 23,07 | |
| 11 | A02BX | ostatní léčiva peptického vředu | parent. | H |
|---|
| 11.1 | A02BX03 | pirenzepin | parent. | 20 | MG | 105,58 | H |
| 12 | A02DA | antiflatulencia a spasmolytika ATC skupiny A03A | p.o. | |
|---|
| 12.1 | A02DA01 | silikony (pevné lékové formy) | p.o. | 0.50 | GM | 11,24 | |
| 91846 | CEOLAT | ctb 20x80mg | SVP | D |
| 12.2 | A02DA01 | silikony (tekuté lékové formy) | p.o. | 0.50 | GM | 19,89 | |
| 55950 | SAB SIMPLEX | sus 50x15ml(sacky) | PDA | D |
| 93500 | SAB SIMPLEX | sus 1x30ml | PDA | D |
| 93501 | SAB SIMPLEX | sus 4x30ml | PDA | D |
| 12.3 | A03AA04 | mebeverin | p.o. | 0.30 | GM | 4,99 | |
|
| 12.4 | A03AA05 | trimebutin | p.o. | 0.30 | GM | 4,99 | |
|
| 12.5 | A03AX58 | alverin | p.o. | 0.18 | GM | 4,99 | |
| 13 | A03AB | anticholinergika s kvarterní oniovou skupinou | p.o. | |
|---|
| 13.1 | A03AB03 | oxyfenon | p.o. | 25 | MG | 2,30 | |
| |
| 13.2 | A03AB06 | otilonium bromid | p.o. | 0.12 | GM | 12,42 | |
| |
| 13.3 | A03AB11 | poldin | p.o. | 12 | MG | 2,30 | |
| |
| 13.4 | A03AB20 | trospium chlorid | p.o. | 40 | MG | 12,42 | |
| 12528 | SPASMEX 15 | tbl 50x15mg | PFL | D |
| 12527 | SPASMEX 15 | tbl 30x15mg | PFL | D |
| 12525 | SPASMEX 5 | tbl 30x5mg | PFL | D |
| 14 | A03AD | muskulotropní spasmolytika | p.o. | |
|---|
| 14.1 | A03AD01 | papaverin | p.o. | 0.1 | GM | 0,68 | |
|
| 14.2 | A03AD02 | drotaverin | p.o. | 0.1 | GM | 4,94 | |
| 02551 | NO-SPA | tbl 20x40mg | CHN | H |
| 15 | A03AD | muskulotropní spasmolytika | parent. | |
|---|
| 15.1 | A03AD01 | papaverin | parent. | 0.1 | GM | 17,94 | |
| 03576 | PAPAVERIN SPOFA | inj. 10x2 ml/60 mg | SPX | CZ |
| 15.2 | A03AD02 | drotaverin | parent. | 0.1 | GM | 25,32 | |
| 02552 | NO-SPA | inj 5x2ml/40mg | CHN | H |
| 16 | A03BA | alkaloidy beladony s terciální aminovou skupinou | p.o. | |
|---|
| 16.1 | A03BA01 | atropin | p.o. | 1.5 | MG | 0,49 | |
| 000444 | ATROPIN SPOFA | tbl 20x0.5mg | LEX | CZ |
| 17 | A03BA | alkaloidy beladony s terciální aminovou skupinou | parent. | |
|---|
| 17.1 | A03BA01 | atropin (1 mg a více v 1 ampuli) | parent. | 1.5 | MG | 7,82 | |
| 00394 | ATROPIN BIOTIKA 1MG | inj 10x1ml/1mg | HBS | SK |
| 17.2 | A03BA01 | atropin (do 1mg v 1 ampuli) | parent. | 1.5 | MG | 15,15 | |
| 00392 | ATROPIN BIOTIKA 0.5MG | inj 10x1ml/0.5mg | HBS | SK |
| 18 | A03BB | alkaloidy beladony s kvarterní aminovou skupinou | p.o. | |
|---|
| 18.1 | A03BB01 | butylskopolamin | p.o. | 60 | MG | 14,61 | |
| 01317 | BUSCOPAN | drg 20x10 mg | BOE | D |
| 10154 | BUSCOLYSIN | drg 20x10 mg | PMM | BG |
| 19 | A03BB | alkaloidy beladony s kvarterní aminovou skupinou | p.rect. | |
|---|
| 19.1 | A03BB01 | butylskopolamin | p.rect. | 60 | MG | 14,66 | |
| 20 | A03BB | alkaloidy beladony s kvarterní aminovou skupinou | parent. | |
|---|
| 20.1 | A03BB01 | butylskopolamin | parent. | 60 | MG | 38,71 | |
| 98169 | BUSCOPAN | inj 5x1ml/20mg | BOE | D |
| 21 | A03DA | syntetická anticholinergika v kombinaci s analgetiky | p.o. | |
|---|
| 21.1 | A03DA | syntetická anticholinergika v komb. s analgetiky | p.o. | 2 | DF | 3,96 | |
|
| 21.2 | A03DA02 | pitofenon kombinace s analgetiky (pevné lékové formy) | p.o. | 2 | DF | 3,96 | |
| 21.3 | A03DA02 | pitofenon kombinace s analgetiky (tekuté lékové formy) | p.o. | 2 | ML | 5,28 | |
| 91981 | ALGIFEN | gtt 1x10ml 500mg/ml | GNO | CZ |
| 22 | A03DA | syntetická anticholinergika v kombinaci s analgetiky | p.rect. | |
|---|
| 22.1 | A03DA02 | pitofenon kombinace s analgetiky | p.rect. | 2 | DF | 12,90 | |
| 23 | A03DA | syntetická anticholinergika v kombinaci s analgetiky | parent. | |
|---|
| 23.1 | A03DA02 | pitofenon kombinace s analgetiky | parent. | 2 | DF | 51,42 | |
| 88709 | ALGIFEN | inj 5x5ml | HBS | SK |
| 24 | A03EA | spasmolytika, psycholeptika, analgetika v kombinaci | p.rect. | |
|---|
| 24.1 | A03EA | antispasmodika, psycholeptika, analgetika v komb. | p.rect. | 2 | DF | 12,17 | |
| 25 | A03FA | prokinetika (cisaprid) | p.o. | L/GIT,INT,PDD,PSY |
|---|
| 25.1 | A03FA02 | cisaprid (pevné lékové formy, do 5 mg v 1 tabletě včetně) | p.o. | 30 | MG | 41,35 | L/GIT,INT, PDD,PSY |
| 94898 | PREPULSID | tbl 30x5mg | JAN | B |
| 25.2 | A03FA02 | cisaprid (pevné lékové formy, nad 5 mg do 10 mg včetně v 1 tabletě) | p.o. | 30 | MG | 39,98 | L/GIT,INT, PDD, PSY |
| 94899 | PREPULSID 10MG | tbl 50x10 mg | JAN | B |
| 25.3 | A03FA02 | cisaprid (pevné lékové formy, nad 10 mg v 1 tabletě) | p.o. | 30 | MG | 35,14 | L/GIT,INT, PDD, PSY |
|
| 25.4 | A03FA02 | cisaprid (tekuté lékové formy) | p.o. | 30 | MG | 45,16 | L/GIT,INT, PDD, PSY |
| 93392 | PREPULSID | sus 1x200ml | JAN | B |
| 26 | A03FA | prokinetika (ostatní) | p.o. | |
|---|
| 26.1 | A03FA01 | metoclopramid | p.o. | 30 | MG | 4,15 | |
| 93104 | DEGAN | tbl 40x10mg | LEK | SLO |
| 26.2 | A03FA03 | domperidon | p.o. | 30 | MG | 4,15 | |
|
| 26.3 | A03FA05 | alizaprid | p.o. | 0.15 | GM | 4,15 | |
| 27 | A03FA | prokinetika | p.rect. | |
|---|
| 27.1 | A03FA01 | metoclopramid | p.rect. | 30 | MG | 41,50 | |
| 09519 | PASPERTIN PRO INFANTIBUS | sup 5x10mg | KCH | D |
| 27.2 | A03FA02 | cisaprid | p.rect. | 30 | MG | 50,05 | |
| 93391 | PREPULSID | sup 6x30 mg | JAN | B |
| 27.3 | A03FA03 | domperidon | p.rect. | 0.12 | GM | 41,50 | |
| 28 | A03FA | prokinetika | parent. | O |
|---|
| 28.1 | A03FA01 | metoclopramid | parent. | 30 | MG | 20,04 | O |
| 93105 | DEGAN | inj 50x2ml/10mg | LEK | SLO |
| 28.2 | A03FA05 | alizaprid | parent. | 0.15 | GM | 16,47 | O |
| 29 | A04AA | antiemetika ze skupiny serotoninových antagonistů | p.o. | X |
|---|
| 29.1 | A04AA01 | ondansetron (pevné lékové formy do 4 mg v jedné tabletě včetně) | p.o. | 16 | MG | 938,97 | X |
| 98170 | ZOFRAN | tbl 10x4mg | GLA | D |
| 29.2 | A04AA01 | ondansetron (pevné lékové formy nad 4 mg v jedné tabletě) | p.o. | 16 | MG | 762,51 | X |
| 98177 | ZOFRAN | tbl 10x8mg | GLA | D |
| 29.3 | A04AA01 | ondansetron (tekuté lékové formy) | p.o. | 16 | MG | 938,97 | X |
|
| 29.4 | A04AA01 | ondansetron (léková forma čípků) | per rect. | 16 | MG | 824,10 | X |
|
| 29.5 | A04AA02 | granisetron | p.o. | 2 | MG | 762,51 | X |
|
| 29.6 | A04AA03 | tropisetron | p.o. | 5 | MG | 723,41 | X |
| 62529 | NAVOBAN | cps 5x5mg | SAN | CH |
| 30 | A04AA | antiemetika ze skupiny serotoninových antagonistů | parent. | X |
|---|
| 30.1 | A04AA01 | ondansetron (do 4 mg v jedné ampuli včetně) | parent. | 16 | MG | 1548,49 | X |
| 80479 | ZOFRAN | inj 5x2ml/2mg/ml | GLA | I |
| 30.2 | A04AA01 | ondansetron (nad 4 mg v jedné ampuli) | parent. | 16 | MG | 1266,94 | X |
| 80480 | ZOFRAN | inj 5x4ml/2mg/ml | GLA | I |
| 30.3 | A04AA02 | granisetron | parent. | 3 | MG | 830,99 | X |
|
| 30.4 | A04AA03 | tropisetron (nad 2,5 mg v jedné ampuli) | parent. | 5 | MG | 830,99 | X |
| 66849 | NAVOBAN | inj 10x5ml | SAN | CH |
| 96863 | NAVOBAN | inj 1x5ml | SAN | CH |
| 30.5 | A04AA03 | tropisetron (do 2,5 mg včetně v jedné ampuli) | parent. | 5 | MG | 1340,02 | X |
| 31 | A04AD | různá antiemetika | p.o. | |
|---|
| 31.1 | A04AD | různá antiemetika (theoklát embraminu) | p.o. | 50 | MG | 2,79 | |
| 88321 | MEDRIN | tbl 20x25mg | LEX | CZ |
| 31.2 | A04AD | různá antiemetika (theoklát moxastinu) | p.o. | 0.1 | GM | 3,32 | |
| 00320 | THEADRYL | tbl 10x100mg | LEX | CZ |
| 32 | A04AD | různá antiemetika | p.rect. | |
|---|
| 32.1 | A04AD | různá antiemetika (theoklát moxastinu) | p.rect. | 0.1 | GM | 9,38 | |
| 00951 | THEADRYL | sup 10x50mg | LEX | CZ |
| 33 | A05AA | hepatika ze skupiny žlučových kyselin | p.o. | L/GIT,INF |
|---|
| 33.1 | A05AA01 | kyselina chenodeoxycholová | p.o. | 1 | GM | 21,46 | L/GIT,INF |
| 85721 | CHENOFALK | cps 100x250mg | FAK | D |
| 33.2 | A05AA02 | kyselina ursodeoxycholová | p.o. | 0.75 | GM | 27,08 | L/GIT,INF |
| 91017 | URSOFALK | cps 100x250mg | FAK | D |
| 34 | A05AX | ostatní hepatika | p.o. | |
|---|
| 34.1 | A05AX | jiná léčiva onemocnění žlučníku (fenipentol) | p.o. | 3 | DF | 1,61 | |
| 00146 | FEBICHOL | cps 50x100mg | SLO | SK |
| 34.2 | A05AX02 | hymekromon | p.o. | 1.20 | GM | 5,96 | |
| 93157 | ISOCHOL (DRAZOVKA) | drg 30x400mg | LEX | CZ |
| 97881 | ISOCHOL (BLISTR 3X10) | drg 30x400mg | LEX | CZ |
| 35 | A05BA | léčiva onemocnění jater | p.o. | |
|---|
| 35.1 | A05BA | léčiva onemocnění jater (fosfolipidy) | p.o. | 4 | DF | 11,73 | |
|
| 35.2 | A05BA | léčiva onemocnění jater (silymarin v kombinaci) | p.o. | 0.21 | GM | 5,87 | |
|
| 35.3 | A05BA03 | silymarin (do 70 mg včetně v jedné tabletě) | p.o. | 0.21 | GM | 5,87 | |
| 44143 | SILYGAL | tbl obd 30 | GNO | CZ |
| 04368 | FLAVOBION | tbl obd 50x70 mg | LEX | CZ |
| 35.4 | A05BA03 | silymarin (nad 70 mg v jedné tabletě) | p.o. | 0.21 | GM | 4,40 | |
| 36 | A05BA | léčiva onemocnění jater | parent. | H |
|---|
| 36.1 | A05BA | léčiva onemocnění jater (fosfolipidy) | parent. | 1 | DF | 44,58 | H |
| 92325 | ESSENTIALE N | inj. 5x5ml | NAT | D |
| 36.2 | A05BA03 | silymarin | parent. | 0.35 | GM | 2446,10 | H |
| 37 | A06A | osmoticky působící nevstřebatelné cukry | p.o., p.rect. | L/GIT,INT,GER |
|---|
| 37.1 | A06AD10 | kombinace minerálních solí (k přípravě Golytelyho roztoku) | p.o. | 4 | DF | 269,71 | L/GIT,INT, GER, CHI |
| 69482 | FORTRANS | plv 1x4 (sacky) | BEF | F |
| 37.2 | A06AD11 | laktulóza | p.o. | 6,7 | GM | 5,28 | L/GIT,INT, GER,PDD ,CHI |
| 02816 | LACTULOSA INFUSIA | sir 1x500 ml 50% | IHO | CZ |
| 86612 | LACTULOSA INFUSIA | sir 1x250 ml 50% | IHO | CZ |
| 37.3 | A06AD12 | laktitol | p.o. | 10 | GM | 3,71 | L/GIT,INT, GER, CHI |
|
| 37.4 | A06AG10 | sorbitol v kombinaci s kont. laxativem | p.rect. | 2 | DF | 174,01 | |
| 38 | A07AA | střevní antimykotická léčiva | p.o. | |
|---|
| 38.1 | A07AA01 | neomycin | p.o. | 5 | GM | 609,91 | H |
|
| 38.2 | A07AA02 | nystatin | p.o. | 1.5 | MU | 5,96 | |
|
| 38.3 | A07AA03 | natamycin | p.o. | 0.3 | GM | 41,60 | |
| 02046 | PIMAFUCIN | tbl obd 20x100 mg | YEU | NL |
| 39 | A07EA | kortikosteroidy pro rektální aplikaci nebo působící v tlustém střevu | p.rect., p.o. | |
|---|
| 39.1 | A07EA06 | budesonid | p.rect. | 2 | MG | 271,96 | L/GIT,INT |
Treatment with oral budesonide is performed by a gastro-enterologist or an intern in an acute attack or chronic phase of Crohn 's disease, in particular where the need for steroid treatment occurs and the need to minimise their systemic effects.
| 39.2 | A07EA06 | budesonid | p.o. | 9 | MG | 136,86 | P |
| 12701 | ENTOCORT 3MG | cps 50x250mg | APN | S |
| 12702 | ENTOCORT 3MG | cps 100x2mg | APN | S |
| 39.3 | A07EB01 | kyselina kromoglyková | p.o. | 80 | MG | 7,63 | P |
Diagnosis demonstrates and treatment is indicated by an allergologist and a clinical immunologist based on an allergologic examination of skin possibly exposure tests or a specific IgE antibody: with proven food allergy with severe local or overall symptoms that cannot be fully corrected by elimination of food allergens.
| 93797 | NALCROM | cps 100x100mg | FIS | GB |
| 40 | A07EC | aminosalicylová kyselina a její deriváty | p.o. | L/GIT,INT |
|---|
| 40.1 | A07EC01 | sulfasalazin | p.o. | 2 | GM | 17,21 | L/GIT,INT, REV |
| 72968 | SALAZOPYRIN EN | tbl 100x500 mg | KBP | S |
| 04304 | SULFASALAZIN EN | tbl 100x500 mg | KRK | SLO |
| 02159 | SULFASALAZIN | tbl 50x500 mg | KRk | SLO |
| 40.2 | A07EC02 | mesalazin (potahované tablety) | p.o. | 1.5 | GM | 26,30 | L/GIT,INT |
| 93235 | SALOFALK | tbl ent 100x250 mg | FAK | D |
| 40.3 | A07EC02 | mesalazin (tablety s řízeným uvolňováním) | p.o. | 1.5 | GM | 46,44 | L/GIT |
| 85929 | PENTASA SR 500 MG (LAHVIČKA) | tbl ret 100x500 mg | FEI | DK |
| 86616 | PENTASA SR 500 MG (BLISTR) | tbl ret 100x500 mg | FEI | DK |
| 41 | A07EC | aminosalicylová kyselina a její deriváty | p.rect. | L/GIT,INT |
|---|
| 41.1 | A07EC02 | mesalazin (enm.) | p.rect. | 1.5 | GM | 86,66 | L/GIT |
| 93770 | SALOFALK KLYSMEN | enm 7x60gm | FAK | D |
| 76700 | ASACOL 4GM | enm 1x100ml/4gm | TLT | CH |
| 41.2 | A07EC02 | mesalazin (čípky do 250 mg včetně) | p.rect. | 1.5 | GM | 142,78 | L/GIT |
| 93239 | SALOFALK 250 | sup 30x250mg | FAK | D |
| 93238 | SALOFALK 250 | sup 10x250mg | FAK | D |
| 41.3 | A07EC02 | mesalazin (čípky nad 250 mg) | p.rect. | 1.5 | GM | 123,37 | L/GIT |
| 42 | A07FA | protiprůjmové mikroorganismy | p.o. | L/PDD,GIT,GER |
|---|
| 42.1 | A07FA | protiprůjmové mikroorganismy | p.o. | 2 | ML | 3,76 | L/PDD,GIT, GER |
| 09158 | HYLAK FORTE | gtt 1x30ml | MCK | D |
| 09159 | HYLAK FORTE | gtt 1x100ml | MCK | D |
| 42.2 | A07FA01 | organismy produkující kyselinu mléčnou | p.o. | 4 | DF | 3,86 | L/PDD,GIT, GER |
|
| 42.3 | A07FA | protiprůjmové mikroorganismy (Escherichia coli) | p.o. | 1 | DF | 43,99 | L/PDD |
| 42.4 | A07BC | diosmectin (plv. susp.) | p.o. | 1 | DF | 3,86 | L/PDD |
| 43 | A09AA | enzymové přípravky | p.o. | |
|---|
Treatment with Wobenzyme is indicated by an oncologist, surgeon or lymphologist in lymphoedema following radical surgery for malignancy.
| 43.1 | A09AA | enzymové přípravky (s pankreatinem, dle lipázy | p.o. | 5000 | FI | 1,03 | |
| 04139 | PANZYNORM FORTE | drg 30 | KRK | SLO |
| 43.2 | A09AA | multienzymy (Wobenzym) | p.o. | 6 | DF | 8,80 | P |
|
| 43.3 | A09AA02 | multienzymy (dle lipázy, do 10.000 FI v 1 tabletě včetně) | p.o. | 5000 | FI | 1,47 | |
| 02420 | PANCREOLAN FORTE | tbl ent 30x220mg | LEX | CZ |
| 43.4 | A09AA02 | multienzymy (dle lipázy, nad 10.000 do 20.000 FI včetně v jedné tabletě) | p.o. | 5000 | FI | 1,81 | |
| 21362 | PANGROL 400 | tbl obd 48 | BCE | D |
| 43.5 | A09AA02 | multienzymy (dle lipázy, nad 20.000 FI v jedné tabletě) | p.o. | 5000 | FI | 1,61 | |
| 44 | A09AC | pepsin a kyselinotvorné látky | p.o. | |
|---|
| 44.1 | A09AC01 | pepsin a kyselinotvorné látky | p.o. | 2 | DF | 2,79 | |
| 45 | A10A | insuliny (rozpustné humánní) | parent. | L/DIA |
|---|
| 45.1 | A10AB01 | insulin lidský rychle účinkující 100 U/ml, cartridge | parent. | 40 | U | 26,20 | L/DIA |
|
| 45.2 | A10AB01 | insulin lidský rychle účinkující, lahv. | parent. | 40 | U | 19,84 | L/DIA |
| 40875 | INSULIN HM NPH | inj 1x10ml/1 ku | LEX | CZ |
| 40876 | INSULIN - HM R | inj 1x10ml/1 ku | LEX | CZ |
| 40878 | INSULIN-HM MIX 30 | inj 1x10ml/1 ku | LEX | CZ |
| 44576 | HUMULIN R 100 | inj 1x10ml/1ku | LIL | F |
| 54038 | ACTRAPID HM | inj 1x10ml/1ku | NOO | DK |
| 88345 | ACTRAPID HM | inj 1x10ml/400ut | NOO | DK |
| 97520 | HUMULIN R | inj 1x10ml/400ut | LIL | F |
| 45.3 | A10AB01 | insulin lidský rychle účinkující pro aplikaci do insulínových pump | parent. | 40 | U | 27,96 | L/DIA |
| 76316 | VELOSULIN HM | inj 1x10ml/1 ku | NOO | DK |
| 45.4 | A10AB04 | insulin lispro rychle účinkující, lahv. | parent. | 40 | U | 30,74 | L/DIA |
|
| 45.5 | A10AB04 | insulin lispro rychle účinkující 100 U/ml, cartridge | parent. | 40 | U | 33,14 | L/DIA |
| 46 | A10A | insuliny (rozpustné monokomponentní) | parent. | |
|---|
| 46.1 | A10AB03 | insulin vepřový rychle účinkující | parent. | 40 | U | 16,52 | |
| 83725 | INSULIN-MONO N | inj 1x10ml/400ut | LEX | CZ |
| 47 | A10A | insuliny (suspenzní humánní) | parent. | L/DIA |
|---|
| 47.1 | A10AC01 | insulin lidský středně dlouze účinkující 100U/ml, cartridge | parent. | 40 | U | 26,20 | L/DIA |
| 47.2 | A10AC01 | insulin lidský středně dlouze účinkující, lahv. | parent. | 40 | U | 19,84 | L/DIA |
| 42468 | HUMULIN L | inj 1x10ml 40ut/ml | LIL | F |
| 44567 | HUMULIN N 100 M.J./ML | inj 1x10ml/1ku | LIL | F |
| 97521 | HUMULIN N | inj 1x10ml/400ut | LIL | F |
| 53893 | INSULATARD HM | inj 1x10ml/1ku | NOO | DK |
| 62967 | INSULATARD HM | inj 1x10ml/400ut | NOO | DK |
| 88346 | MONOTARD HM | inj 1x10ml/400ut | NOO | DK |
| 47.3 | A10AD01 | insulin lidský kombinace středně a rychle účinného 100U/ml, cartridge | parent. | 40 | U | 26,20 | L/DIA |
|
| 47.4 | A10AD01 | insulin lidský kombinace středně a rychle účinného, lahv. | parent. | 40 | U | 19,84 | L/DIA |
| 44570 | HUMULIN M3(30/70) | inj 1x10ml/1ku | LIL | F |
| 78283 | HUMULIN M2(20/80) | inj 1x10ml | LIL | F |
| 78284 | HUMULIN M3(30/70) | inj 1x10ml | LIL | F |
| 54036 | MIXTARD 30 HM | inj 1x10ml/1ku | NOO | DK |
| 47.5 | A10AE01 | insulin lidský dlouhodobě účinkující | parent. | 40 | U | 19,84 | L/DIA |
| 78281 | HUMULIN U | inj 1x10ml 40ut/ml | LIL | F |
| 90980 | ULTRATARD HM | inj 1x10ml/400ut | NOO | DK |
| 48 | A10A | insuliny (suspenzní monokomponentní) | parent. | |
|---|
| 48.1 | A10AC03 | insulin vepřový středně dlouze účinkující | parent. | 40 | U | 12,66 | |
| 83726 | INSULIN-MONO D | inj 1x10ml/400ut | LEX | CZ |
| 48.2 | A10AC30 | insulin kombinace zvířecí středně dlouze účinkující | parent. | 40 | U | 12,66 | |
| 83727 | INSULIN-MONO ID | inj 1x10ml/400ut | LEX | CZ |
| 48.3 | A10AE30 | insulin kombinace zvířecí dlouhodobě účinkující | parent. | 40 | U | 12,66 | |
| 83728 | INSULIN-MONO SD | inj 1x10ml/400ut | LEX | CZ |
| 49 | A10BA | léčiva snižující hladinu cukru ze skupiny derivátů biguanidu a inhibitorů alfa-glukosidáz | p.o. | |
|---|
| 49.1 | A10BA02 | metformin | p.o. | 2 | GM | 7,33 | |
|
| 49.2 | A10BA03 | buformin | p.o. | 0.2 | GM | 3,47 | |
| 02558 | SILUBIN RETARD | drg 60x100 mg | GRU | D |
| 08498 | ADEBIT | tbl 40x50 mg | CHN | H |
| 49.3 | A10BF01 | akarboza | p.o. | 0.3 | GM | 10,26 | |
| 50 | A10BB | léčiva snižující hladinu cukru ze skupiny derivátů sulfonylmočoviny | p.o. | |
|---|
| 50.1 | A10BB01 | glibenklamid (do 1 mg v jedné tabletě včetně) | p.o. | 10 | MG | 2,30 | |
|
| 50.2 | A10BB01 | glibenklamid (nad 1 mg v jedné tabletě) | p.o. | 10 | MG | 0,93 | |
| 91783 | BETANASE | tbl 10x10x5mg | CAD | IND |
| 94556 | GILEMAL | tbl 120x5mg | CHN | H |
| 91880 | MANINIL 5 | tbl 120x5mg | BCE | D |
| 50.3 | A10BB01 | glibenklamid (mikronizované formy, do 1,75 mg včetně v jedné tabletě) | p.o. | 7 | MG | 1,37 | |
| 94523 | GLUCOBENE | tbl 120x1.75mg | MCK | D |
| 50.4 | A10BB01 | glibenklamid (mikronizované formy, nad 1,75 mg v jedné tabletě) | p.o. | 7 | MG | 0,93 | |
| 94525 | GLUCOBENE | tbl 120x3.5mg | MCK | D |
| 50.5 | A10BB02 | chlorpropamid | p.o. | 0.37 | GM | 0,78 | |
|
| 50.6 | A10BB03 | tolbutamid | p.o. | 1.5 | GM | 2,40 | |
| 00120 | DIRASTAN | tbl 5x10x500 mg | SLO | SK |
| 50.7 | A10BB04 | glibornurid | p.o. | 38 | MG | 4,79 | |
|
| 50.8 | A10BB05 | tolazamid | p.o. | 1 | GM | 2,49 | |
|
| 50.9 | A10BB07 | glipizid | p.o. | 10 | MG | 4,55 | |
| 87110 | ANTIDIAB | tbl obd 30x5 mg | KRK | SLO |
| 88628 | MINIDIAB | tbl 30x5 mg | PHA | I |
| 50.10 | A10BB08 | gliquidon | p.o. | 60 | MG | 5,82 | |
| 99336 | GLURENORM | tbl 30x30 mg | SLO | SK |
| 50.11 | A10BB09 | gliklazid | p.o. | 0.16 | GM | 7,87 | |
| 04345 | DIAPREL (DIAMICRON) | tbl 60x80 mg | SVE | F |
| 50.12 | A10BB12 | glymepirid | p.o. | 2 | MG | 8,31 | |
| 55734 | AMARYL 3.0 | tbl 30x3 mg | HOE | D |
| 55735 | AMARYL 4.0 | tbl 30x4 mg | HOE | D |
| 51 | A11CA | vitamin A a jeho deriváty | p.o. | |
|---|
| 51.1 | A11CA01 | retinol (vitamin A) | p.o. | 50 | kU | 1,17 | |
| 00347 | VITAMIN A SLOVAKOFARMA | cps 50x30ku | SLO | SK |
| 52 | A11CA | vitamin A a jeho deriváty | parent. | |
|---|
| 52.1 | A11CA01 | retinol (vitamin A) | parent. | 50 | KU | 10,75 | |
| 00396 | AXEROPHTHOL BIOTIKA | inj 5x1ml/50ku | BTA | SK |
| 53 | A11CC | vitamin D a jeho deriváty (kalcitriol) | p.o. | P |
|---|
Treatment is performed by an internist, endocrinologist, urologist, pediatrician and physician on the dialysis unit:
(a) treatment of renal osteodystrophy in patients with chronic renal insufficiency (particularly in patients on dialysis),
(b) vitamin D resistant curve treatment,
(c) treatment of vitamin D resistant osteomalacia,
(d) treatment with vitamin D and calcium-resistant hypoparathyroidism.
| 53.1 | A11CC04 | kalcitriol | p.o. | 1 | RG | 48,59 | P |
| 91548 | ROCALTROL | cps 30x0.25rg | HLR | CH |
| 54 | A11CC | vitamin D a jeho deriváty (ostatní) | p.o. | |
|---|
| 54.1 | A11CC01 | ergokalciferol (tekuté lékové formy, do 200 U/ml včetně) | p.o. | 6 | kU | 13,10 | |
| 00679 | INFADIN RYBI TUK | sol 100ml 0.1mg/1ml | SLO | SK |
| 54.2 | A11CC01 | ergokalciferol (tekuté lékové formy, nad 200 U/ml) | p.o. | 6 | kU | 0,78 | |
| 00716 | INFADIN | gtt 1x10ml 10mg/1ml | SLO | SK |
| 54.3 | A11CC01 | ergocalciferol (pevné lékové formy) | p.o. | 6 | kU | 0,54 | |
|
| 54.4 | A11CC02 | dihydrotachysterol | p.o. | 1 | MG | 18,04 | |
|
| 54.5 | A11CC03 | alfakalcidol | p.o. | 1 | RG | 32,26 | P |
Treatment with alfakalcidol is performed by an internist, an endocrinologist, a urologist, a pediatrician and a physician in the dialysis unit:
(a) treatment of renal osteodystrophy in patients with chronic renal insufficiency (particularly in patients on dialysis),
(b) vitamin D resistant curve treatment,
(c) treatment of vitamin D resistant osteomalacia,
(d) treatment with vitamin D and calcium-resistant hypoparathyroidism.
| 54.6 | A11CC05 | cholekalciferol | p.o. | 0.5 | MG | 3,91 | |
| 55 | A11CC | vitamin D a jeho deriváty (kalcitriol) | parent. | P |
|---|
Treatment is performed by an internist, endocrinologist, urologist, pediatrician or a physician working on a dialysis unit: treatment of severe forms of renal osteopathy not responding to oral treatment with calcitriol.
| 55.1 | A11CC04 | kalcitriol | parent. | 1 | RG | 174,20 | P |
| 76423 | CALCIJEX | inj 25x1ml/2rg | ABB | USA |
| 94426 | CALCIJEX | inj 25x1ml/1rg | ABB | USA |
| 56 | A11CC | vitamin D a jeho deriváty (ostatní) | parent. | |
|---|
| 56.1 | A11CC01 | ergokalciferol | parent. | 6 | kU | 0,78 | |
| 00405 | CALCIFEROL BIOTIKA FORTE | inj 1x1ml/7.5mg | BTA | SK |
| 56677 | CALCIFEROL BIOTIKA FORTE | inj 5x1ml/7.5mg | BTA | SK |
| 56.2 | A11CC05 | cholekalciferol | parent. | 1 | kU | 0,93 | |
| 57 | A11DA | vitamin B1 a jeho deriváty | parent. | H |
|---|
|
| 57.1 | A11DA | thiamin (vit. B1), prostý | parent. | 75 | MG | 5,38 | H |
|
| 57.2 | A11DA01 | thiamin (vit. B1) | parent. | 50 | MG | 5,38 | H |
| 00616 | THIAMIN LECIVA | inj 10x2 ml/100 mg | LEX | CZ |
| 58.1 | A11GA01 | kyselina askorbová (vitamín C) | parent. | 0.2 | GM | 3,91 | H |
| 92729 | ACIDUM ASCORBICUM BIOTIKA | inj 5x5 ml/500 mg | HBS | SK |
| 92730 | ACIDUM ASCORBICUM BIOTIKA | inj 50x5 ml/500 mg | HBS | SK |
| 59 | A11HA | vitamin B2, B6 a E | parent. | H |
|---|
|
| 59.1 | A11HA02 | pyridoxin (vitamín B6) | parent. | 0.16 | GM | 15,84 | H |
| 00584 | PYRIDOXIN LECIVA | inj 5x1 ml/50mg | LEX | CZ |
| 59.2 | A11HA03 | tokoferol (vitamín E, do 30 mg/ml včetně) | parent. | 0.2 | GM | 69,90 | H |
|
| 59.3 | A11HA03 | tokoferol (vitamín E, nad 30 mg/ml) | parent. | 0.2 | GM | 7,58 | H |
|
| 59.4 | A11HA04 | riboflavin (vitamín B2) | parent. | 20 | MG | 6,11 | H |
| 60 | A11JA | kombinace vitamínů | parent. | H |
|---|
| 60.1 | A11JA | kombinace vitamínů | parent. | 10 | ML | 121,42 | H |
| 94847 | VITALIPID N INFANT | inf 10x10 ml | KBP | S |
| 60.2 | A11DB | kombinace vitamínů (vitamin B1, B6, B12) | parent. | 10 | ML | 121,42 | H |
| 61 | A12A | soli vápníku včetně kombinací vápníku a fluoru | p.o. | |
|---|
| 61.1 | A12AA | vápník (na obsah vápníku) | p.o. | 0.5 | GM | 1,66 | |
|
| 61.2 | A12AA03 | glukonát vápenatý (na obsah vápníku) | p.o. | 0.5 | GM | 0,59 | |
| 00064 | CALCIUM SLOVAKOFARMA | tbl 50x500 mg | SLO | SK |
| 61.3 | A12AA04 | uhličitan vápenatý (na obsah vápníku) | p.o. | 0.5 | GM | 2,54 | |
| 88663 | TBL.CALCII CARBONICI 0.5 GLO | tbl 100 | GAO | CZ |
| 61.4 | A12AA07 | chlorid vápenatý (tekuté lékové formy, na obsah vápníku) | p.o. | 0.2 | GM | 0,64 | |
|
| 61.5 | A12AA20 | vápník (kombinace různých solí, na obsah vápníku) | p.o. | 0.5 | GM | 2,54 | |
|
| 61.6 | A12AX | vápník v kombinaci s fluorem (fluorofosfat sodný) | p.o. | 1 | DF | 5,38 | L/INT,GYN,ORT, REV |
|
| 61.7 | A12AX | vápník v kombinaci s fluorem (levoglutamid fluorofosfat) | p.o. | 1 | DF | 4,01 | L/INT,GYN,ORT, REV |
| 62 | A12AA | soli vápníku | parent. | |
|---|
|
| 62.1 | A12AA03 | glukonát vápenatý (na obsah vápníku) | parent. | 3 | GM | 59,93 | |
| 00407 | CALCIUM BIOTIKA | inj 10x10ml/1gm | HBS | SK |
| 62.2 | A12AA07 | chlorid vápenatý (na obsah vápníku) | parent. | 0.2 | GM | 2,98 | |
| 00409 | CALCIUM CHLORATUM BIOTIKA | inj 5x10 ml 10% | HBS | SK |
| 63.1 | A12BA | draslík v kombinaci s hořčíkem (na obsah draslíku) | p.o. | 1 | GM | 9,78 | |
|
| 63.2 | A12BA | draslík (na obsah draslíku) | p.o. | 1.5 | GM | 2,44 | |
|
| 63.3 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | p.o. | 3 | GM | 2,49 | |
| 91600 | KALNORMIN | tbl 30x1gm | IDA | H |
| 55661 | KALIUM CHLORATUM INFUSIA - BLISTR | tbl obd 100x500 mg | IHO | CZ |
| 64 | A12BA | soli draslíku | parent. | O |
|---|
|
| 64.1 | A12BA | draslík v kombinaci s hořčíkem | parent. | 1 | DF | 13,20 | O |
| 02132 | CARDILAN | inj 10x10 ml | HBS | SK |
| 02031 | TROMCARDIN | inj 5x10 ml | TRM | D |
| 64.2 | A12BA01 | chlorid draselný (na obsah chloridu draselného) | parent. | 3 | GM | 50,54 | O |
| 02486 | KALIUM CHLORATUM LECIVA 7.5% | inj 5x10ml 7.5% | LEX | CZ |
| 65 | A12CC | soli hořčíku | p.o. | L/INT,NEU,PSY |
|---|
| 65.1 | A12CC | hořčík (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU,PSY, GYN |
| 99891 | MAGNESIUM 250MG PHARMAVIT | tbl eff 20 | PVI | H |
| 65.2 | A12CC03 | glukonat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU,PSY, GYN |
|
| 65.3 | A12CC04 | citronan hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU,PSY, GYN |
|
| 65.4 | A12CC05 | aspartat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU,PSY, GYN |
|
| 65.5 | A12CC06 | mléčnan hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU,PSY, GYN |
|
| 65.6 | A12CC09 | orotat hořečnatý (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU,PSY, GYN |
|
| 65.7 | A12CC30 | kombinace hořečnatých solí (na obsah hořčíku) | p.o. | 1 | GM | 11,63 | L/INT,NEU,PSY, GYN |
| 66 | A12CC | soli hořčíku | parent. | O |
|---|
| 66.1 | A12CC02 | síran hořečnatý (koncentrace do 10 % včetně) | parent. | 1 | GM | 20,38 | O |
| 00498 | MAGNESIUM SULFURICUM BIOTIKA | inj 5x10ml 10% | HBS | SK |
| 66.2 | A12CC02 | síran hořečnatý (koncentrace nad 10%) | parent. | 1 | GM | 10,31 | O |
| 00499 | MAGNESIUM SULFURICUM BIOTIKA | inj 5x10ml 20% | HBS | SK |
| 67.1 | A12CD01 | fluorid sodný | p.o. | 88 | MG | 4,06 | |
| 09495 | OSSIN RETARDDRAGEES | tbl obd 100x40mg | GRU | D |
| 68 | A14A | anabolické steroidy | parent. | |
|---|
|
| 68.1 | A14AB01 | nandrolon | parent. | 2 | MG | 2,98 | |
| 00609 | SUPERANABOLON | inj 5x1ml/25mg | SPX | CZ |
| 69 | A16A | ostatní léčiva alimentárního traktu | parent. | O |
|---|
| 69.1 | A16AA01 | levokarnitin | parent. | 2 | GM | 356,82 | O |
|
| 69.2 | A16AX01 | tioktová kyselina | parent. | 0.2 | GM | 102,25 | O |
| 86092 | THIOCTACID 600 T | inj 5x24ml/600mg | ASD | D |
| 69.3 | A16AA02 | ademetionin | parent. | 0,5 | GM | 110,08 | Z |
| 12319 | TRANSMETIL 500 MG | inj 5x500mg+5ml | KNO | I |
| 69.4 | A16AA02 | ademetionin | p.o. | 1 | GM | 59,83 | Z |
|
| 69.5 | A16AB02 | imiglucerasa | parent. | 1 | DF | 97,76 | Z |
| 70 | B01AA | antithrombotika ze skupiny antagonistů vitaminu K | p.o. | |
|---|
| 70.1 | B01AA03 | warfarin | p.o. | 7.5 | MG | 3,67 | |
| 94114 | WARFARIN | tbl 100x5 mg | ORN | SF |
| 94113 | WARFARIN | tbl 100x3 mg | ORN | SF |
| 70.2 | B01AA08 | ethylbiskumacetát (do 75 mg v jedné tabletě včetně) | p.o. | 0.6 | GM | 4,59 | |
| | |
| 70.3 | B01AA08 | ethylbiskumacetát (nad 75 mg v jedné tabletě) | p.o. | 0.6 | GM | 5,47 | |
| 71 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (antithrombin III) | parent. | U |
|---|
| 71.1 | B01AB02 | antithrombin (z tuzemské plazmy zakázkovou frakcionací) | parent. | 2.1 | KU | 29367,29 | U |
| 66533 | KYBERNIN P | inj 1x500ut+10ml aq | BEH | A |
| 66532 | KYBERNIN P | inj 1x1ku+20ml aqua | BEH | A |
| 71.2 | B01AB02 | antithrombin | parent. | 2.1 | KU | 29367,29 | U |
| 72 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (heparin) | parent. | O |
|---|
| 72.1 | B01AB01 | heparin | parent. | 10 | KU | 15,35 | O |
| 74999 | HEPARIN BIOCHEMIE 25000UT | inj 100x5ml/25ku | BCA | A |
| 93746 | HEPARIN LECIVA | inj 1x10ml/50ku | LEX | CZ |
| 00477 | HEPARIN RETARD LECIVA | inj 5x1ml/25ku | LEX | CZ |
| 73 | B01AB | antithrombotika ze skupiny heparinu a jeho derivátů (ostatní) | p.o.,parent. | O |
|---|
| 73.1 | B01AB04 | dalteparin do 2,5 KU | včetně v jedné ampuli | parent. | 3 | KU | 101,23 | O |
| 94857 | FRAGMIN | inj 10x0.2ml/2.5ku | PHA | S |
| 73.2 | B01AB04 | dalteparin nad 2,5 KU do 5 KU včetně v jedné ampuli | parent. | 3 | KU | 88,08 | O |
| 94858 | FRAGMIN | inj 10x0.2ml/5ku | PHA | S |
| 73.3 | B01AB04 | dalteparin nad 5 KU v jedné ampuli | parent. | 3 | KU | 64,67 | O |
| 94855 | FRAGMIN | inj 10x1ml/10ku | PHA | S |
| 94856 | FRAGMIN | inj 10x4ml/10ku | PHA | S |
| 73.4 | B01AB05 | enoxaparin do 20 mg včetně v jedné ampuli | parent. | 3 | KU | 101,23 | O |
|
| 73.5 | B01AB05 | enoxaparin nad 20 mg do 40 mg včetně v jedné ampuli | parent. | 3 | KU | 88,08 | O |
|
| 73.6 | B01AB05 | enoxaparin nad 40 mg do 80 mg včetně v jedné ampuli | parent. | 3 | KU | 81,87 | O |
|
| 73.7 | B01AB05 | enoxaparin nad 80 mg v jedné ampuli | parent. | 3 | KU | 64,67 | O |
|
| 73.8 | B01AB06 | nadroparin do 2,85 KU včetně v jedné ampuli | parent. | 3 | KU | 101,23 | O |
|
| 73.9 | B01AB06 | nadroparin nad 2,85 do 3,8 KU včetně v jedné ampuli | parent. | 3 | KU | 88,08 | O |
|
| 73.10 | B01AB06 | nadroparin nad 3,8 do 7,6 KU včetně v jedné ampuli | parent. | 3 | KU | 81,87 | O |
| 62402 | FRAXIPARINE | inj. 10x0,8ml/7,6ku | SWI | F |
| 73.11 | B01AB06 | nadroparin nad 7,6 KU v jedné ampuli | parent. | 3 | KU | 64,67 | O |
|
| 73.12 | B01AB07 | parnaparin do 3,2 KU v jedné ampuli včetně | parent. | 3 | KU | 88,08 | O |
| 76570 | FLUXUM 3200UT AXA | inj 6x0.3ml/3200ut | ASW | I |
| 73.13 | B01AB07 | parnaparin nad 3,2 do 4,250 KU včetně v jedné ampuli | parent. | 3 | KU | 80,89 | O |
| 56535 | FLUXUM 4250UI AXA | inj 6x0.4ml/4250ut | ASW | I |
| 73.14 | B01AB07 | parnaparin nad 4,250 KU v jedné ampuli | parent. | 3 | KU | 81,87 | O |
| 76571 | FLUXUM 6400UI AXA | inj 6x0,4ml/6400ut | ASW | I |
| 73.15 | B01AB08 | reviparin do 1,432 KU včetně v jedné ampuli | parent. | 3 | KU | 101,23 | O |
|
| 73.16 | B01AB08 | reviparin nad 1,432 KU v jedné ampuli | parent. | 3 | KU | 88,08 | O |
|
| 73.17 | B01AB11 | sulodexid | parent. | 600 | U | 63,44 | O |
|
| 73.18 | B01AB11 | sulodexid | p.o. | 250 | U | 12,46 | L/OPH,INT,NEU, DIA,GER |
| 74 | B01AC | antiagregancia trombocytů | p.o. | |
|---|
Treatment with ticlopidine and clopidogrel is performed by an internist, cardiologist or neurologist:
(a) allergy and evident intolerance to acetylsalicylic acid,
(b) numbness to acetylsalicylic acid detected by an aggregation test in a haematocoagulation laboratory;
(c) administration to patients following intervascular interventions (stents, PTCA, rotabulation, atherectomy, laser atheroplastics, etc.), usually in combination with acetylsalicylic acid for a limited period of time (usually one month after exercise).
Indobufen treatment is administered by an internist, cardiologist or neurologist:
(a) allergy and evident intolerance to acetylsalicylic acid,
(b) the need for only a short-term antiaggregation effect (e.g. prior to surgery).
| 74.1 | B01AC05 | ticlopidin | p.o. | 0.5 | GM | 33,92 | P |
| 66938 | TAGREN | tbl 30x250 mg | KRK | SLO |
| 74.2 | B01AC06 | kyselina acetylsalicylová (do 30 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,54 | |
| 72813 | ANOPYRIN 30MG | tbl 20x30mg | SLO | SK |
| 72812 | ANOPYRIN 30MG | tbl 50x30mg | SLO | SK |
| 74.3 | B01AC06 | kyselina acetylsalicylová (nnad 100 do 150 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,98 | |
|
| 74.4 | B01AC06 | kyselina acetylsalicylová (nad 30 mg do 100 mg v jedné tabletě včetně) | p.o. | 1 | DF | 0,68 | |
| 99295 | ANOPYRIN 100MG | tbl 20x100mg | SLO | SK |
| 71960 | ANOPYRIN 100MG | tbl 50x100mg | SLO | SK |
| 74.5 | B01AC10 | indobufen | p.o. | 0.3 | GM | 17,11 | P |
|
| 74.6 | B01AC | lysin acetylosalicylát (do 160 mg ekvivalentu kys. acetylosalicylové včetně v jedné dávce) | p.o. | 1 | DF | 0,68 | |
|
| 74.7 | B01AC04 | clopidogrel | p.o. | 75 | MG | 33,92 | P |
|
| 74.8 | B01AC | lysin acetylosalicylát (nad 160 mg ekvivalentu kys. acetylosalicylové v jedné dávce) | p.o. | 1 | DF | 0,64 | |
| 75 | B01AC | antiagregancia trombocytů | parent. | H |
|---|
| 75.1 | B01AC07 | dipyridamol | parent. | 0.2 | GM | 224,45 | H |
|
| 75.2 | B01AC10 | indobufen | parent. | 0.3 | GM | 89,35 | H |
|
| 75.3 | B01AC13 | abciximab | parent. | 1 | DF | 14735,36 | H |
| 56610 | REOPRO 2MG/ML | inj 1x5ml | CEO | NL |
| 75.4 | B01AC11 | iloprost | parent. | 50 | RG | 660,60 | X |
| 76 | B01AD | trombolytika | parent. | U |
|---|
Alteplase and urokinase at all workplaces:
(a) treatment for acute myocardial infarction who have been treated with streptokinase for the past 12 months or have a history of allergic reactions to streptokinase.
In workplaces which have specialised treatment in the contract with the health insurance company:
(a) intracoronary thrombolysis,
(b) thrombolysis of acute and subacute peripheral vessel closures.
| 76.1 | B01AD01 | streptokináza (do 0,75 MU včetně v jedné dávce) | parent. | 1.5 | MU | 3608,44 | U |
| 10937 | STREPTASE | inj sic 1x750 ku | BEH | D |
| 76.2 | B01AD01 | streptokináza (nad 0,75 MU v jedné dávce) | parent. | 1.5 | MU | 3426,91 | U |
| 94697 | KABIKINASE | inj sic 1x1.5mu | KBP | S |
| 62461 | STREPTASE | inj sic 1x1.5 MU | HMD | D |
| 76.3 | B01AD02 | alteplaza | parent. | 0.1 | GM | 43265,44 | U/P |
| 76.4 | B01AD04 | urokináza (do 100 kU v jedné dávce včetně) | parent. | 3 | MU | 53928,40 | U/P |
| 97843 | UKIDAN | inj.100ku +2ml solv | SRO | CH |
| 76.5 | B01AD04 | urokináza (nad 500 kU v jedné dávce) | parent. | 3 | MU | 42565,93 | U/P |
|
| 76.6 | B01AD04 | urokináza (nad 100 do 500 kU v jedné dávce) | parent. | 3 | MU | 45346,56 | U/P |
|
| 76.7 | B01AD07 | retepláza | parent. | 20 | U | 43265,44 | U/P |
| 77 | B02AA | antifibrinolytika ze skupiny aminokyselin | p.o. | |
|---|
| 77.1 | B02AA01 | kyselina aminokaproová | p.o. | 16 | GM | 38,86 | |
|
| 77.2 | B02AA02 | kyselina tranexámová (do 250 mg v jedné tabletě včetně) | p.o. | 2 | GM | 40,72 | |
|
| 77.3 | B02AA02 | kyselina tranexámová (nad 250 mg v jedné tabletě) | p.o. | 2 | GM | 38,57 | |
| 97410 | EXACYL | tbl fc 20x500mg | SFH | F |
| 97412 | EXACYL | sol 5x10 ml/1gm | KBP | S |
| 57480 | EXACYL | tbl obd 20x500 mg | SWP | P |
| 77.4 | B02AA03 | kyselina aminomethylbenzoová | p.o. | 0.25 | GM | 20,14 | |
| 02123 | PAMBA | tbl 10x250mg | CWO | D |
| 78 | B02AA | antifibrinolytika ze skupiny aminokyselin | parent. | |
|---|
| 78.1 | B02AA01 | kyselina aminokaproová | parent. | 16 | GM | 65,01 | |
|
| 78.2 | B02AA02 | kyselina tranexámová | parent. | 2 | GM | 63,74 | |
| 97411 | EXACYL I.V. | inj 5x5ml/500mg | SFH | F |
| 78.3 | B02AA03 | kyselina aminomethylbenzoová | parent. | 0.25 | GM | 196,40 | |
| 69793 | PAMBA | inj 5x5ml/50mg | CWO | D |
| 79 | B02AB | antifibrinolytika ze skupiny inhibitorů proteináz | parent. | H |
|---|
| 79.1 | B02AB01 | aprotinin | parent. | 500 | KU | 664,66 | H |
| 02787 | ANTILYSIN SPOFA | inj 5x10ml/100ku | SPX | CZ |
| 80 | B02BA | vitamin K a jeho deriváty a další lokální hemostyptika | p.o. | |
|---|
| 80.1 | B02BA01 | fytomenadion | p.o. | 20 | MG | 10,66 | |
| 00720 | KANAVIT | gtt 1x5ml 20mg/ml | SLO | SK |
| 80.2 | B02BX01 | etamsylat | p.o. | 0.75 | GM | 29,33 | L/OPH,HEM |
| 81 | B02B | vitamin K a jeho deriváty a další lokální hemostyptika | parent. | |
|---|
| 81.1 | B02BA | menadiolfosfat sodná sůl | parent. | 10 | MG | 14,27 | |
|
| 81.2 | B02BA01 | fytomenadion | parent. | 20 | MG | 15,64 | |
| 00489 | KANAVIT | inj 5x1ml/10mg | HBS | SK |
| 81.3 | B02BX01 | etamsylat | parent. | 0.75 | GM | 83,29 | O/OPH,HEM |
| 02213 | DICYNONE | inj. 100x2ml/250mg | OML | CH |
| 01821 | DICYNONE | inj. 20x2ml/250mg | OML | CH |
| 82 | B02BB | lidský fibrinogen | parent. | U |
|---|
| 82.1 | B02BB01 | lidský fibrinogen | parent. | 5 | GM | 5355,18 | U |
| 52772 | FIBRINOGEN IMMUNO I.V. 1000MG | inj sic 1000mg+50ml | IMM | A |
| 83 | B02BC | lokální hemostatika | lok. | |
|---|
| 83.1 | B02BC | lokální hemostatika (rektální lékové formy) | lok. | 1 | DF | 7,19 | |
| 88753 | SPOFAX (CIPKY HEMOSTAT.KON.) | sup 5x2.2gm | LEX | CZ |
| 83.2 | B02BC | lokální hemostatika (pěna) | lok. | 1 | C2 | 1,47 | |
| 94888 | HYPRO-SORB (60X100X3.5MM) | ext 1ks | HVV | CZ |
| 97230 | HYPRO-SORB O (TVAR TROJUHELN.) | ext 20ks | HVV | CZ |
| 83.3 | B02BC01 | absorbovatelná želatinová houba | lok. | 1 | C2 | 2,69 | |
|
| 83.4 | B02BC06 | thrombin (houba) | lok. | 1 | DF | 56,80 | |
|
| 83.5 | B02BC | lokální hemostatika - karboxycelulosa (zásyp) | lok. | 1 | GM | 15,40 | |
| 84 | B02BD | koagulační faktory (faktor VIII a faktor IX) | parent. | B/P |
|---|
Treatment with coagulation factor VIII is administered by a haematologist:
(a) prevention and treatment of bleeding conditions in patients with congenital or acquired factor VIII deficiency;
(b) in patients with a low titre (up to 5 Bethesda units) inhibitor
(c) Pigs factor VIII is indicated in patients with high antibody titre against human factor VIII and low antibody titre against swine factor VIII.
Treatment with coagulation factor IX is administered by a haematologist:
prevention and treatment of bleeding conditions in patients with evidence of factor IX deficiency, possibly in patients with factor VIII inhibitor.
| 84.1 | B02BD02 | koagulační faktor VIII (středně čištěný, z tuzemské plazmy zakázkovou frakcionací) | parent. | 500 | U | 5083,42 | B/P |
|
| 84.2 | B02BD02 | koagulační faktor VIII (středně čištěný) | parent. | 500 | U | 5083,42 | B/P |
| 88800 | PORCINE FACTOR VIII:C(HYATE:C) | inj 20ml/400-700ut | SPY | GB |
| 84.3 | B02BD04 | koagulační faktor IX (středně čištěný, z tuzemské plazmy zakázkovou frakcionací) | parent. | 350 | U | 3284,67 | B/P |
| | | | | | | |
| 84.4 | B02BD04 | koagulační faktor IX (středně čištěný) | parent. | 350 | U | 3284,67 | B/P |
|
| 84.5 | B02BD01 | kombinace koagulačních faktorů IX,II,VII a X | parent. | 350 | U | 3284,67 | B/P |
| 88602 | BERIPLEX P/N | inj sic 1x500 ut+ sol | CTO | D |
| 84.6 | B02BD02 | koagulační faktor VIII (vysoce čištěný, z tuzemské plazmy zakázkovou frakcionací) | parent. | 500 | U | 6109,88 | B/P |
|
| 84.7 | B02BD02 | koagulační faktor VIII (vysoce čištěný) | parent. | 500 | U | 6109,88 | B/P |
|
| 84.8 | B02BD04 | koagulační faktor IX (vysoce čištěný, z tuzemské plazmy zakázkovou frakcionací) | parent. | 350 | U | 4174,27 | B/P |
|
| 84.9 | B02BD04 | koagulační faktor IX (vysoce čištěný) | parent. | 350 | U | 4174,27 | B/P |
|
| 84.10 | B02BD02 | koagulační faktor VIII středně čištěný s von Willebrandovým faktorem | parent. | 500 | U | 7820,64 | B/P |
|
| 84.11 | B02BD02 | koagulační faktor VIII vysoce čištěný s von Wilebrandovým faktorem | parent. | 500 | U | 8553,83 | B/P |
| 85 | B02BD | koagulační faktory (ostatní koagulační faktory) | parent. | X |
|---|
| 85.1 | B02BD | srážecí faktory | parent. | 350 | U | 2975,02 | X |
| 85667 | FIBROGAMMIN P | inj 1x250ut+1x4ml | BEH | D |
| 85668 | FIBROGAMMIN P | inj 1x1.25ku+1x20ml | BEH | D |
| 85.3 | B02BD03 | aktivita obcházející inhibitor faktoru VIII | parent. | 10 | KU | 331888,41 | X |
|
| 85.4 | B02BD05 | koagulační faktor VII | parent. | 6 | KU | 87982,20 | X |
|
| 85.5 | B02BD08 | eptakog alfa (aktivovaný) | parent. | 2.5 | kU | 1508,65 | X |
| 89825 | NOVOSEVEN 1,2 MG (=60 KU) | inj. sic. 1x1,2 mg + sol | NOO | DK |
| 89826 | NOVOSEVEN 2,4 MG (=120 KU) | inj. sic. 1x2,4 mg + sol | NOO | DK |
| 92641 | NOVOSEVEN 4,8 MG (=240 KU) | inj. sic. 1x4,8 + sol | NOO | DK |
| 86 | B03AA | soli dvojmocného železa | p.o. | |
|---|
| 86.1 | B03AA02 | fumarát železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 2,74 | |
|
| 86.2 | B03AA02 | fumarát železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 2,98 | |
| 00677 | FERRONAT | sus 1x100ml/3gm | GNO | CZ |
| 86.3 | B03AA03 | glukonát železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 5,33 | |
|
| 86.4 | B03AA03 | glukonát železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 5,33 | |
|
| 86.5 | B03AA05 | chlorid železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 5,33 | |
|
| 86.6 | B03AA05 | chlorid železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 5,67 | |
| 85662 | FERRO 66 | gtt1x20 ml | PRA | D |
| 86.7 | B03AA07 | síran železnatý (pevné lékové formy) | p.o. | 0.1 | GM | 1,12 | |
| 04370 | FERRONAT RETARD | tbl obd 30 | LEX | CZ |
| 86.8 | B03AA07 | síran železnatý (tekuté lékové formy) | p.o. | 0.1 | GM | 5,33 | |
|
| 86.9 | B03AB | soli trojmocného železa (tekuté lékové formy) | p.o. | 0.1 | GM | 5,47 | |
| 87 | B03AC | soli trojmocného železa | parent. | O |
|---|
| 87.1 | B03AC | železo trojmocné | parent. | 0.1 | GM | 29,67 | O |
| 04084 | FERRUM LEK I.M. | inj 50x2ml/100mg | LEK | SLO |
| 87.2 | B03AC02 | hydroxid železitý se sacharózou | parent. | 0.1 | GM | 31,48 | O |
| 02788 | FERRUM LEK I.V. | inj 50x5ml/100mg | LEK | SLO |
| 87.3 | B03AC03 | komplex železo-sorbitol-citronová kyselina | parent. | 0.1 | GM | 25,56 | O |
| 88 | B03AD | soli dvojmocného železa v kombinaci s kyselinou listovou | p.o. | L/GYN,HEM |
|---|
| 88.1 | B03AD | chlorid železnatý/ kyselina listová | p.o. | 0.1 | GM | 5,18 | L/GYN,HEM |
|
| 88.2 | B03AD | glukonat železnatý/ kyselina listová | p.o. | 0.1 | GM | 5,18 | L/GYN,HEM |
|
| 88.3 | B03AD02 | fumarat železnatý/ kyselina listová | p.o. | 0.1 | GM | 2,10 | L/GYN,HEM,INT |
| 89141 | FERRETAB COMP. | cps 100 | LAR | A |
| 89140 | FERRETAB COMP. | cps 30 | LAR | A |
| 88.4 | B03AD03 | síran železnatý/ kyselina listová | p.o. | 0.1 | GM | 5,18 | L/GYN,HEM |
| 89 | B03AE | soli dvojmocného železa v ostatních kombinacích | p.o. | |
|---|
| 89.1 | B03AE01 | dvojmocné soli železa/kyselina listová/vitamin B12 | p.o. | 0.1 | GM | 5,57 | |
|
| 89.2 | B03AE02 | dvojmocné soli železa/kyselina listová/vitaminy | p.o. | 0.1 | GM | 5,33 | |
|
| 89.3 | B03AE10 | chlorid železnatý/ kyselina listová | p.o. | 0.1 | GM | 5,33 | |
|
| 89.4 | B03AE10 | fumarat železnatý/ kyselina listová | p.o. | 0.1 | GM | 5,33 | |
|
| 89.5 | B03AE10 | glukonat železnatý/ kyselina listová | p.o. | 0.1 | GM | 5,33 | |
|
| 89.6 | B03AE10 | různé kombinace bez kyseliny listové | p.o. | 0.1 | GM | 2,00 | |
| 97402 | SORBIFER DURULES | tbl. fc 50x 100 mg | EGI | H |
| 89.7 | B03AE10 | síran železnatý/ kyselina listová | p.o. | 0.1 | GM | 6,31 | |
| 96043 | AKTIFERRIN COMPOSITUM | cps 100 | MCK | A |
| 96042 | AKTIFERRIN COMPOSITUM | cps 30 | MCK | A |
| 89.8 | B03AE10 | síran železnatý/serin (pevné lékové formy) | p.o. | 0.1 | GM | 5,47 | |
| 94584 | AKTIFERRIN | cps 50 | MCK | D |
| 89.9 | B03AE10 | síran železnatý/serin (tekuté lékové formy) | p.o. | 0.1 | GM | 6,89 | |
| 99138 | AKTIFERRIN | gtt 1x30ml | MCK | D |
| 90 | B03BA | vitamin B12 a jeho deriváty | parent. | |
|---|
| 90.1 | B03BA01 | cyanokobalamin (do 0,3 mg v jedné ampuli včetně) | parent. | 0.02 | MG | 0,49 | |
| 00641 | VITAMIN B12 LECIVA 300RG | inj 5x1ml/300rg | LEX | CZ |
| 90.2 | B03BA01 | cyanokobalamin (nad 0,3 mg v jedné ampuli) | parent. | 0.02 | MG | 0,20 | |
| 92503 | NEUROBENE | inj 6x1ml/1000rg | MCK | D |
| 09979 | VITAMIN B12 | inj 10x1ml/1mg | VJP | D |
| 23608 | VITAMIN B12 | inj 100x1ml/1mg | VJP | D |
| 00643 | VITAMIN B12 LECIVA 1000RG | inj 5x1ml/1000rg | LEX | CZ |
| 97506 | VITAMIN B12-RATIOPHARM | inj 6x1ml/1000rg | MCK | D |
| 91 | B03BB | kyselina listová a její deriváty | p.o. | |
|---|
| 91.1 | B03BB01 | kyselina listová | p.o. | 10 | MG | 1,27 | |
| 76064 | ACIDUM FOLICUM LECIVA | drg 30x10mg | LEX | CZ |
| 92 | B03XA | ostatní protianemická léčiva | parent. | K/P |
|---|
Treatment with erythropoietin is indicated by an oncologist, a hematologist, an intern or a pediatrician:
(a) treatment of clinically significant anaemia (with haemoglobin levels below 90 g / l, with higher manifestations of anaemia) in patients on dialysis, chronic renal failure patients, cancer patients following radical cytostatic therapy or radiation therapy,
(b) the treatment of anaemia in patients with aplastic anaemia, erythroblastophysis, myelodysplastic syndrome and bone marrow transplantation anaemia,
(c) the treatment of severe anaemia of immature children.
| 92.1 | B03XA01 | erythropoetin | parent. | 2 | KU | 1011,84 | K/P |
| 85532 | EPREX | inj 6x10ku/ml+str. | CIL X | CH |
| 94346 | EPREX | inj 6x10ku/ml | CIL X | CH |
| 93 | B05AA | substituenty plazmy a plazmatické proteiny (albumin) | parent. | B |
|---|
| 93.1 | B05AA01 | albumin (z tuzemské plazmy zakázkovou frakcionací) | parent. | 20 | GM | 2815,72 | B |
|
| 93.2 | B05AA01 | albumin | parent. | 20 | GM | 2815,72 | B |
| 10124 | HUMAN ALBUMIN 20% | inf 1x100ml | BTP | D |
| 20818 | HUMAN ALBUMIN 50 DESSAU | inf 1x100ml | PDE | D |
| 20819 | HUMAN ALBUMIN 50 DESSAU | inf 1x250ml | PDE | D |
| 97907 | HUMAN ALBUMIN GRIFOLS 5% I.V. | inf 1x250ml | GFO | E |
| 97908 | HUMAN ALBUMIN GRIFOLS 5% I.V. | inf 1x500ml | GFO | E |
| 97909 | HUMAN ALBUMIN GRIFOLS 20% I.V. | inf 1x50ml | GFO | E |
| 97910 | HUMAN ALBUMIN GRIFOLS 20% I.V. | inf 1x100ml | GFO | E |
| 98147 | ALBUMIN LIDSKY SP 20% SEVAC | inj 5x1ml | USO | CZ |
| 10117 | HUMAN ALBUMIN 20% | inf 1x50 ml | BTP | D |
| 93.3 | B05AA02 | ostatní bílkoviny plasmy užívané jako její náhrady | parent. | 100 | ML | 952,16 | B |
| 94 | B05AA | substituenty plazmy a plazmatické proteiny (ostatní) | parent. | O |
|---|
| 94.1 | B05AA05 | dextran (koncentrace 10%) | parent. | 500 | ML | 185,84 | O |
| 00589 | RHEODEXTRAN INFUSIA (SOL.PHYS.) | inf 1x500ml 10% | IHO | CZ |
| 00590 | RHEODEXTRAN INFUSIA 10% V GLUC. | inf 1x500ml | IHO | CZ |
| 94.2 | B05AA05 | dextran (koncentrace 6%) | parent. | 500 | ML | 108,80 | O |
| 00431 | DEXTRAN INFUSIA 6% V F1/1 | inf 1x500ml(sklo) | IHO | CZ |
| 94.3 | B05AA05 | dextran (koncentrace 6% v hyperosmolárním roztoku) | parent. | 500 | ML | 123,86 | O |
| 96380 | TENSITON I.V.(KREVNI EXPANDER) | inf 1x500ml(lahev) | IHO | CZ |
| 94.4 | B05AA06 | želatinové přípravky | parent. | 500 | ML | 227,87 | O |
| 56063 | GELIFUNDOL | inf 10x500ml | BTP | D |
| 02536 | GELIFUNDOL | inf 1x500ml | BTP | D |
| 62639 | HAEMACCEL 3,5% | inf 10x500 ml | HMD | D |
| 99635 | GELAFUNDIN | inf 1x500 ml | BME | D |
| 56412 | GELOFUSINE | inf 1x500 ml | BME | CH |
| 94.5 | B05AA07 | hydroxyethyl-škrob | parent. | 500 | ML | 390,05 | O |
| 98352 | ELOHAST 6% | inf 1x500ml(plast) | LPD | A |
| 98351 | ELOHAST 6% | inf 1x500ml(sklo) | LPD | A |
| 72155 | HAES-STERIL 6% | inf 1x500ml(plast) | FRE | D |
| 72154 | HAES-STERIL 6% | inf 1x500ml(sklo) | FRE | D |
| 44431 | HEMOHES 6% | inf 1x500 ml (p) | BME | D |
| 44467 | HEMOHES 10% | inf 1x500 ml (p) | BME | D |
| 95 | B05BA | roztoky k parenterální výživě (glukóza až do 40% koncentrace) | parent. | O |
|---|
| 95.1 | B05BA03 | glukóza 10% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 12,71 | O |
| 62376 | INFUSIO GLUCOSI 10 IMUNA | inf 1x250ml (sklo) | IMA | SK |
| 66872 | INFUSIO GLUCOSI 10% INFUSIA | inf 1x250ml (sklo) | IHO | CZ |
| 92531 | 10% DEXTROSE IN WATER F. INJ. USP | inf. 1x250ml (sklo) | SFR | I |
| 95.2 | B05BA03 | glukóza 10% (nad 250 do 500 ml v jednom balení včetně) | parent. | 100 | ML | 6,94 | O |
| 78248 | 10% GLUCOSE I.V.INFUSION BAXTER | inf 20x500ml (vak) | BXT | GB |
| 92534 | 10% DEXTROSE IN WATER F. INJ. USP | inf 1x500ml (pp) | SFR | D |
| 95.3 | B05BA03 | glukóza 10% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 28,84 | O |
| 92530 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x100ml (sklo) | SFR | I |
| 69747 | ARDEANUTRISOL G 10 | inf 1x80ml | ARD | CZ |
| 86524 | ARDEANUTRISOL G 10 | inf 40x80ml | ARD | CZ |
| 62374 | INFUSIO GLUCOSI 10 IMUNA | inf 1x100ml (sklo) | IMA | SK |
| 86346 | INFUSIO GLUCOSI 10% INFUSIA | inf 1x100ml (sklo) | IHO | CZ |
| 92536 | 10% DEXTROSE IN WATER F. INJ. USP | inf 1x100ml (vak) | SFR | D |
| 95.4 | B05BA03 | glukóza 10% (nad 500 ml v jednom balení) | parent. | 100 | ML | 5,82 | O |
| 92540 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x2000ml (vak) | SFR | I |
| 92539 | 10% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml (vak) | SFR | I |
| 95.5 | B05BA03 | glukóza 20% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 30,01 | O |
| 55623 | INFUSIO GLUCOSI 20 IMUNA | inf 1x100ml (sklo) | IMA | SK |
| 95.6 | B05BA03 | glukóza 20% (nad 100 ml v jednom balení) | parent. | 100 | ML | 6,70 | O |
| 75194 | GLUCOSE - LOSUNG 20 SALVIA (PLAST) | inf 1x1000m 20% | CLS | D |
| 95.7 | B05BA03 | glukóza 5% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 12,90 | O |
| 97729 | GLUCOSE INJECTION 5%W/V BIEFFE | inf 1x250ml (sklo) | BFF | I |
| 62372 | INFUSIO GLUCOSI 5 IMUNA | inf 1x250ml (sklo) | IMA | SK |
| 92520 | 5% DEXTROSE IN WATER F. INJ. USP | inf 1x250ml (sklo) | SFR | I |
| 95.8 | B05BA03 | glukóza 5% (nad 250 do 500 ml v jednom balení včetně) | parent. | 100 | ML | 6,89 | O |
| 83695 | GLUCOSE I.V. B.P. 50GM/LT CORE | inf 1x500ml | CPL | IND |
| 92521 | 5% DEXTROSE IN WATER F. INJ. USP | inf 1x500ml (sklo) | SFR | I |
| 92523 | 5% DEXTROSE IN WATER F. INJ. USP | inf 1x500ml (pp) | SFR | I |
| 92527 | 5% DEXTROSE IN WATER F. INJ. USP | inf 1x500ml (vak) | SFR | I |
| 96873 | GLUCOSE 5 BRAUN (PLASCO LAHV.) | inf 1x500ml 5% | BME | D |
| 95.9 | B05BA03 | glukóza 5% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 27,76 | O |
| 92519 | 5% DEXTROSE IN WATER F. INJ. USP | inf. 1x100ml (sklo) | SFR | I |
| 96871 | GLUCOSE 5 BRAUN (SKLO LAHV.) | inf 1x100ml 5% | BME | D |
| 95.10 | B05BA03 | glukóza 5% (nad 500 ml v jednom balení) | parent. | 100 | ML | 3,96 | O |
| 92529 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x2000ml (vak) | SFR | I |
| 83696 | GLUCOSE I.V. B.P.50GM/LT CORE | inf 1x1000ml | CPL | IND |
| 92528 | 5% DEXTROSE IN WATER F.INJ.USP | inf 1x1000ml (vak) | SFR | I |
| 95.11 | B05BA03 | glukóza do 10% včetně (do 10 ml v jedné ampuli včetně) | parent. | 100 | ML | 91,31 | O |
| 00465 | GLUCOSUM LECIVA 10% | inj 10x10ml 10% | LEX | CZ |
| 95.12 | B05BA03 | glukóza nad 10% do 39 % (do 10 ml v jedné ampuli včetně) | parent. | 100 | ML | 98,74 | O |
|
| 95.13 | B05BA03 | glukóza nad 20% (nad 100 do 250 ml v jednom balení včetně) | parent. | 100 | ML | 18,18 | O |
| 86972 | ARDEANUTRISOL G 33 | inf 1x250ml | ARD | CZ |
| 55630 | INFUSIO GLUCOSI 40 IMUNA | inf 1x250ml (sklo) | IMA | SK |
| 95.14 | B05BA03 | glukóza nad 20% (do 100 ml v jednom balení včetně) | parent. | 100 | ML | 31,97 | O |
| 55628 | INFUSIO GLUCOSI 40 IMUNA | inf 1x100ml (sklo) | IMA | SK |
| 95.15 | B05BA03 | glukóza nad 20% (nad 250 ml v jednom balení) | parent. | 100 | ML | 8,26 | O |
| 75199 | GLUCOSE-LOSUNG 40 SALVIA (SKLO) | inf 1x1000ml 40% | CLS | D |
| 75206 | GLUCOSE-LOSUNG 40 SALVIA (PLAST) | inf 1x1000ml 40% | CLS | D |
| 95.16 | B05BA03 | glukóza inj. 40% (do 10 ml včetně v jedné ampuli ) | parent. | 100 | ML | 98,64 | O |
| 00471 | GLUCOSUM LECIVA 40% | inj 10x10ml 40% | LEX | CZ |
| 96 | B05BA | roztoky k parenterální výživě (ostatní) | parent. | H |
|---|
| 96.1 | B05BA01 | aminokyseliny (koncentrace do 6% včetně) | parent. | 100 | ML | 38,76 | H |
| 91112 | NUTRAMIN NEO | inf 1x500ml 4% | IHO | CZ |
| 96338 | AMINO-MEL OPTIMAL 3,5% | inf. 1x1000ml | LPD | A |
| 96.2 | B05BA01 | aminokyseliny (koncentrace nad 14%) | parent. | 100 | ML | 74,49 | H |
| 75111 | ELOAMIN 15% PUR | inf 6x1000 ml | LPD | A |
| 96.3 | B05BA01 | aminokyseliny (koncentrace nad 10% do 14% včetně) | parent. | 100 | ML | 77,86 | H |
| 55971 | SALVIAMIN 12,5 E | inf 1x1000 ml | CTT | F |
| 55969 | SALVIAMIN 12,5 E | inf 1x500 ml | CTT | F |
| 96.4 | B05BA01 | aminokyseliny (koncentrace nad 6% do 10 % včetně) | parent. | 100 | ML | 48,39 | H |
| 92631 | SALVIAMIN 10 E | inf 1x1000 ml | CTT | F |
| 96.5 | B05BA02 | tukové emulze (do 10% včetně do 100 ml v jednom balení včetně) | parent. | 100 | ML | 175,28 | H |
| 45303 | INTRALIPID 10% | inf 1x100ml | PAU | S |
| 96.6 | B05BA02 | tukové emulze (nad 10% do 100 ml v jednom balení včetně) | parent. | 100 | ML | 196,40 | H |
|
| 96.7 | B05BA02 | tukové emulze (do 10% včetně nad 100 ml v jednom balerní) | parent. | 100 | ML | 55,48 | H |
| 75442 | INTRALIPID | INF 12X500ML 10% | KPB | S |
| 96.8 | B05BA02 | tukové emulze (nad 10% nad 100 ml v jednom balení) | parent. | 100 | ML | 74,20 | H |
|
| 96.9 | B05BA03 | fruktóza (koncentrace do 5% včetně) | parent. | 100 | ML | 14,47 | H |
| 69765 | ARDEANUTRISOL FR 5 | inf 1x500ml | ARD | CZ |
| 69764 | ARDEANUTRISOL FR 5 | inf 1x300ml | ARD | CZ |
| 86464 | ARDEANUTRISOL FR 5 | inf 12x500ml | ARD | CZ |
| 92222 | ARDEANUTRISOL FR 5 | inf 12x300ml | ARD | CZ |
| 86463 | ARDEANUTRISOL FR 5 | inf 12x400ml | ARD | CZ |
| 86459 | ARDEANUTRISOL FR 5 | inf 1x400ml | ARD | CZ |
| 96.10 | B05BA03 | fruktóza (koncentrace nad 10%) | parent. | 100 | ML | 17,74 | H |
| 69771 | ARDEANUTRISOL FR 20 | inf 1x500ml | ARD | CZ |
| 86473 | ARDEANUTRISOL FR 20 | inf 1x400ml | ARD | CZ |
| 86478 | ARDEANUTRISOL FR 20 | inf 12x500ml | ARD | CZ |
| 86477 | ARDEANUTRISOL FR 20 | inf 12x400ml | ARD | CZ |
| 96.11 | B05BA03 | fruktóza (koncentrace nad 5% do 10% včetně) | parent. | 100 | ML | 15,54 | H |
| 69768 | ARDEANUTRISOL FR 10 | inf 1x500ml | ARD | CZ |
| 86466 | ARDEANUTRISOL FR 10 | inf 1x400ml | ARD | CZ |
| 86471 | ARDEANUTRISOL FR 10 | inf 12x500ml | ARD | CZ |
| 86470 | ARDEANUTRISOL FR 10 | inf 12x400ml | ARD | CZ |
| 69767 | ARDEANUTRISOL FR 10 | inf 1x300ml | ARD | CZ |
| 96.12 | B05BA03 | sorbitol (koncentrace do 5% včetně) | parent. | 100 | ML | 8,02 | H |
| 55611 | INFUSIO SORBITOLI 5 IMUNA | inf 1x3000 (vak) | IMA | SK |
| 96.13 | B05BA03 | sorbitol (koncentrace nad 10%) | parent. | 100 | ML | 11,10 | H |
| 85590 | INFUSIO SORBITOLI 20 IMUNA | inf 1x1000 (vak) | IMA | SK |
| 44331 | INFUSIO SORBITOLI 20 IMUNA | inf 1x500 (sklo) | IHO | CZ |
| 68878 | INFUSIO SORBITOLI 20 IMUNA | inf 1x500 (vak) | IMA | SK |
| 96.14 | B05BA03 | sorbitol (koncentrace nad 5% do 10% včetně) | parent. | 100 | ML | 8,60 | H |
| 85586 | INFUSIO SORBITOLI 10 IMUNA | inf 1x1000 (vak) | IMA | SK |
| 68873 | INFUSIO SORBITOLI 10 IMUNA | inf 1x500 (sklo) | IMA | SK |
| 96.15 | B05BA03 | xylitol (koncentrace do 5% včetně) | parent. | 100 | ML | 16,62 | H |
|
| 96.16 | B05BA03 | xylitol (koncentrace nad 5%) | parent. | 100 | ML | 22,83 | H |
| 86224 | ARDEANUTRISOL XY 10 | inf 12x500ml | ARD | CZ |
| 69716 | ARDEANUTRISOL XY 10 | inf 1x500ml | ARD | CZ |
| 96.17 | B05BA10 | kombinace bez obsahu aminokyselin | parent. | 100 | ML | 13,20 | H |
| 96.18 | B05BA10 | kombinace s obsahem aminokyselin | parent. | 100 | ML | 61,83 | H |
| 72160 | AMINO-MEL 3,5% G | inf 6x1000ml | LPD | A |
| 72159 | AMINO-MEL 3,5% G | inf 10x500ml | LPD | A |
| 72162 | AMINO-MEL 5% G | inf 6x1000ml | LPD | A |
| 72163 | AMINO-MEL 5% G | inf 10x500ml | LPD | A |
| 72164 | AMINO-MEL 5% G | inf 6x900ml | LPD | A |
| 80580 | NUTRAMIN C | inf 1x250ml | IHO | CZ |
| 91305 | NUTRAMIN C | inf 1x500ml | IHO | CZ |
| 91663 | NUTRAMIN NEO SX | inf 1x500ml 4% | IHO | CZ |
| 91665 | NUTRAMIN NEO SX | inf 1x500ml 8% | IHO | CZ |
| 96204 | NUTRAMIN U | inf 1x500ml | IHO | CZ |
| 97 | B05BB | roztoky ovlivňující elektrolytovou rovnováhu (chlorid sodný 0,9%) | parent. | O |
|---|
| 97.1 | B05BB01 | chlorid sodný 0.9% (nad 100 ml do 250 ml včetně) | parent. | 100 | ML | 11,54 | O |
| 62328 | INFUSIO NATR.CHLOR.ISOT.IMUNA | inf 1x250ml (sklo) | IMA | SK |
| 92509 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x250ml(sklo) | SFR | I |
| 92515 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x250ml(vak) | SFR | I |
| 97749 | SODIUM CHLORIDE 0,9% BIEFFE. | inf 1x250ml(sklo) | BFF | I |
| 97.2 | B05BB01 | chlorid sodný 0.9% (do 100 ml v balení včetně) | parent. | 100 | ML | 22,09 | O |
| 92508 | 0.9% W/V SODIUM CHLORIDE I.V. | inf 1x100ml (sklo) | SFR | I |
| 97748 | SODIUM CHLORIDE 0.9% BIEFFE | inf 1x100ml(sklo) | BFF | I |
| 97751 | SODIUM CHLORIDE 0.9% BIEFFE | inf 49x100ml(sklo) | SFR | I |
| 43906 | 0,9% SODIUM CHL. IN WATER F. INJ. | inf 49x100ml(sklo) | SFR | I |
| 97.3 | B05BB01 | chlorid sodný 0.9% (nad než 250 ml v balení) | parent. | 100 | ML | 3,81 | O |
| 92585 | INFUSIO NATR.CHLOR.ISOT.IMUNA | inf 1x3000ml (vak) | IMA | SK |
| 83698 | SODIUM CHLORIDE I.V.B.P.CORE | inf 1x1000ml 0.9% | CPL | IND |
| 92518 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x2000ml(vak) | SFR | I |
| 92513 | 0.9% SODIUM CHL.IN WATER F.INJ. | inf 1x1000ml(pp) | SFR | I |
| 97.4 | B05BB01 | chlorid sodný 0.9% (do 10 ml včetně v jedné ampuli) | parent. | 100 | ML | 42,82 | O |
| 96886 | CHLORID SODNÝ 0,9% BRAUN | inj 20x10 ml (pl. amp.) | BMM | D |
| 98 | B05BB | roztoky ovlivňující elektrolytovou rovnováhu (ostatní) | parent. | 92518 |
|---|
| 98.1 | B05BB | roztoky ovlivňující rovnováhu elektrolytů | parent. | 100 | ML | 10,46 | H |
| 75372 | ELO-MEL BASIS MIT GLUCOSE | inf 6x1000ml(sklo) | LPD | A |
| 75374 | ELO-MEL BASIS MIT GLUCOSE | inf 6x1000ml(plast) | LPD | A |
| 75360 | ELO-MEL ISOTON MIT GLUCOSE | inf 6x1000ml(sklo) | LPD | A |
| 75362 | ELO-MEL ISOTON MIT GLUCOSE | inf 6x1000ml(plast) | LPD | A |
| 75370 | ELO-MEL SEMITON MIT GLUCOSE | inf 6x1000ml(plast) | LPD | A |
| 75368 | ELO-MEL SEMITON MIT GLUCOSE | inf 6x1000ml(sklo) | LPD | A |
| 75358 | ELO-MEL ISOTON | inf 6x1000ml(plast) | LPD | A |
| 75356 | ELO-MEL ISOTON | inf 6x1000ml(sklo) | LPD | A |
| 75366 | ELO-MEL OP (POSTOPERATIV) | inf 6x1000ml(plast) | LPD | A |
| 75364 | ELO-MEL OP (POSTOPERATIV) | inf 6x1000ml(sklo) | LPD | A |
| 98.2 | B05BB01 | elektrolyty | parent. | 100 | ML | 8,07 | H |
| 93527 | ARDEAELYTOSOL R 1/1 | inf 1x500ml | ARD | CZ |
| 85112 | ARDEAELYTOSOL R 1/1 | inf 12x500ml | ARD | CZ |
| 83702 | COMPOUND SODIUM LACTAT.B.P.CORE | inf 1x1000ml | CPL | IND |
| 83701 | COMPOUND SODIUM LACTAT.B.P.CORE | inf 1x500ml | CPL | IND |
| 98238 | DARROWS SOLUTION | inf 1x500ml | BME | D |
| 85896 | INFUSIO DARROWI IMUNA | inf 1x1000ml(vak) | IMA | SK |
| 91841 | PLASMA-LYTE 148 ELECTROLYT.SOL. | inf 10x1000ml | BXT | GB |
| 55617 | INFUSIO RINGERI IMUNA | inf 1x3000ml(vak) | IMA | SK |
| 96889 | RINGERLACTAT DAB 7 BRAUN | inf 1x1000ml(pe) | BME | D |
| 92802 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x2000ml (vak) | MKS | CZ |
| 96892 | RINGER'S INJECTION BRAUN | inf 1x1000ml | BME | D |
| 66833 | PLASMA-LYTE 148 ELECTROLYT.SOL. | inf 1x1000ml | BXT | GB |
| 69440 | RINGER-LOSUNG SALVIA (PLAST) | inf 1x1000ml | CLS | D |
| 92581 | INFUSIO HARTMANNI IMUNA | inf 1x3000ml (vak) | IMA | SK |
| 84545 | INFUSIO RINGER. C. NAT. LACT. IMUNA | inf 1x3000ml (vak) | IMA | SK |
| 69438 | RINGER-LACTAT SALVIA (PLAST) | inf 1x1000ml | CLS | D |
| 92600 | INFUSIO DARROWI IMUNA | inf 1x3000ml (vak) | IMA | SK |
| 97013 | INFUSIO DARROWI INSTITUTE HUMAN | inf 1x500ml | HUA | H |
| 69442 | RINGER-LOSUNG SALVIA (SKLO) | inf 1x1000ml | CLS | D |
| 69439 | RINGER-LACTAT SALVIA (SKLO) | inf 1x1000ml | CLS | D |
| 01695 | NATRII CHLORIDI 10% MEDVIR | inf 1x100ml | VYS | CZ |
| 55616 | INFUSIO RINGERI IMUNA | inf 1x2000ml (vak) | IMA | SK |
| 92778 | INFUSIO HARTMANNI MEDIEKOS H1/1 | inf 1x2000ml (vak) | MKS | CZ |
| 96891 | RINGER'S INJECTION BRAUN | inf 1x500ml | BME | D |
| 96888 | RINGERLACTAT DAB 7 BRAUN | inf 1x500ml (pe) | BME | D |
| 92580 | INFUSIO HARTMANNI IMUNA | inf 1x2000ml (vak) | IMA | SK |
| 84554 | INFUSIO RINGER. C. NAT. LACT. IMUNA | inf 1x2000ml (vak) | IMA | SK |
| 69235 | RINGER'S SOLUTION U. S. P. BIEFFE | inf 1x500ml (sklo) | BFF | I |
| 92599 | INFUSIO DARROWI IMUNA | inf 1x2000ml (vak) | IMA | SK |
| 85578 | INFUSIO RINGERI IMUNA | inf 1x1000ml (vak) | IMA | SK |
| 89861 | INFUSIO RINGERI INFUSIA R 1/1 | inf 1x500ml (sklo) | IHO | CZ |
| 72793 | INFUSIO RINGERI IMUNA | inf 1x500ml (sklo) | IMA | SK |
| 84543 | INFUSIO RINGER. C. NAT. LACT. IMUNA | inf 1x1000ml (vak) | IMA | SK |
| 70529 | INFUSIO RINGERI MEDICAMENTA | inf 1x500ml | MVM | CZ |
| 69736 | ARDEALYTOSOL H 1/1 | inf 1x500ml | ARD | CZ |
| 69695 | ARDEALYTOSOL RL 1/1 | inf 1x500ml | ARD | CZ |
| 99168 | INFUSIO HARTMANNI IMUNA | inf 1x500ml (sklo) | IMA | SK |
| 92801 | INFUSIO RINGERI MEDIEKOS R1/1 | inf 1x1000ml (vak) | MKS | CZ |
| 86486 | ARDEALYTOSOL H 1/1 | inf 12x500ml | ARD | CZ |
| 92775 | INFUSIO DARROWI MEDIEKOS R1/1 | inf 1x2000ml (vak) | MKS | CZ |
| 85887 | INFUSIO HARTMANNI IMUNA | inf 1x1000ml (vak) | IMA | SK |
| 87250 | INFUSIO HARTMANNI INFUSIA H 1/1 | inf 1x500ml (sklo) | IHO | CZ |
| 70524 | INFUSIO HARTMANNI MEDICAMENTA | inf 1x500ml | MVM | CZ |
| 98.3 | B05BB02 | elektrolyty se sacharidy | parent. | 100 | ML | 9,04 | H |
| 56706 | INFUSIO R 1/2 INFUSIA | inf 1x500ml(sklo) | IHO | CZ |
| 56702 | INFUSIO F 1/2 INFUSIA | inf 1x500ml(sklo) | IHO | CZ |
| 98.4 | B05BB03 | trometamol | parent. | 100 | ML | 23,02 | H |
| 69698 | ARDEALYTOSOL THAM 1/1 | inf 1x500 ml | ARD | CZ |
| 99 | B05BC | roztoky k osmotické diuréze | parent. | H |
|---|
|
| 99.1 | B05BC01 | mannitol (koncentrace do 10% včetně, nad 250 ml v jednom balení) | parent. | 100 | ML | 12,17 | H |
| 89155 | INFUSIO MANNITOLI 10% INFUSIA | inf 1x500ml(sklo) | IHO | CZ |
| 99.2 | B05BC01 | mannitol (koncentrace do 10% včetně, do 250 ml v jednom balení včetně) | parent. | 100 | ML | 19,31 | H |
| 89154 | INFUSIO MANNITOLI 10% INFUSIA | inf 1x250ml(sklo) | IHO | CZ |
| 99.3 | B05BC01 | mannitol (koncentrace nad 10%, nad 250 ml v jednom balení) | parent. | 100 | ML | 13,78 | H |
| 44383 | INFUSIO MANNITOLI 20% INFUSIA | inf 1x500ml(sklo) | IHO | CZ |
| 99.4 | B05BC01 | mannitol (koncentrace nad 10%, do 250 ml v jednom balení včetně) | parent. | 100 | ML | 21,70 | H |
| 44382 | INFUSIO MANNITOLI 20% INFUSIA | inf 1x250ml(sklo) | IHO | CZ |
| 99.5 | B05BC02 | karbamid | parent. | 90 | GM | 1133,11 | H |
| 00628 | UREA VUAB | inf sic 1x90gm | VUA | CZ |
| 100 | B05C | roztoky k irigaci | lok. | H |
|---|
| 100.1 | B05CB01 | chlorid sodný | lok. | 1000 | ML | 37,29 | H |
|
| 100.2 | B05CX02 | sorbitol | lok. | 1000 | ML | 37,29 | H |
|
| 100.3 | B05CX03 | glycin | lok. | 1000 | ML | 54,04 | H |
| 76598 | CLEAR FLEX GLYCINE 1,5% | liq 1x5 lt | BFF | I |
| 100.4 | B05CX10 | kombinované roztoky k irigaci | lok. | 1000 | ML | 54,04 | H |
| 76600 | CLEAR FLEX GLYCINE | liq 1x5lt | BFF | I |
| 76602 | CLEAR FLEX MANN 0,54% + SORB. 2,7% | liq 1x5 lt | BFF | I |
| 101 | B05D | roztoky k peritoneální dialýze | parent. | H |
|---|
| 101.1 | B05D | přípravky pro peritoneální dialýzu | parent. | 1000 | ML | 138,72 | H |
| 69183 | PERITONEAL DIAL.SOL.+DEXTR.1.5% | sol 1x5000ml(vak) | BFF | I |
| 85924 | PERITONEAL DIAL.SOL.+DEXTR.2.5% | sol 1x5000ml(vak) | BFF | I |
| 85926 | PERITONEAL DIAL.SOL+DEXTR.4.25% | sol 1x5000ml(vak) | BFF | I |
| 76616 | DIANEAL PD 4(+GLUCOSE 1.36%) | sol 1x5000ml(vak) | BXT | IRL |
| 76621 | DIANEAL PD 4(+GLUCOSE 2.27%) | sol 1x1500ml(vak) | BXT | IRL |
| 76625 | DIANEAL PD 4(+GLUCOSE 2.27%) | sol 1x5000ml(vak) | BXT | IRL |
| 76623 | DIANEAL PD 4(+GLUCOSE 2.27%) | sol 1x2500ml(vak) | BXT | IRL |
| 76622 | DIANEAL PD 4(+GLUCOSE 2.27%) | sol 1x2000ml(vak) | BXT | IRL |
| 76634 | DIANEAL PD 4(+GLUCOSE 3.86%) | sol 1x5000ml(vak) | BXT | IRL |
| 76614 | DIANEAL PD 4(+GLUCOSE 1.36%) | sol 1x2500ml(vak) | BXT | IRL |
| 76613 | DIANEAL PD 4(+GLUCOSE 1.36%) | sol 1x2000ml(vak) | BXT | IRL |
| 76632 | DIANEAL PD 4(+GLUCOSE 3.86%) | sol 1x2500ml(vak) | BXT | IRL |
| 76631 | DIANEAL PD 4(+GLUCOSE 3.86%) | sol 1x2000ml(vak) | BXT | IRL |
| 55846 | PERITONEAL DIAL.SOL+DEXTR.4.25% | sol 1x2500ml(vak) | BFF | I |
| 55847 | PERITONEAL DIAL.SOL.+DEXTR.1.5% | sol 1x2500ml(vak) | BFF | I |
| 55848 | PERITONEAL DIAL.SOL.+DEXTR.2.5% | sol 1x2500ml(vak) | BFF | I |
| 76613 | DIANEAL PD 4(+GLUCOSE 1.36%) | sol 1x2000ml(vak) | BXT | IRL |
| 76614 | DIANEAL PD 4(+GLUCOSE 1.36%) | sol 1x2500ml(vak) | BXT | IRL |
| 102 | B05X | přídavky do nitrožilně podávaných roztoků (hydrogenuhličitan sodný) | parent. | O |
|---|
| 102.1 | B05XA02 | hydrogenuhličitan sodný (do 20 ml v jedné ampuli včetně) | parent. | 100 | ML | 124,74 | O |
| 00524 | NATRIUM HYDROGENCARBONIC. LECIVA | inj 6x20ml 4.2% | LEX | CZ |
| 102.2 | B05XA02 | hydrogenuhličitan sodný (nad 20 ml v jedné ampuli) | parent. | 100 | ML | 11,00 | O |
| 31352 | ALKALIGEN-INSTITUTE HUMAN | inf 1x400ml | HUA | H |
| 103 | B05X | přídavky do nitrožilně podávaných roztoků (ostatní) | parent. | H |
|---|
| 103.1 | B05X | přídavky do i.v. roztoků | parent. | 100 | ML | 257,49 | H |
| 69597 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x500ml | ARD | CZ |
| 86799 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x400ml | ARD | CZ |
| 69596 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x300ml | ARD | CZ |
| 86798 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x250ml | ARD | CZ |
| 86797 | ARDEAELYTOSOL L-ARGININCHL.21% | inf 1x200ml | ARD | CZ |
| 103.2 | B05XA01 | chlorid draselný (koncentrace 7,45%) | parent. | 100 | ML | 17,40 | H |
| 70523 | INFUSIO KALII CHLORATI CONC.MVM | inf 1x250ml | MVM | CZ |
| 103.3 | B05XA03 | chlorid sodný (koncentrace do 5,85% včetně) | parent | 100 | ML | 22,88 | H |
| 69727 | ARDEAELYTOSOL NATRIUMCHLOR.5.85 | inf 1x200ml | ARD | CZ |
| 103.4 | B05XA03 | chlorid sodný (koncentrace nad 5,85%) | parent. | 100 | ML | 24,93 | H |
| 87726 | ARDEAELYTOSOL NATRIUMCHLOR.10% | inf 1x200ml | ARD | CZ |
| 103.5 | B05XA04 | chlorid amonný | parent. | 100 | ML | 11,68 | H |
| 86596 | ARDEAELYTOSOL AMMONCL 1/1 | inf 12x500ml | ARD | CZ |
| 69576 | ARDEAELYTOSOL AMMONCL 1/1 | inf 1x500ml | ARD | CZ |
| 103.6 | B05XA06 | fosforečnan draselný, vč. kombinací | parent. | 100 | ML | 52,35 | H |
|
| 103.7 | B05XA30 | kombinace elektrolytů (stopové prvky) | parent. | 10 | ML | 12,46 | H |
| 72998 | SOLUTIO SHILS I.ARDEAPHARMA | inf 1x50ml | ARD | CZ |
| 72998 | SOLUTIO SHILS I. ARDEAPHARMA | inf 1x50 ml | ARD | CZ |
| 103.8 | B05XA31 | elektrolyty v kombinaci s jinými léčivy | parent. | 100 | ML | 127,87 | H |
| 72997 | SOLUTIO THOMASI ARDEAPHARMA | sol 1x50 ml | ARD | CZ |
| 103.9 | B05XB01 | chlorid argininu (koncentrace 21%) | parent. | 100 | ML | 27,67 | H |
|
| 103.10 | B05XC | vitamíny | parent. | 1 | DF | 43,99 | H |
|
| 103.11 | B05XX | ostatní i.v. roztoky | parent. | 100 | ML | 7,63 | H |
| 104 | B05Z | roztoky k hemodialýze a hemofiltraci | lok. | H |
|---|
| 104.1 | B05Z | hemodialytika a hemofiltráty | lok. | 1000 | ML | 166,19 | H |
| 87560 | ARDEADIALYSOL MAX I | inf 1x250ml | ARD | CZ |
| 87562 | ARDEADIALYSOL MAX I | inf 1x300ml | ARD | CZ |
| 87576 | ARDEADIALYSOL MAX I | inf 1x400ml | ARD | CZ |
| 69646 | ARDEADIALYSOL MAX I | inf 1x500ml | ARD | CZ |
| 87612 | ARDEADIALYSOL MAX II | inf 1x250ml | ARD | CZ |
| 87613 | ARDEADIALYSOL MAX II | inf 1x300ml | ARD | CZ |
| 87614 | ARDEADIALYSOL MAX II | inf 1x400ml | ARD | CZ |
| 69649 | ARDEADIALYSOL MAX II | inf 1x500ml | ARD | CZ |
| 104.2 | B05ZA | hemodialytika, koncentráty | lok. | 1000 | ML | 125,72 | H |
| 104.3 | B05ZB | hemofiltráty | lok. | 1000 | ML | 166,19 | H |
| 105 | C01AA | kardioglykosidy z náprstníku | p.o. | |
|---|
| 105.1 | C01AA02 | acetyldigoxin | p.o. | 0.5 | MG | 1,03 | |
|
| 105.2 | C01AA04 | digitoxin | p.o. | 0.1 | MG | 1,03 | |
|
| 105.3 | C01AA05 | digoxin | p.o. | 0.25 | MG | 1,03 | |
| 00705 | DIGOXIN | gtt 1x10ml 0.5mg/ml | GNO | CZ |
| 03542 | DIGOXIN 0.250 LECIVA | tbl 30x0.25mg | LEX | CZ |
| 83318 | DIGOXIN 0.125 LECIVA | tbl 30x0.125mg | LEX | CZ |
| 105.4 | C01AA08 | metildigoxin | p.o. | 0.2 | MG | 1,03 | |
| 106 | C01AA | kardioglykosidy z náprstníku | parent. | |
|---|
| 106.1 | C01AA05 | digoxin | parent. | 0.25 | MG | 6,99 | |
| 00435 | DIGOXIN SPOFA | inj 10x2ml/0.5mg | SPX | CZ |
| 106.2 | C01AA08 | metildigoxin | parent. | 0.2 | MG | 6,99 | |
|
| 106.3 | C01AC01 | g-strofantin | parent. | 0.25 | MG | 23,46 | |
| 107 | C01BA | antiarytmika, třída la | p.o. | |
|---|
| 107.1 | C01B | ipratropium | p.o. | 30 | MG | 53,77 | |
| 88433 | ITROP | tbl fc 20x10mg | BOE | D |
| 107.2 | C01BA | detajmii bitartras | p.o. | 75 | MG | 14,71 | |
| 23113 | TACHMALCOR | drg 50x25mg | VAD | D |
| 107.3 | C01BA01 | chinidin | p.o. | 1.2 | GM | 19,36 | |
| 70549 | TBL.CHINIDINI SULFURICI 0.2 MVM | tbl 1000x0.2gm | MVM | CZ |
| 107.4 | C01BA01 | chinidin (retardované lékové formy) | p.o. | 1.2 | GM | 27,27 | |
|
| 107.5 | C01BA02 | prokainamid | p.o. | 3 | GM | 38,61 | |
| 62311 | APO-PROCAINAMIDE 250MG | cps 100x250mg | APT | CND |
| 107.6 | C01BA03 | disopyramid | p.o. | 0.4 | GM | 12,37 | |
|
| 107.7 | C01BA08 | prajmalin | p.o. | 30 | MG | 14,08 | |
| 90992 | NEO-GILURYTMAL | tbl obd 50x20mg | SVP | D |
| 108 | C01BA | antiarytmika, třída la | parent. | O |
|---|
| 108.1 | C01B | ipratropium | parent. | 3 | MG | 782,94 | O |
| 88432 | ITROP | inj 5x1ml/0.5mg | BOE | D |
| 108.2 | C01BA02 | prokainamid | parent. | 3 | GM | 251,87 | O |
|
| 108.3 | C01BA03 | disopyramid | parent. | 0.4 | GM | 251,87 | O |
|
| 108.4 | C01BA05 | ajmalin | parent. | 0.3 | GM | 251,87 | O |
| 99356 | GILURYTMAL 10 I.V. | inj 5x10ml/50mg | GIU | D |
| 109 | C01BB | antiarytmika, třída Ib | p.o. | |
|---|
| 109.1 | C01BB02 | mexiletin | p.o. | 0.8 | GM | 9,68 | |
| 93311 | KATEN RETARD | tbl 50x400mg | SLO | SK |
| 109.2 | C01BB03 | tocainid | p.o. | 1.2 | GM | 10,22 | |
| 110 | C01BB | antiarytmika, třída Ib | parent. | O/INT,KAR |
|---|
| 110.1 | C01BB01 | lidokain | parent. | 1 | ML | 1,22 | O/INT,KAR |
|
| 110.2 | C01BB02 | mexiletin | parent. | 0.8 | GM | 351,64 | O/INT,KAR |
| 04100 | MEXITIL | inj 5x10ml 250mg | BOE | D |
| 110.3 | C01BB03 | tocainid | parent. | 1.2 | GM | 351,64 | O/INT,KAR |
| 111 | C01BC | antiarytmika, třída Ic | p.o. | |
|---|
| 111.1 | C01BC03 | propafenon (100 mg a více v jedné tabletě) | p.o. | 0.3 | GM | 12,12 | |
|
| 111.2 | C01BC03 | propafenon (méně než 100 mg v jedné tabletě) | p.o. | 0.3 | GM | 17,55 | |
| 76761 | RYTMONORM 10MG | tbl obd 500x10mg | KNO | D |
| 112 | C01BC | antiarytmika, třída Ic | parent. | O/INT,KAR |
|---|
| 112.1 | C01BC03 | propafenon | parent. | 0.3 | GM | 165,41 | O/INT,KAR |
| 91275 | PROLEKOFEN | inj 10x10ml/35mg | LEK | SLO |
| 112.2 | C01BC07 | lorcainid | parent. | 0.2 | GM | 139,01 | O/INT,KAR |
| 113 | C01BD | antiarytmika, třída III | p.o. | |
|---|
| 113.1 | C01BD01 | amiodaron | p.o. | 0.2 | GM | 4,64 | |
| 96599 | SEDACORON 200MG | tbl 50x200mg | EBW | A |
| 80156 | CORDARONE | tbl 60x200 mg | KRK | SLO |
| 114 | C01BD | antiarytmika, třída III a adenosin | parent. | O/INT,KAR |
|---|
| 114.1 | C01BD01 | amiodaron | parent. | 0.2 | GM | 19,94 | O/INT,KAR |
| 96600 | SEDACORON | inj 5x3ml/150mg | EBW | A |
| 114.2 | C01BD02 | bretylium tosilát | parent. | 100 | MG | 139,01 | O/INT,KAR |
|
| 114.3 | C01EB10 | adenosin | parent. | 15 | MG | 728,30 | O/INT,KAR |
| 91615 | ADENOCOR | inj 6x2ml/6mg | SWI | F |
| 115 | C01CA | adrenergní a dopaminergní léčiva (norepinefrin a dopamin) | parent. | O |
|---|
| 115.1 | C01CA03 | norepinefrin | parent. | 6 | MG | 72,05 | O |
| 00536 | NORADRENALIN LECIVA | inj 5x1ml/1mg | LEX | CZ |
| 115.2 | C01CA04 | dopamin | parent. | 0.5 | GM | 109,39 | O |
| 04380 | TENSAMIN | inj 10x5ml | LEX | CZ |
| 116 | C01CA | adrenergní a dopaminergní léčiva (ostatní) | parent. | H |
|---|
| 116.1 | C01CA02 | isoprenalin | parent. | 90 | MG | 15620,16 | H |
|
| 116.2 | C01CA05 | norfenefrin | parent. | 25 | MG | 23,76 | H |
|
| 116.3 | C01CA07 | dobutamin | parent. | 0.5 | GM | 350,71 | H |
| 86762 | DOBUJECT | inf 5x5ml/250mg | LOY | SF |
| 92483 | DOBUDAMIN LACHEMA 250 | inj sic 1x250 mg | LCM | CZ |
| 59267 | DOBUDAMIN LACHEMA 250 | inj sic 10x250 mg | LCM | CZ |
| 116.4 | C01CA09 | metaraminol | parent. | 50 | MG | 191,26 | H |
|
| 116.5 | C01CA10 | metoxamin | parent. | 30 | MG | 40,91 | H |
|
| 116.6 | C01CA11 | mepentermin | parent. | 30 | MG | 101,67 | H |
|
| 116.7 | C01CA17 | midodrin | parent. | 7.5 | MG | 83,44 | H |
|
| 116.8 | C01CA24 | epinefrin (lékové formy autoinjektoru) | parent. | 1 | DF | 684,31 | P |
Medicinal product containing epinephrine in autoinjector formulations is prescribed by an allergologist and a clinical immunologist in patients with a history of anaphylactic shock caused by an insect allergy.
| 116.9 | C01CA24 | epinefrin | parent. | 0.5 | MG | 4,50 | O |
| 00362 | ADRENALIN LECIVA | inj 5x1ml/1mg | LEX | CZ |
| 116.10 | C01CA14 | dopexamin | parent. | 500 | MG | 109,39 | H |
| 117 | C01CE | léčiva ze skupiny inhibitorů fosfodiesterázy | parent. | X |
|---|
| 117.1 | C01CE01 | amrinon | parent. | 0.5 | GM | 4250,80 | X |
| 91980 | WINCORAM | inj 10x20ml 5mg/ml | SWI | F |
| 118 | C01DA | vazodilatancia ze skupiny organických nitrátů | p.o. | |
|---|
| 118.1 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tablet) | p.o. | 5 | MG | 2,15 | |
| 86677 | NIT-RET | tbl 50x2.5mg | SLO | SK |
| 118.2 | C01DA02 | glycerol trinitrát (do 2,5 mg v jedné tabletě včetně, lékové formy tobolek s peletami) | p.o. | 5 | MG | 3,52 | |
|
| 118.3 | C01DA02 | glycerol trinitrát (nad 2,5 mg v jedné tabletě) | p.o. | 5 | MG | 2,49 | |
|
| 118.4 | C01DA08 | isosorbid dinitrát (do 20 mg v jedné tabletě včetně) | p.o. | 60 | MG | 4,11 | |
|
| 118.5 | C01DA08 | isosorbid dinitrát (nad 80 mg v jedné tabletě) | p.o. | 60 | MG | 4,50 | |
|
| 118.6 | C01DA08 | isosorbid dinitrát (nad 20 do 80 mg v jedné tabletě včetně) retardované lékové formy | p.o. | 60 | MG | 2,93 | |
|
| 118.7 | C01DA14 | isosorbid mononitrát do 20 mg včetně v jedné tabletě | p.o. | 40 | MG | 3,23 | |
| 76402 | SORBIMON 20MG | tbl 100x20mg | MCK | D |
| 76400 | SORBIMON 20MG | tbl 20x20mg | MCK | D |
| 76401 | SORBIMON 20MG | tbl 50x20mg | MCK | D |
| 61467 | ISMN AL 20 | tbl 100x20mg | APA | D |
| 92568 | ISMN AL 20 | tbl 60x20mg | APA | D |
| 96190 | MONOSAN 20MG | tbl 30x20mg | PMP | CZ |
| 118.8 | C01DA08 | isosorbid dinitrát (nad 20 do 80 mg v jedné tabletě včetně) neretardované lékové formy | p.o. | 60 | MG | 1,47 | |
| 97720 | APO-ISDN 30MG | tbl 100x30mg | APT | CND |
| 118.9 | C01DA14 | isosorbid mononitrát nad 20 mg v jedné tabletě | p.o. | 40 | MG | 2,93 | |
| 76405 | SORBIMON 40MG | tbl 100x40mg | MCK | D |
| 76403 | SORBIMON 40MG | tbl 20x40mg | MCK | D |
| 76404 | SORBIMON 40MG | tbl 50x40mg | MCK | D |
| 61469 | ISMN AL 40 | tbl 100x40 mg | APA | D |
| 119 | C01DA | vazodilatancia ze skupiny organických nitrátů | parent. | H |
|---|
| 119.1 | C01DA02 | glycerol trinitrát | parent. | 2.5 | MG | 13,59 | H |
| 04348 | NITRO-MACK | inj 10x5ml/5mg | MAC | D |
| 119.2 | C01DA08 | isosorbid dinitrát | parent. | 20 | MG | 123,96 | H |
| 120 | C01DA | vazodilatancia ze skupiny organických nitrátů | spr. | |
|---|
| 120.1 | C01DA02 | glycerol trinitrát | spr. | 5 | DF | 2,59 | |
| 60032 | MAYCOR NITROSPRAY-PUMPSPRAY | spr 1x11.8gm=14.5ml | PDA | D |
| 31407 | NITROMINT | aer dos 1x10 g | EGY | H |
| 120.2 | C01DA08 | isosorbid dinitrát (mimo přípravků určených k transdermální aplikaci) | spr. | 20 | MG | 8,80 | |
| 121 | C01DA | vazodilatancia ze skupiny organických nitrátů | sublng. | |
|---|
| 121.1 | C01DA02 | glycerol trinitrát | sublng. | 2.5 | MG | 6,11 | |
| 00231 | NITROGLYCERIN SLOVAKOFARMA | tbl 20x0.5mg | SLO | SK |
| 121.2 | C01DA08 | isosorbid dinitrát | sublng. | 20 | MG | 3,03 | |
| 122 | C01DX | ostatní vazodilatancia | p.o. | |
|---|
| 122.1 | C01DX03 | oxifedrin | p.o. | 40 | MG | 4,79 | |
|
| 122.2 | C01DX12 | molsidomin (do 2 mg v jedné tabletě včetně) | p.o. | 6 | MG | 5,57 | |
| 83662 | MOLSIHEXAL 2MG | tbl 50x2mg | HEX | D |
| 83663 | MOLSIHEXAL 2MG | tbl 100x2mg | HEX | D |
| 76154 | CORVATON | tbl30x2 mg | HBS | SK |
| 122.3 | C01DX12 | molsidomin (nad 2 do 4 mg v jedné tabletě včetně) | p.o. | 6 | MG | 3,96 | |
| 83474 | MOLSIHEXAL 4MG | tbl 30x4mg | HEX | D |
| 83664 | MOLSIHEXAL 4MG | tbl 50x4mg | HEX | D |
| 86442 | MOLSIHEXAL 4MG | tbl 60x4mg | HEX | D |
| 83665 | MOLSIHEXAL 4MG | tbl 100x4mg | HEX | D |
| 76155 | CORVATON FORTE | tbl 30x4mg | HBS | SK |
| 122.4 | C01DX12 | molsidomin (nad 4 mg v jedné tabletě) | p.o. | 6 | MG | 2,10 | |
| 49560 | MOLSIHEXAL RETARD | tbl ret 30x8mg | HEX | D |
| 49561 | MOLSIHEXAL RETARD | tbl ret 60x8mg | HEX | D |
| 49559 | MOLSIHEXAL RETARD | tbl ret 100x8mg | HEX | D |
| 122.5 | C01EB15 | trimetazidin | p.o. | 40 | MG | 7,23 | |
| 123 | C01DX | ostatní vazodilatancia | parent. | H |
|---|
| 123.1 | C01DX03 | oxifedrin | parent. | 40 | MG | 13,78 | H |
|
| 123.2 | C01DX12 | molsidomin | parent. | 6 | MG | 105,38 | H |
| 87732 | CORVATON | inj 10x1ml/2mg | HOE | D |
| 124 | C01EA | prostaglandiny | parent. | X |
|---|
|
| 124.1 | C01EA01 | alprostadil | parent. | 0,5 | MG | 3365,32 | X |
| 92305 | ALPROSTAN | inf 10x0.2ml/100rg | LEX | CZ |
| 70426 | KARON | inj 0.2ml/100rg+sol | LEX | CZ |
| 61219 | PROSTIN VR | inj 1x1ml/0.5mg | UPJ | B |
| 124.2 | C01EA01 | alprostadil (vázaný na cyklodextrin) | parent. | 20 | RG | 661,58 | X |
| 91731 | PROSTAVASIN | inj sic 10x20rg | SWP | D |
| 125 | C02 | antihypertenziva působící na centrální alfa-2 receptory a jejich kombinace s diuretiky | p.o. | |
|---|
| 125.1 | C02AB01 | methyldopa (levotočivá) | p.o. | 1 | GM | 7,28 | |
| 68571 | DOPAGEN | tbl obd 50x250mg | ANN | IRL |
| 01328 | DOPEGYT | tbl 50x250mg | EGI | H |
| 125.2 | C02AC01 | klonidin | p.o. | 0.45 | MG | 10,75 | |
|
| 125.3 | C02AC02 | guanfacin | p.o. | 3 | MG | 10,75 | |
|
| 125.4 | C02AC05 | moxonidin | p.o. | 0.3 | MG | 10,75 | |
|
| 125.5 | C02LA51 | reserpin a diuretika | p.o. | 1 | DF | 1,56 | |
| 02629 | CRYSTEPIN | drg 30 | LEX | CZ |
| 125.6 | C02LB01 | methyldopa/ hydrochlorothiazid (do 15 mg v jedné tabletě včetně) | p.o. | 3 | DF | 4,94 | |
|
| 125.7 | C02LB01 | methyldopa/ hydrochlorothiazid (nad 15 mg v jedné tabletě) | p.o. | 2 | DF | 3,42 | |
|
| 125.8 | C02AC06 | rilmenidin | p.o. | 1 | MG | 10,75 | |
| 126 | C02A | antihypertenziva působící na centrální alfa-2 receptory | parent. | H |
|---|
| 126.1 | C02AC01 | klonidin | parent. | 0.45 | MG | 70,09 | H |
| 92074 | CATAPRESAN | inj 5x1ml/0.15mg | BOE | D |
| 127 | C02CA | antihypertenziva působící na periferní alfa-1 receptory | p.o. | |
|---|
| 127.1 | C02CA | metazosin | p.o. | 20 | MG | 5,96 | |
|
| 127.2 | C02CA01 | prazosin (do 1 mg v jedné tabletě včetně) | p.o. | 5 | MG | 6,89 | |
| 94315 | DEPRAZOLIN MITE | tbl 10x1mg | LEX | CZ |
| 127.3 | C02CA01 | prazosin (nad 1 mg v jedné tabletě) | p.o. | 5 | MG | 2,99 | |
| 88173 | DEPRAZOLIN | tbl 30x2mg | LEX | CZ |
| 127.4 | C02CA06 | urapidil | p.o. | 50 | MG | 6,89 | |
|
| 127.5 | C02CA04 | doxazosin | p.o. | 4 | MG | 20,33 | L/URN |
| 128 | C02CA | antihypertenziva působící na periferní alfa-1 receptory | parent. | O |
|---|
| 128.1 | C02CA06 | urapidil | parent. | 50 | MG | 225,87 | O |
| 90763 | EBRANTIL I.V.25 | inj 5x5ml/25mg | BGL | D |
| 90765 | EBRANTIL I.V.50 | inj 5x10ml/50mg | BGL | D |
| 129 | C02D | antihypertenziva působící přímou vazodilataci | p.o. | |
|---|
| 129.1 | C02DB01 | dihydralazin | p.o. | 75 | MG | 2,00 | |
| 00110 | DIHYDRALAZIN SLOVAKOFARMA | tbl 50x25mg | SLO | SK |
| 129.2 | C02DB03 | endralazin | p.o. | 10 | MG | 9,43 | |
|
| 129.3 | C02DC01 | minoxidil | p.o. | 20 | MG | 20,14 | L/INT,KAR |
| 130 | C02D | antihypertenziva působící přímou vazodilataci | parent. | H |
|---|
| 130.1 | C02DA01 | diazoxid | parent. | 300 | MG | 283,99 | H |
|
| 130.2 | C02DB01 | dihydralazin | parent. | 25 | MG | 30,40 | H |
| 90484 | NEPRESOL | inj 5x25mg+solv. | CGC | CH |
| 130.3 | C02DD01 | nitroprusid sodný | parent. | 50 | MG | 273,97 | H |
| 131 | C03AA | thiazidová diuretika | p.o. | |
|---|
|
| 131.1 | C03AA03 | hydro-chlorothiazid | p.o. | 25 | MG | 0,78 | |
| 00168 | HYDROCHLOROTHIAZID LECIVA | tbl 20x25mg | LEX | CZ |
| 132 | C03B | sulfonamidová diuretika a antihypertenziva | p.o. | |
|---|
| 132.1 | C03BA | metipamid | p.o. | 2.5 | MG | 1,03 | |
| 94810 | HYPOTYLIN | tbl 30x2.5mg | LEX | CZ |
| 132.2 | C03BA04 | chlortalidon | p.o. | 25 | MG | 0,59 | |
| 83551 | URANDIL | tbl 30x50mg(blistr.) | LEX | CZ |
| 132.3 | C03BA10 | xipamid | p.o. | 20 | MG | 1,03 | |
|
| 132.4 | C03BA11 | indapamid | p.o. | 2.5 | MG | 1,12 | |
| 96696 | INDAP | cps 30x2.5mg | PMP | CZ |
| 132.5 | C03B | cikletanin | p.o. | 50 | MG | 1,03 | |
|
| 132.6 | C03BA11 | indapamid s řízeným uvolňováním | p.o. | 1,5 | MG | 1,12 | |
| 133 | C03CA | kličková diuretika | p.o. | |
|---|
|
| 133.1 | C03CA01 | furosemid (méně než 125 mg v jedné tabletě) | p.o. | 40 | MG | 0,88 | |
| 98219 | FURON | tbl 50x40mg | MCK | D |
| 02079 | FUROSEMID SLOVAKOFARMA | tbl 2x10x40 mg | SLO | SK |
| 86717 | FURANTHRIL | tbl 50x40 mg | PMM | BG |
| 133.2 | C03CA01 | furosemid (125 mg a více v jedné tabletě) | p.o. | 40 | MG | 1,08 | |
| 02785 | FUROSEMID SLOVAKOFARMA FORTE | tbl 10x250mg | SLO | SK |
| 133.3 | C03CA04 | torasemid (do 10 mg v jedné tabletě včetně) | p.o. | 15 | MG | 0,88 | |
|
| 133.4 | C03CA04 | torasemid (nad 10 mg v jedné tabletě) | p.o. | 15 | MG | 1,08 | |
| 134 | C03CA | kličková diuretika | parent. | O |
|---|
| 134.1 | C03CA01 | furosemid (méně než 125 mg v jedné ampuli) | parent. | 40 | MG | 16,28 | O |
| 08984 | FURANTRAL | inj 25x2ml/20mg | PVVO | PL |
| 02133 | FUROSEMID BIOTIKA | inj 5x2ml/20mg | BTA | SK |
| 134.2 | C03CA01 | furosemid (125 mg a více v jedné ampuli) | parent. | 40 | MG | 7,28 | O |
| 99333 | FUROSEMID BIOTIKA FORTE | inj 10x10ml/125mg | HBS | SK |
| 134.3 | C03CA04 | torasemid (do 10 mg v jedné ampuli včetně) | parent. | 15 | MG | 16,03 | O |
|
| 134.4 | C03CA04 | torasemid (nad 10 mg v jedné ampuli) | parent. | 15 | MG | 7,72 | O |
|
| 134.5 | C03C | kyselina etakrynová | parent. | 50 | MG | 543,63 | O |
| 135 | C03D | kalium šetřící diuretika | p.o. | |
|---|
|
| 135.1 | C03DA01 | spironolakton | p.o. | 75 | MG | 4,84 | |
| 96362 | XENALON-100 | tbl obd 20x100mg | MHA | CH |
| 96361 | XENALON-50 | tbl obd 20x50mg | MHA | CH |
| 135.2 | C03DB01 | amilorid | p.o. | 10 | MG | 1,56 | |
| 87662 | AMICLARAN | tbl 50x5mg | SLO | SK |
| 135.3 | C03DB02 | triamteren | p.o. | 100 | MG | 1,22 | |
| 136 | C03EA | kombinace thiazidových a kalium šetřících diuretik | p.o. | |
|---|
| 136.1 | C03EA | středně silná diuretika a kalium šetřící látky | p.o. | 1 | DF | 1,17 | |
| 88518 | AMICLOTON | tbl 30 | SLO | SK |
| 136.2 | C03EA01 | hydrochlorothiazid a kalium šetřící látky | p.o. | 0.5 | DF | 0,54 | |
| 83717 | AMILORID HCT AL | tbl 50 | APA | D |
| 83718 | AMILORID HCT AL | tbl 100 | APA | D |
| 76380 | RHEFLUIN | tbl 30 | LEX | CZ |
| 136.3 | C03EA14 | spironolakton/butizid | p.o. | 1 | DF | 9,78 | |
| 137 | C04AB | periferní vazodilatancia ze skupiny derivátů imidazolu | parent. | O |
|---|
| 137.1 | C04AB01 | fentolamin | parent. | 10 | MG | 20,82 | O |
|
| 137.2 | C04AB02 | tolazolin | parent. | 75 | MG | 83,14 | O |
| 00440 | DIVASCOL | inj 10x1ml/10mg | SPX | CZ |
| 138 | C04A | periferní vazodilatancia ze skupiny derivátů purinu a kyseliny nikotinové | p.o. | |
|---|
| 138.1 | C04AC01 | kyselina nikotinová | p.o. | 0.2 | GM | 0,44 | |
|
| 138.2 | C04AD | etophyllin | p.o. | 0.3 | GM | 1,52 | |
| 00243 | OXYPHYLLIN | tbl 50x100mg | SLO | SK |
| 138.3 | C04AD02 | xantinol nikotinát | p.o. | 0.9 | GM | 5,08 | |
| 02673 | XANIDIL | tbl 30x150mg | LEX | CZ |
| 75028 | XANIDIL RETARD | tbl ret 20x500mg | LEX | CZ |
| 138.4 | C04AD03 | pentoxifyllin (do 100 mg v jedné tabletě včetně) | p.o. | 1 | GM | 5,08 | |
|
| 138.5 | C04AD03 | pentoxifyllin (nad 400 mg v jedné tabletě) | p.o. | 1 | GM | 8,46 | |
| 96180 | AGAPURIN 600 RETARD | tbl obd 20x600mg | SLO | SK |
| 138.6 | C04AD03 | pentoxifyllin (nad 100 mg do 400 mg v jedné tabletě včetně) | p.o. | 1 | GM | 7,92 | |
| 139 | C04A | periferní vazodilatancia ze skupiny derivátů purinu a kyseliny nikotinové | parent. | |
|---|
| 139.1 | C04AC | olamini nicotinas | parent. | 0.9 | GM | 20,04 | |
| |
| 139.2 | C04AD | etophyllin/theophyllin | parent. | 0.3 | GM | 11,05 | |
| 57351 | OXANTIL | inj 5x2 mg | HBS | SK |
| 139.3 | C04AD02 | xantinol nikotinát | parent. | 0.9 | GM | 4,25 | |
|
| 139.4 | C04AD03 | pentoxifyllin | parent. | 0.3 | GM | 28,40 | |
| 69241 | PENTILIN 100 | inj 5x5ml/100mg | KRK | SLO |
| 43709 | TRENTAL | inf 10x15ml/300mg | HBS | SK |
| 140 | C04AE | periferní vazodilatancia ze skupiny derivátů námelových alkaloidů | p.o. | |
|---|
| 140.1 | C04AE01 | hydrogenované ergotové alkaloidy | p.o. | 3 | MG | 2,00 | |
| 91032 | SECATOXIN FORTE | gtt 1x25ml/62.5mg | GNO | CZ |
| 140.2 | C04AE02 | nicergolin | p.o. | 30 | MG | 8,50 | |
|
| 140.3 | C04AE51 | hydrogenované ergotové alkaloidy, kombinace | p.o. | 2 | ML | 1,71 | |
| 88088 | ERSILAN | gtt 50ml | GNO | CZ |
| 141 | C04AE | periferní vazodilatancia ze skupiny derivátů námelových alkaloidů | parent. | |
|---|
| 141.1 | C04AE01 | hydrogenované ergotové alkaloidy | parent. | 3 | MG | 69,21 | |
| 00432 | DH-ERGOTOXIN LECIVA | inj 5x1ml/0.3mg | LEX | CZ |
| 142 | C04AX | jiná periferní vasodilatancia | p.o. | |
|---|
| 142.1 | C04AX | jiná periferní vasodilatancia | p.o. | 3 | DF | 5,72 | |
|
| 142.2 | C04AX02 | fenoxybenzamin | p.o. | 30 | MG | 15,54 | |
|
| 142.3 | C04AX19 | sulkotidil | p.o. | 0.3 | GM | 5,72 | |
|
| 142.4 | C04AX20 | buflomedil | p.o. | 0.6 | GM | 5,72 | |
|
| 142.5 | C04AX21 | naftidrofuryl | p.o. | 0.2 | GM | 5,72 | |
| 97026 | ENELBIN 100 RETARD | tbl ret 50x100mg | LEX | CZ |
| 143 | C04AX | jiná periferní vasodilatancia | parent. | |
|---|
| 143.1 | C04AX | jiná periferní vasodilatancia | parent. | 2 | DF | 14,86 | |
|
| 143.2 | C04AX11 | bencyklan | parent. | 0.6 | GM | 51,52 | |
|
| 143.3 | C04AX21 | naftidrofuryl | parent. | 0.2 | GM | 51,52 | |
| 98049 | ENELBIN | inj 10x5ml/40mg | LEX | CZ |
| 144 | C05AD | antihemorhoidalia obsahující lokální anestetika | lok. | |
|---|
| 144.1 | C05AD | přípravky obsahující lokální anestetika (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
|
| 144.2 | C05AD | přípravky obsahující lokální anestetika (lékové formy mastí) | lok. | 1 | GM | 0,78 | |
|
| 144.3 | C05AD01 | lidokain (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
|
| 144.4 | C05AD01 | lidokain (lékové formy mastí) | lok. | 1 | GM | 0,78 | |
|
| 144.5 | C05AD04 | cinchokain (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
|
| 144.6 | C05AD04 | cinchokain (lékové formy mastí) | lok. | 1 | GM | 0,78 | |
| 00832 | AVIRIL H | ung 1x30gm | LEX | CZ |
| 145 | C05AX | jiná antihemorrhoidalia k zevnímu použití | lok. | |
|---|
| 145.1 | C05AX | jiná antihemorrhoidalia k zevnímu použití (lékové formy mastí) | lok. | 1 | GM | 0,78 | |
| 01966 | KETAZON H | ung 1x20gm 5% | LEX | CZ |
| 145.2 | C05AX | jiná antihemorrhoidalia k zevnímu použití (lékové formy čípků) | lok. | 1 | DF | 0,98 | |
| 146 | C05BA | lokální léčiva s heparinem nebo heparinoidy k zevnímu použití | lok. | |
|---|
| 146.1 | C05BA | heparin nebo heparinoidy k zevnímu použití | lok. | 1 | GM | 0,83 | |
|
| 146.2 | C05BA01 | organo-heparinoidy | lok. | 1 | GM | 0,83 | |
| 03575 | HEPAROID LECIVA | ung 1x30gm | LEX | CZ |
| 146.3 | C05BA03 | heparin k zevnímu použití | lok. | 1 | GM | 0,83 | |
| 86042 | HEPARIN AL SALBE 30000 | ung 1x100gm | APA | D |
| 86044 | HEPARIN AL GEL 30000 | gel 1x100gm | APA | D |
| 72931 | THROMBAREDUCT 60000 | ung 1x200gm | AZU | D |
| 147 | C05CA | kapiláry stabilizující léčiva ze skupiny flavonoidů | p.o. | |
|---|
| 147.1 | C05CA | bioflavonoidy (hydroxy-ethylrutosid) | p.o. | 0.9 | GM | 6,35 | |
|
| 147.2 | C05CA | bioflavonoidy (kombinace, pevné lékové formy) | p.o. | 3 | DF | 1,37 | |
| 96303 | ASCORUTIN | tbl obd 50 | SLO | SK |
| 147.3 | C05CA | bioflavonoidy (kombinace, tekuté lékové formy) | p.o. | 2 | ML | 3,03 | |
| 02635 | ANAVENOL | gtt 1x25ml | GNO | CZ |
| 147.4 | C05CA | bioflavonoidy (tribenosid) | p.o. | 0.6 | GM | 6,35 | |
| 09121 | GLYVENOL 400 | cps 20x400 mg | CGC | CHA |
| 147.5 | C05CA04 | troxerutin | p.o. | 0.9 | GM | 6,35 | |
|
| 147.6 | C05CA53 | diosmin, kombinace | p.o. | 2 | DF | 7,09 | |
|
| 147.7 | C05CA | standardizovaný extrakt gingko biloba v kombinaci | p.o. | 2 | DF | 6,35 | |
| 148 | C05 | jiné kapiláry stabilizující látky | p.o. | |
|---|
| 148.1 | C05CX | jiné kapiláry stabilizující látky (dobesilat vápenatý) | p.o. | 0.75 | GM | 6,52 | |
|
| 148.2 | C05CX | jiné kapiláry stabilizující látky (escin) | p.o. | 60 | MG | 6,52 | |
| 94327 | YELLON | cps 30x20mg | SLO | SK |
| 149 | C05 | jiné kapiláry stabilizující látky | parent. | H |
|---|
| 149.1 | C05CX | jiné kapiláry stabilizující látky (escin) | parent. | 5 | MG | 54,26 | H |
|
| 149.2 | C05BB02 | polidokanol (do 0,5% včetně) | parent. | 1 | ML | 14,71 | O |
| 08512 | AETHOXYSKLEROL 0,5% | inj 1x30ml 0,5% | KRS | D |
| 08510 | AETHOXYSKLEROL 0,5% | inj 5x2ml 0.5% | KRS | D |
| 149.3 | C05BB02 | polidokanol (nad 0,5 do 1 % včetně) | parent. | 1 | ML | 16,91 | O |
| 20034 | AETHOXYSKLEROL 1% | inj 1x30ml 1% | KRS | D |
| 20033 | AETHOXYSKLEROL 1% | inj 5x2ml 1% | KRS | D |
| 149.4 | C05BB02 | polidokanol (nad 1 % do 3 % včetně) | parent. | 1 | ML | 18,87 | O |
| 08511 | AETHOXYSKLEROL 2% | inj 5x2ml 2% | KRS | D |
| 02529 | AETHOXYSKLEROL 3% | inj 5x2ml 3% | KRS | D |
| 149.5 | C05BB02 | polidokanol (více než 3 %) | parent. | 1 | ML | 20,38 | O |
| 90799 | AETHOXYSKLEROL 4% | inj 5x2ml 4% | KRS | D |
| 150 | C07AA | beta-blokátory, bez beta-1 selektivity (sotalol) | p.o. | L/KAR,INT |
|---|
|
| 150.1 | C07AA07 | sotalol | p.o. | 0.16 | GM | 6,06 | L/KAR,INT |
| 83481 | SOTAHEXAL | tbl 20x160mg | HEX | D |
| 83670 | SOTAHEXAL | tbl 50x160mg | HEX | D |
| 83671 | SOTAHEXAL | tbl 100x160mg | HEX | D |
| 151 | C07AA | beta-blokátory, bez beta-1 selektivity (ostatní) | p.o. | |
|---|
| 151.1 | C07AA | metipranolol (do 5 mg včetně v 1 tabletě) | p.o. | 10 | MG | 0,78 | |
| 50043 | TRIMEPRANOL 5MG | tbl 50x5mg | SLO | SK |
| 151.2 | C07AA | metipranolol (nad 5 do 10 mg včetně v 1 tabletě) | p.o. | 10 | MG | 0,68 | |
| 02483 | TRIMEPRANOL | tbl 50x10mg | SLO | SK |
| 151.3 | C07AA | metipranolol (nad 10 mg v 1 tabletě) | p.o. | 10 | MG | 0,29 | |
| 02484 | TRIMEPRANOL | tbl 50x40mg | SLO | SK |
| 151.4 | C07AA02 | oxprenolol | p.o. | 0.1 | GM | 2,74 | |
|
| 151.5 | C07AA03 | pindolol | p.o. | 15 | MG | 2,74 | |
| 96757 | APO-PINDOL 5 | tbl 100x5mg | APT | CND |
| 151.6 | C07AA05 | propranolol | p.o. | 0.16 | GM | 2,74 | |
|
| 151.7 | C07AA12 | nadolol | p.o. | 0.16 | GM | 2,74 | |
|
| 151.8 | C07AA16 | tertatolol | p.o. | 5 | MG | 2,74 | |
|
| 151.9 | C07AA17 | bopindolol | p.o. | 1 | MG | 4,30 | |
| 96998 | SANDONORM | tbl 30x1mg | LEX | CZ |
| 151.10 | C07AA23 | penbutolol | p.o. | 40 | MG | 2,74 | |
|
| 151.11 | C07AA27 | kloranolol | p.o. | 20 | MG | 2,74 | |
| 152 | C07AA | beta-blokátory, bez beta-1 selektivity | parent. | O |
|---|
| 152.1 | C07AA | metipranolol | parent. | 10 | MG | 68,63 | O |
| 85886 | TRIMEPRANOL | inj 10x1ml/1mg | HBS | SK |
| 152.2 | C07AA | talinolol | parent. | 50 | MG | 93,65 | O |
| 20405 | CORDANUM | inj 10x5ml/10mg | VAD | D |
| 152.3 | C07AA02 | oxprenolol | parent. | 0.1 | GM | 99,13 | O |
|
| 152.4 | C07AA03 | pindolol | parent. | 15 | MG | 99,13 | O |
|
| 152.5 | C07AA07 | sotalol | parent. | 0.16 | GM | 900,64 | O |
| 91614 | DAROB | inj 5x4ml/40mg | KNO | D |
| 153 | C07AB | beta-blokátory, s beta-1 selektivitou | p.o. | |
|---|
|
| 153.1 | C07AB02 | metoprolol (do 0,05 GM včetně v jedné tabletě) | p.o. | 0.15 | GM | 2,93 | |
| 96753 | APO-METOPROLOL 50 | tbl 100x50mg | APT | CND |
| 50080 | VASOCARDIN 50 | tbl 50x50mg - blistr | SLO | SK |
| 153.2 | C07AB02 | metoprolol (nad 0,05 GM v jedné tabletě) | p.o. | 0.15 | GM | 2,79 | |
| 96755 | APO-METOPROLOL 100 | tbl 100x100mg | APT | CND |
| 45592 | VASOCARDIN 100 | tbl 50x100mg - blistr | SLO | SK |
| 153.3 | C07AB02 | metoprolol - retardované lékové formy | p.o. | 0.15 | GM | 3,52 | |
| 46980 | BETALOC SR 200 MG | tbl ret 100x200 mg | APN | S |
| 46981 | BETALOC SR 200 MG | tbl ret 30x200 mg | APN | S |
| 153.4 | C07AB03 | atenolol | p.o. | 75 | MG | 3,52 | |
| 65388 | TENORMIN | tbl obd 28x50mg | ZNC | GB |
| 65389 | TENORMIN | tbl obd 28x100mg | ZNC | GB |
| 72987 | CATENOL 50 | tbl 100x50mg | CAD | IND |
| 72988 | CATENOL 100 | tbl 100x100mg | CAD | IND |
| 75001 | APO-ATENOL 50MG | tbl 100x50mg | APT | CND |
| 75003 | APO-ATENOL 100MG | tbl 100x100mg | APT | CND |
| 89252 | ATENOLOL AL 25 | tbl obd 30x25mg | APA | D |
| 89253 | ATENOLOL AL 25 | tbl obd 50x25mg | APA | D |
| 89254 | ATENOLOL AL 25 | tbl obd 100x25mg | APA | D |
| 89255 | ATENOLOL AL 50 | tbl obd 30x50mg | APA | D |
| 89256 | ATENOLOL AL 50 | tbl obd 50x50mg | APA | D |
| 89257 | ATENOLOL AL 50 | tbl obd 100x50mg | APA | D |
| 89258 | ATENOLOL AL 100 | tbl obd 30x100mg | APA | D |
| 89259 | ATENOLOL AL 100 | tbl obd 50x100mg | APA | D |
| 89260 | ATENOLOL AL 100 | tbl obd 100x100mg | APA | D |
| 96444 | COROTENOL 50 | tbl obd 30x50mg | MHA | CH |
| 96445 | COROTENOL 100 | tbl obd 30x100mg | MHA | CH |
| 153.5 | C07AB04 | acebutolol | p.o. | 0.4 | GM | 5,87 | |
| 86324 | SECTRAL | tbl obd 20x200mg | RRO | F |
| 80058 | SECTRAL 400 | tbl obd 30x400mg | RRO | F |
| 75939 | ACECOR 400MG | tbl obd 30x400mg | SPA | I |
| 153.6 | C07AB05 | betaxolol | p.o. | 20 | MG | 5,87 | |
| 96475 | LOKREN 20MG | tbl fc 28x20mg | LSY | F |
| 153.7 | C07AB07 | bisoprolol | p.o. | 10 | MG | 5,87 | |
|
| 153.8 | C07AB08 | celiprolol | p.o. | 0.2 | GM | 5,87 | |
|
| 153.9 | C07AB12 | nebivolol | p.o. | 5 | MG | 5,87 | |
| 154 | C07AB | beta-blokátory, s beta-1 selektivitou | parent. | O |
|---|
| 154.1 | C07AB02 | metoprolol | parent. | 0.15 | GM | 1398,18 | O |
|
| 154.2 | C07AB03 | atenolol | parent. | 75 | MG | 1904,42 | O |
| 65387 | TENORMIN | inj 10x10ml/5mg | ZNC | GB |
| 154.3 | C07AB04 | acebutolol | parent. | 0.4 | GM | 1398,18 | O |
|
| 154.4 | C07AB09 | esmolol | parent. | 2,5 | GM | 4836,19 | H |
| 155 | C07AG | alfa, beta-blokátory | p.o. | L/KAR,INT |
|---|
|
| 155.1 | C07AG01 | labetalol | p.o. | 0.6 | GM | 19,50 | L/KAR,INT |
| 87669 | TRANDATE | tbl 250x200mg | GLA | GB |
| 155.2 | C07AG02 | karvedilol (do 6,25 mg v 1 tabletě včetně) | p.o. | 37.5 | MG | 23,46 | L/KAR,INT |
|
| 155.3 | C07AG02 | karvedilol (nad 6,25 mg v 1 tabletě) | p.o. | 37.5 | MG | 23,46 | L/KAR,INT |
| 156 | C07AG | alfa, beta-blokátory | parent. | H |
|---|
| 156.1 | C07AG01 | labetalol | parent. | 0.6 | GM | 1012,92 | H |
| 87508 | TRANDATE | inj 5x20ml/100mg | GLA | GB |
| 157 | C07F | beta-blokátory v kombinaci s jinými antihypertenzivy | p.o. | |
|---|
| 157.1 | C07BB03 | atenolol a thiazidy | p.o. | 1 | DF | 4,40 | |
|
| 157.2 | C07CA17 | bopindolol a thiazidy | p.o. | 1 | DF | 4,40 | |
|
| 157.3 | C07FA | beta-blokátory, neselektivní, a jiná antihypertens. | p.o. | 0.5 | DF | 0,73 | |
| 76981 | TRIMECRYTON | tbl 30(blistr) | LEX | CZ |
| 157.4 | C07BB07 | bisoprolol a thiazidy | p.o. | 1 | DF | 3,71 | |
| 158 | C08CA | antagonisté vápníku dihydropyridinové řady | p.o. | |
|---|
| 158.1 | C08CA01 | amlodipin | p.o. | 5 | MG | 12,71 | L/INT,KAR |
|
| 158.2 | C08CA02 | felodipin | p.o. | 5 | MG | 9,09 | |
|
| 158.3 | C08CA03 | isradipin | p.o. | 5 | MG | 8,11 | |
|
| 158.4 | C08CA05 | nifedipin | p.o. | 30 | MG | 1,96 | |
| 91199 | CORINFAR | drg 100x10mg | VAD | D |
| 97771 | NIFESAN | tbl obd 50x10mg | PMP | CZ |
| 87164 | SPONIF 10 | tbl obd 50x10mg | SLO | SK |
| 88754 | CORDIPIN | tbl 50x10mg | KRK | SLO |
| 158.5 | C08CA05 | nifedipin (retadrované lékové formy s obsahem 20 mg) | p.o. | 30 | MG | 2,10 | |
| 98043 | CORINFAR RETARD | drg 30x20mg | VAD | D |
| 98044 | CORINFAR RETARD | drg 50x20mg | VAD | D |
| 98045 | CORINFAR RETARD | drg 100x20mg | VAD | D |
| 94129 | DEPIN-E RETARD | tbl ret 100x20mg | CAD | IND |
| 91692 | NIFECARD RETARD | tbl ret 30x20mg | LEK | SLO |
| 65381 | NIFEHEXAL 20 RETARD | tbl obd 50x20mg | HEX | D |
| 65382 | NIFEHEXAL 20 RETARD | tbl obd 100x20mg | HEX | D |
| 93460 | CORDIPIN RETARD | tbl ret 30x20mg | KRK | SLO |
| 158.6 | C08CA05 | nifedipin (retardované lékové formy s obsahem 40 mg) | p.o. | 30 | MG | 1,37 | |
| 65384 | NIFEHEXAL 40 RETARD | tbl obd 50x40mg | HEX | D |
| 65385 | NIFEHEXAL 40 RETARD | tbl obd 100x40mg | HEX | D |
| 83667 | NIFEHEXAL 40 RETARD | tbl ret 20x40mg | HEX | D |
| 158.7 | C08CA06 | nimodipin | p.o. | 0.3 | GM | 160,23 | X |
| 88860 | NIMOTOP S | tbl 100x30mg | BAY | D |
| 158.8 | C08CA07 | nisoldipin | p.o. | 20 | MG | 9,09 | |
|
| 158.9 | C08CA08 | nitrendipin | p.o. | 20 | MG | 9,09 | |
|
| 158.10 | C08CA09 | lacidipin | p.o. | 4 | MG | 9,09 | |
|
| 158.11 | C08CX01 | mibefradil | p.o. | 50 | MG | 13,20 | L/INT,KAR |
|
| 158.12 | C08CA03 | isradipin (retardované lékové formy) | p.o. | 5 | MG | 9,09 | |
| 159 | C08CA | antagonisté vápníku dihydropyridinové řady | parent. | H |
|---|
| 159.1 | C08CA03 | isradipin | parent. | 5 | MG | 3074,59 | H |
| 96533 | LOMIR I.V. | inj 5x10ml 0.1mg/ml | SAN | CH |
| 159.2 | C08CA05 | nifedipin | parent. | 30 | MG | 3074,59 | H |
|
| 159.3 | C08CA06 | nimodipin | parent. | 50 | MG | 3438,25 | X |
| 88858 | NIMOTOP S | inf 1x50ml/10mg | BAY | D |
| 94535 | NIMOTOP S | inf 5x50ml/10mg | BAY | D |
| 160 | C08DA | antagonisté vápníku fenylalkylaminové řady | p.o. | |
|---|
| 160.1 | C08DA01 | verapamil | p.o. | 0.24 | GM | 5,13 | |
| 77034 | VERAPAMIL AL 40 | tbl obd 50x40mg | APA | D |
| 77035 | VERAPAMIL AL 40 | tbl obd 100x40mg | APA | D |
| 77036 | VERAPAMIL AL 80 | tbl obd 50x80mg | APA | D |
| 77037 | VERAPAMIL AL 80 | tbl obd 100x80mg | APA | D |
| 86045 | VERAPAMIL AL 120 | tbl obd 50x120mg | APA | D |
| 86046 | VERAPAMIL AL 120 | tbl obd 100x120mg | APA | D |
| 98019 | VERAPAMIL DH 120MG DIAG HUMAN | tbl obd 500x120mg | GNS | GB |
| 160.2 | C08DA01 | verapamil (retardované lékové formy s obsahem 240 | p.o. | 0.24 | GM | 5,91 | |
| 43877 | VEROGALID ER 240MG | tbl ret 30x240mg | GNO | CZ |
| 160.3 | C08DA02 | gallopamil | p.o. | 0.1 | GM | 5,13 | |
| 161 | C08DA | antagonisté vápníku fenylalkylaminové řady | parent. | H |
|---|
| 161.1 | C08DA01 | verapamil | parent. | 0.24 | GM | 317,03 | H |
| 09210 | LEKOPTIN | inj 50x2ml/5mg | LEK | SLO |
| 162 | C08DB | antagonisté vápníku benzothiazepinové řady | p.o. | |
|---|
| 162.1 | C08DB01 | diltiazem | p.o. | 0.24 | GM | 5,28 | |
| 93186 | BLOCALCIN | tbl 50x60mg | LCM | CZ |
| 94321 | BLOCALCIN 90 RETARD | tbl ret 30x90mg | LCM | CZ |
| 94314 | DIACORDIN 60 | tbl 50x60mg | LEX | CZ |
| 93711 | DIACORDIN 90 RETARD | tbl 30x90mg | LEX | CZ |
| 162.2 | C08DB01 | diltiazem (retardované lékové formy s obsahem 120 mg a více) | p.o. | 0.24 | GM | 5,77 | |
| 76736 | DIACORDIN 120 RETARD | tbl ret 30x120mg | LEX | CZ |
| 163 | C08DB | antagonisté vápníku benzothiazepinové řady | parent. | H |
|---|
| 163.1 | C08DB01 | diltiazem | parent. | 25 | MG | 319,18 | H |
| 99136 | DILZEM PARENTERAL | inj sic 5x100mg+sol | GOD | D |
| 93135 | DILZEM PARENTERAL | inj sic 5x25mg+5ml | GOD | D |
| 164 | C09AA | inhibitory angiotenzin konvertujícího enzymu | p.o. | |
|---|
| 164.1 | C09AA01 | kaptopril (do 12,5 mg v 1 tabletě včetně) | p.o. | 50 | MG | 4,74 | |
| 96903 | APO-CAPTO | tbl 100x12.5mg | APT | CND |
| 56200 | CAPOTEN 12.5MG | tbl 90x12.5mg | BMS | AUS |
| 55737 | KAPTOPRIL - K 12.5MG | 20x12.5 | KRK | SLO |
| 164.2 | C09AA01 | kaptopril (nad 12,5 mg do 25 mg v 1 tabletě včetně) | p.o. | 50 | MG | 4,59 | |
| 68839 | APO-CAPTO | tbl 100x25mg | APT | CND |
| 91021 | CAPOTEN | tbl 90x25mg | BMS | GB |
| 60242 | CAPOTEN | tbl 30x25mg | BMS | GB |
| 56195 | CAPOTEN | tbl 30x25mg | BMS | AUS |
| 56196 | CAPOTEN | tbl 90x25mg | BMS | AUS |
| 97873 | ALKADIL | tbl 40x25mg | ALK | MAC |
| 31215 | TENSIOMIN 25MG | tbl 30x25mg | EGI | H |
| 164.3 | C09AA02 | enalapril (do 5 mg v jedné tabletě včetně) | p.o. | 10 | MG | 5,62 | |
| 45273 | ENAP 5 MG | tbl 30x5 mg | KRK | SLO |
| 55637 | ENALAPRIL LACHEMA 5 | tbl 100x5 mg | LCM | CZ |
| 59916 | ENALAPRIL LACHEMA 5 | tbl 60x5 mg | LCM | CZ |
| 85927 | ENALAPRIL LACHEMA 5 | tbl 20x5 mg | LCM | CZ |
| 83508 | EDNYT 5 MG | tbl 100x5 mg | GED | H |
| 83503 | APO-ENALAPRIL 5 MG | tbl 100x5 mg | APQ | MEX |
| 164.4 | C09AA02 | enalapril (nad 5 do 10 mg v jedné tabletě včetně) | p.o. | 10 | MG | 4,55 | |
| 92576 | ENALAPRIL LACHEMA 10 | tbl 20x10mg | LCM | CZ |
| 83510 | EDNYT 10 MG | tbl 100x 10 mg | GED | H |
| 45274 | ENAP 10 MG | tbl 30x10 mg | KRK | SLO |
| 64839 | APO-ENALAPRIL 10 MG | tbl 100x10 mg | APQ | MEX |
| 164.5 | C09AA02 | enalapril (nad 10 mg v jedné tabletě) | p.o. | 10 | MG | 3,57 | |
| 55639 | ENALAPRIL LACHEMA 20 | tbl 100x20mg | LCM | CZ |
| 59918 | ENALAPRIL LACHEMA 20 | tbl 60x20mg | LCM | CZ |
| 85928 | ENALAPRIL LACHEMA 20 | tbl 20x20mg | LCM | CZ |
| 45275 | ENAP 20 MG | tbl 30x20 mg | KRK | SLO |
| 64840 | APO-ENALAPRIL 20 MG | tbl 100x20 mg | APQ | MEX |
| 164.6 | C09AA03 | lisinopril | p.o. | 10 | MG | 8,55 | |
| 67562 | DAPRIL 10 | tbl 30x10mg | MOE | CY |
| 67563 | DAPRIL 20 | tbl 20x20mg | MOE | CY |
| 67561 | DAPRIL 5 | tbl 30x5mg | MOE | CY |
| 164.7 | C09AA04 | perindopril | p.o. | 4 | MG | 9,09 | |
|
| 164.8 | C09AA05 | ramipril | p.o. | 2.5 | MG | 9,09 | |
|
| 164.9 | C09AA06 | quinapril | p.o. | 15 | MG | 9,09 | |
|
| 164.10 | C09AA07 | benazepril | p.o. | 7.5 | MG | 9,09 | |
|
| 164.11 | C09AA08 | cilazapril | p.o. | 2.5 | MG | 9,09 | |
|
| 164.12 | C09AA10 | trandolapril | p.o. | 2 | MG | 9,09 | |
|
| 164.13 | C09AA11 | spirapril | p.o. | 6 | MG | 9,09 | |
|
| 164.14 | C09AA12 | delapril | p.o. | 30 | MG | 9,09 | |
|
| 164.15 | C09AA13 | moexipril | p.o. | 15 | MG | 9,09 | |
|
| 164.16 | C09AA01 | kaptopril (nad 25 mg v 1 tabletě) | p.o. | 50 | MG | 4,59 | |
| 91022 | CAPOTEN | tbl 90x50mg | BMS | GB |
| 56198 | CAPOTEN | tbl 90x50mg | BMS | AUS |
| 97874 | ALKADIL | tbl 40x50mg | ALK | MAC |
| 31216 | TENSIOMIN 50MG | tbl 20x50mg | EGI | H |
| 165 | C09AA | inhibitory angiotenzin konvertujícího enzymu | parent. | H |
|---|
| 165.1 | C09AA02 | enalaprilát | parent. | 1.25 | MG | 27,76 | H |
| 62597 | ENAP I.V. | inj 5x1ml/1.25mg | KRK | SLO |
| 166 | C09BA | inhibitory angiotenzin konvertujícího enzymu v kombinaci s diuretiky | p.o. | |
|---|
| 166.1 | C09BA01 | kaptopril a diuretika | p.o. | 1 | DF | 5,96 | |
|
| 166.2 | C09BA02 | enalapril a diuretika | p.o. | 1 | DF | 5,47 | |
| 166.3 | C09BA06 | quinapril a diuretika | p.o. | 1 | DF | 6,31 | |
|
| 166.4 | C09BA07 | benazepril a diuretika | p.o. | 1 | DF | 6,79 | |
|
| 166.5 | C09BB10 | trandolapril/ verapamil | p.o. | 1 | DF | 15,64 | |
| 167 | C09CA | antagonisté angiotensinu II | p.o. | Z |
|---|
| 167.1 | C09CA01 | losartan | p.o. | 50 | MG | 32,26 | Z |
|
| 167.2 | C09CA03 | valsartan | p.o. | 80 | MG | 32,26 | Z |
| 56239 | DIOVAN 80 | cps 28x80 | NPA | CH |
| 167.3 | C09CA04 | irbesartan | p.o. | 150 | MG | 32,26 | Z |
|
| 167.4 | C09CA06 | kandesartan | p.o. | 8 | MG | 32,26 | Z |
|
| 167.5 | C09CA07 | telmisartan | p.o. | 40 | MG | 32,26 | Z |
|
| 167.6 | C09DA01 | losartan v kombinaci s thiazidy | p.o. | 1 | DF | 32,65 | Z |
| 168 | C10AA | hypolipidemika ze skupiny statinů | p.o. | P |
|---|
Treatment is performed by a cardiologist, an intern or a physician working in a treatment centre for lipid disorders:
(a) treatment of patients with familial hypercholesterolaemia,
(b) treatment of patients with manifested atherosclerosis with isolated hypercholesterolaemia or combined hyperlipoproteinaemia with only slight increase in triglyceride,
(c) treatment of patients with accumulation of risk factors for isolated hypercholesterolaemia or combination hyperlipoproteinaemia with only slight increase in triglyceride,
(d) in other patients only after prior approval by a revision physician.
| 168.1 | C10AA01 | simvastatin (do 10 mg v jedné tabletě včetně) | p.o. | 15 | MG | 38,71 | P |
|
| 168.2 | C10AA01 | simvastatin (nad 10 do 20 mg v jedné tabletě včetně) | p.o. | 15 | MG | 32,36 | P |
|
| 168.3 | C10AA01 | simvastatin (nad 20 mg v jedné tabletě) | p.o. | 15 | MG | 29,33 | P |
|
| 168.4 | C10AA02 | lovastatin (do 20 mg v jedné tabletě včetně) | p.o. | 30 | MG | 38,71 | P |
|
| 168.5 | C10AA02 | lovastatin (nad 20 mg v jedné tabletě) | p.o. | 30 | MG | 30,79 | P |
|
| 168.6 | C10AA03 | pravastatin (do 10 mg v jedné tabletě včetně) | p.o. | 20 | MG | 43,01 | P |
|
| 168.7 | C10AA03 | pravastatin (nad 10 mg v jedné tabletě) | p.o. | 20 | MG | 34,22 | P |
| 86040 | LIPOSTAT 20MG | tbl 30x20mg | BMS | I |
| 168.8 | C10AA04 | fluvastatin (do 20 mg v jedné tabletě včetně) | p.o. | 40 | MG | 34,22 | P |
| 65335 | LESCOL 20MG | cps 28x20mg | SAN | CH |
| 168.9 | C10AA04 | fluvastatin (nad 20 mg v jedné tabletě) | p.o. | 40 | MG | 27,57 | P |
| 65336 | LESCOL 40MG | cps 28x40mg | SAN | CH |
| 168.10 | C10AA05 | atorvastatin (do 10 MG včetně v jedné tabletě) | p.o. | 10 | MG | 38,32 | P |
|
| 168.11 | C10AA05 | atorvastatin (nad 10 MG v jedné tabletě) | p.o. | 10 | MG | 23,12 | P |
| 169 | C10A | hypolipidemika ze skupiny fibrátů a některých dalších skupin | p.o. | |
|---|
| 169.1 | C10AB | etofylin klofibrát | p.o. | 0.5 | GM | 4,79 | |
| 49609 | DUOLIP FORTE | tbl 100x500mg | MCK | A |
| 49608 | DUOLIP FORTE | tbl 30x500mg | MCK | A |
| 169.2 | C10AB02 | bezafibrát | p.o. | 0.6 | GM | 9,78 | |
|
| 169.3 | C10AB04 | gemfibrozil | p.o. | 1.2 | GM | 9,78 | |
|
| 169.4 | C10AB05 | fenofibrát | p.o. | 0.3 | GM | 8,41 | |
|
| 169.5 | C10AB05 | fenofibrát (mikronisované lékové formy) | p.o. | 1 | DF | 13,00 | |
| 92327 | LIPANTHYL 200 M | cps 30x200mg | LCM | CZ |
| 76502 | LIPANTHYL 200 M | cps 30x200mg | FFR | F |
| 169.6 | C10AB08 | ciprofibrát | p.o. | 0.1 | GM | 9,78 | |
| 84430 | LIPANOR | cps 30x100mg | SWI | F |
| 169.7 | C10AD06 | acipimox | p.o. | 500 | MG | 11,73 | |
| 170 | C10AC | hypolipidemika ze skupiny pryskyřic | p.o. | P |
|---|
Treatment is performed by a cardiologist, an intern or a physician working in a treatment centre for lipid disorders:
(a) the treatment of patients with high cholesterol hyperlipoproteinaemia;
(b) treatment of patients with pruritus during biliary cirrhosis.
| 170.1 | C10AC01 | cholestyramin | p.o. | 14 | GM | 31,77 | P |
| 94031 | VASOSAN P | plv 1x400gm | FOP | D |
| 94033 | VASOSAN S | plv 1x400gm | FOP | D |
| 170.2 | C10AC02 | colestipol | p.o. | 20 | GM | 59,39 | P |
| 171 | D01AA | antimykotika pro lokální podání ze skupiny antibiotik | lok. | |
|---|
| 171.1 | D01AA01 | nystatin | lok. | 1 | GM | 2,54 | |
| 01069 | FUNGICIDIN LECIVA | ung 1x10gm | LEX | CZ |
| 171.2 | D01AA02 | natamycin | lok. | 1 | GM | 1,96 | |
| 172 | D01AC | antimykotika pro lokální podání ze skupiny derivátu imidazolu | lok. | |
|---|
| 172.1 | D01AC01 | klotrimazol | lok. | 1 | GM | 1,96 | |
| 86262 | CANESTEN | crm 1x20gm | LEX | CZ |
| 65484 | CLOTRIMAZOL AL 1% | crm 1x20gm 1% | APA | D |
| 86397 | CLOTRIMAZOL AL 1% | crm 1x50gm 1% | APA | D |
| 93483 | CLOTRIMAZOLUM POLFA | crm 20gm 1% | POL | PL |
| 172.2 | D01AC02 | mikonazol | lok. | 1 | GM | 1,96 | |
|
| 172.3 | D01AC03 | ekonazol lékové formy krému | lok. | 1 | GM | 1,96 | |
|
| 172.4 | D01AC03 | ekonazol (lékové formy tekuté, lipogelu a pasty) | lok. | 1 | GM | 3,52 | |
| 62665 | PEVARYL | pst 1x30gm 1% | CIL | CH |
| 172.5 | D01AC05 | isokonazol | lok. | 1 | ML | 1,96 | |
|
| 172.6 | D01AC08 | ketokonazol | lok. | 1 | GM | 1,96 | |
|
| 172.7 | D01AC10 | bifonazol | lok. | 1 | GM | 3,52 | |
|
| 172.8 | D01AC11 | oxikonazol | lok. | 1 | GM | 2,49 | |
| 99248 | MYFUNGAR | crm 1x30gm | LEX | CZ |
| 172.9 | D01AC12 | fenticonazol | lok. | 1 | GM | 1,96 | |
|
| 172.10 | D01AC20 | kombinace | lok. | 1 | GM | 1,96 | |
|
| 172.11 | D01AC51 | clotrimazol/urea | lok. | 1 | GM | 1,96 | |
|
| 172.12 | D01AC60 | bifonazol, kombinace | lok. | 1 | GM | 29,33 | P |
Treatment is administered by a dermatologist in onychomycosis, supported by culture testing and documented contraindication to the use of systemic antifungal therapy.
| 172.13 | D01AC | sertakonazol | lok. | 1 | GM | 3,52 | |
|
| 172.14 | D01AC01 | klotrimazol tekuté lékové formy | lok. | 1 | GM | 2,54 | |
| 173 | D01AE | antimykotika pro lokální podání ostatních skupin | lok. | |
|---|
| 173.1 | D01AE | jiná antimykotika k zevnímu použití (nitroethanoldodecylsulfonat) | lok. | 1 | ML | 0,83 | |
| 00799 | NITROFUNGIN | liq 1x25ml | GNO | CZ |
| 02772 | MYCO-DECIDIN | liq 25ml | GNO | CZ |
| 173.2 | D01AE04 | kyselina undecylenová | lok. | 1 | GM | 0,93 | |
| 00871 | MYKOSEPTIN | ung 1x30gm | LEX | CZ |
| 173.3 | D01AE14 | ciclopirox | lok. | 1 | GM | 3,91 | |
| 06291 | BATRAFEN ROZTOK | sol 1x20ml 1% | HOE | D |
| 76150 | BATRAFEN | crm 1x20gm | HBS | SK |
| 76152 | BATRAFEN | liq 1x20ml | HBS | SK |
| 173.4 | D01AE15 | terbinafin | lok. | 1 | GM | 3,91 | |
|
| 173.5 | D01AE16 | amorolfin | lok. | 1 | GM | 3,91 | |
|
| 173.6 | D01AE18 | tolnaftat | lok. | 1 | GM | 1,96 | |
|
| 173.7 | D01AE19 | tolciklát | lok. | 1 | GM | 1,96 | |
|
| 173.8 | D01AE20 | kombinace antimykotik (tolnaftat/cetrimid) | lok. | 1 | GM | 1,96 | |
|
| 173.9 | D01AE20 | kombinace antimykotik (ostatní kombinace) | lok. | 1 | GM | 0,64 | |
| 02353 | HEXADECYL | spr 1x70ml | GNO | CZ |
| 173.10 | D01AE | naftini hydrochlorid | lok. | 1 | GM | 2,93 | |
| 174 | D01BA | antimykotika pro celkové podání | p.o. | P |
|---|
Treatment with terbinafine is performed by dermatologist:
(a) severe forms of dermatomycosis of selected dermatophytes based on culture or microscopic examination
(b) heavy forms of nail mycosis, if at least one of the following conditions applies:
Disability of the whole nail plate
Disability of at least four nail plates such that each has a disability affecting more than 30% for the free edge of the nail in a axial direction
Influenza of the fingernail of the lower limb
A positive microscopic finding and mycological culture sampling are a condition for initiating treatment ad (b).
| 174.1 | D01BA01 | griseofulvin | p.o. | 0.5 | GM | 8,02 | |
| 01606 | GRICIN | tbl 100x125mg | VAD | D |
| 94717 | GRISOVIN | tbl obd 100x125mg | GLA | GB |
| 174.2 | D01BA02 | terbinafin | p.o. | 0.25 | GM | 69,51 | P |
| 62387 | LAMISIL | tbl 14x125mg | SAN | CH |
| 62388 | LAMISIL | tbl 14x250mg | SAN | CH |
| 175 | D02AB | emolliencia obsahující oxid zinečnatý | lok. | |
|---|
| 175.1 | D02AB | přípravky obsahující oxid zinečnatý (do 120 g v jednom balení včetně) | lok. | 1 | GM | 0,78 | |
| 88597 | TEKUTY PUDR AA 100GM GLO | sus 1x100gm | GAO | CZ |
| 88598 | TEKUTY PUDR S MENTOLEM | sus 1x116gm | GAO | CZ |
| 54249 | SUSPENSIO ZINCI OXYDATI HERBAC. | sus 1x100gm | HEO | CZ |
| 176 | D02AC | emolliencia obsahující měkký parafin a tukové produkty | lok. | L/DER,PDD |
|---|
| 176.1 | D02AC91 | měkký parafin a tukové produkty (do 250 ml v 1 balení včetně) - tekuté lékové formy | lok. | 1 | ML | 0,59 | L/DER,PDD |
|
| 176.2 | D02AC91 | měkký parafin a tukové produkty (nad 250 ml v 1 balení) - tekuté lékové formy | lok. | 1 | ML | 0,54 | L/DER,PDD |
|
| 176.3 | D02AC91 | měkký parafin a tukové produkty (do 250 gm v 1 balení včetně) | lok. | 1 | GM | 0,59 | L/DER,PDD |
|
| 176.4 | D02AC91 | měkký parafin a tukové produkty (nad 250 gm v 1 balení) | lok. | 1 | GM | 0,54 | L/DER,PDD |
|
| 176.5 | D02AE01 | měkký parafin a tukové produkty s obsahem močoviny -tekuté lékové formy | lok. | 1 | ML | 0,59 | L/DER,PDD |
| 97152 | EXCIPIAL U LIPOLOTIO | lot 1x200ml | SEG | CH |
| 97153 | EXCIPIAL U HYDROLOTIO | lot 1x200ml | SEG | CH |
| 177 | D02AX | jiná emolliencia a protektiva | lok. | |
|---|
| 177.1 | D02AX | jiná emolliencia a protektiva (do 50 g v balení včetně) | lok. | 1 | GM | 1,71 | |
| 00891 | POLYSAN | pst 1x50gm | SLO | SK |
| 177.2 | D02AX | jiná emolliencia a protektiva (nad 50 g v balení) | lok. | 1 | GM | 0,64 | |
| 04192 | POLYSAN | pst 1x650gm | SLO | SK |
| 88603 | POLYSAN CUM OLEUM HELIANTI GLO | ung 1x900gm | GAO | CZ |
| 177.3 | D03AX92 | jiná léčiva podporující tvorbu jizev (chlorofyl) | lok. | 1 | ML | 0,49 | |
|
| 177.4 | D03AX02 | dextranomer | lok. | 1 | GM | 3,91 | |
|
| 177.5 | D03AX91 | jiná léčiva podporující zajizvení (kombinace celulosa + karboxycelulosa, na obsah karboxycelulosy) | lok. | 1 | GM | 15,40 | |
| 93561 | SYSTOGEN | plv.ads.1x20GM | IHO | CZ |
| 178 | D03BA | proteolytické enzymy | lok. | P |
|---|
Treatment is performed by a surgeon, orthopaedic surgeon, gynecologist, otorhinolaryngologist or dermatologist:
(a) the treatment of leg ulcers,
(b) treatment of necrotic post-injury or post-operative wounds;
(c) treatment of necrotic wounds and decubits.
| 178.1 | D03BA | proteolytické enzymy (chymotrypsin) | lok. | 1 | GM | 79,28 | P |
| 01915 | CHYMOTRYPSIN INFUSIA | plv ads 1x1gm | IHO | CZ |
| 178.2 | D03BA | proteolytické enzymy (kolagenáza - do 10 GM v jednom balení včetně) | lok. | 1 | GM | 18,57 | P |
|
| 178.3 | D03BA | proteolytické enzymy (plasmin/deoxiribonukleáza) | lok. | 1 | GM | 13,69 | P |
| 42261 | FIBROLAN | ung 1x100gm | PDA | D |
| 42262 | FIBROLAN | ung 1x25gm | PDA | D |
| 62518 | FIBROLAN | ung 1x50gm | PDA | D |
| 178.4 | D03BA | proteolytické enzymy (trypsin/chymotrypsin) | lok. | 1 | GM | 28,84 | P |
|
| 178.5 | D03BA | proteolytické enzymy (kolagenáza - nad 10 GM v jednom balení) | lok. | 1 | GM | 16,62 | P |
|
| 178.6 | D04AB01 | lidokain (lékové formy spreje, koncentrace 10%) | lok. | 1 | GM | 2,10 | O |
| 179 | D05AA | antipsoriatika ze skupiny dehtů a derivátů vitaminu D | lok. | |
|---|
Treatment of vitamin derivatives D in local pharmaceutical forms is operated by dermatologist:
(a) treatment for torpid localized psoriasis not responding to standard therapy of up to 100 g per week.
(b) in other cases only after approval by the medical insurance undertaking's medical examiner.
| 179.1 | D05AA | dehty (odbarvený dehet) | lok. | 1 | GM | 1,17 | |
|
| 179.2 | D05AA | dehty | lok. | 1 | GM | 0,73 | |
| 92428 | BALSAMUM VISNEVSKI CSC | sus 1x600gm | CSP | CZ |
| 92430 | BALSAMUM VISNEVSKI CSC | sus 1x3kg | CSP | CZ |
| 00889 | PITYOL | ung 1x30gm | LEX | CZ |
| 85950 | SUSPENSIO VISNEVSKI+PICE LIQUID | sus 1x1000gm | HEO | CZ |
| 86399 | SUSPENSIO VISNEVSKI+PICE LIQUID | sus 1x1000gm | PSR | CZ |
| 92553 | SUSPENSIO VISNEV.+PICE LIQ.TAU. | sus 1x400gm | TAU | CZ |
| 92554 | SUSPENSIO VISNEV.+PICE LIQ.TAU. | sus 1x800gm | TAU | CZ |
| 83870 | UNGUENTUM ICHTAMOLI 10% MVM | ung 1x1kg | MVM | CZ |
| 83871 | UNGUENTUM ICHTAMOLI 20% MVM | ung 1x1kg | MVM | CZ |
| 92547 | UNGUENTUM ICHTAMOLI 10% TAURUS | ung 1x400gm | TAU | CZ |
| 92548 | UNGUENTUM ICHTAMOLI 10% TAURUS | ung 1x800gm | TAU | CZ |
| 179.3 | D05AD02 | methoxalen (0,15 % koncentrace) | lok. | 1 | ML | 4,30 | |
| 90618 | OXSORALEN | liq 1x50ml 0.15% | GER | A |
| 179.4 | D05AC01 | dithranol | lok. | 1 | GM | 3,91 | |
|
| 179.5 | D05AX02 | kalcipotriol | lok. | 1 | GM | 11,73 | P |
|
| 179.6 | D05AX04 | tacalcitol | lok. | 1 | GM | 15,64 | P |
| 180 | D05BB | retinoidy pro celkové podání | p.o. | P |
|---|
Treatment is performed by dermatologist:
(a) treatment for severe generalised forms of psoriasis not responding to other treatments;
b) other severe forms of keratinisation disorder not responding to any other treatment only after prior approval by a revision physician
| 180.1 | D05BB01 | etretinát | p.o. | 35 | MG | 81,14 | P |
| 180.2 | D05BB02 | acitretin | p.o. | 35 | MG | 81,14 | P |
| 76660 | NEOTIGASON ROCHE 10MG | cps 30x10mg | HLR | CH |
| 76661 | NEOTIGASON ROCHE 25MG | cps 30x25mg | HLR | CH |
| 180.3 | D05BA02 | methoxalen | p.o. | 10 | MG | 4,06 | L/DER |
| 03733 | OXSORALEN | cps 50x10mg | GER | A |
| 181 | D06AX | antibiotika k zevnímu použití | lok. | |
|---|
| 181.1 | D06AA | tetracyklin a deriváty | lok. | 1 | GM | 2,93 | |
|
| 181.2 | D06AX | neomycin/ bacitracin (k přípravě roztoku) | lok. | 1 | ML | 3,91 | |
| 55759 | PAMYCON NA PRIPRAVU KAPEK | plv 1x1lahv | BTA | SK |
| 181.3 | D06AX | neomycin/ bacitracin (zásyp do 2 g včetně) | lok. | 1 | GM | 13,69 | |
| 01062 | FRAMYKOIN | plv ads 1x2gm | IHO | CZ |
| 181.4 | D06AX | neomycin/ bacitracin (zásyp nad 2 do 5 g v jednom balení včetně) | lok. | 1 | GM | 7,63 | |
|
| 181.5 | D06AX | neomycin/ bacitracin (mast) | lok. | 1 | GM | 2,93 | |
| 01066 | FRAMYKOIN | ung 1x10gm | LEX | CZ |
| 181.6 | D06AX | primycin | lok. | 1 | GM | 2,44 | |
| 31122 | EBRIMYCIN | gel 1x10gm | MIH | H |
| 181.7 | D06AX02 | chloramfenikol | lok. | 1 | GM | 2,88 | |
|
| 181.8 | D06AX09 | mupirocin (do 5 g v jednom balení včetně) | lok. | 1 | GM | 8,31 | |
|
| 181.9 | D06AX09 | mupirocin (nad 5 g v jednom balení) | lok. | 1 | GM | 5,18 | |
|
| 181.10 | D06AX | neomycin/ bacitracin (zásyp nad 5 g v jednom balení) | lok. | 1 | GM | 2,44 | |
| 01063 | FRAMYKOIN | plv ads 1x20gm | IHO | CZ |
| 182 | D06BA | sulfonamidy s obsahem stříbrných solí k lokálnímu podání | lok. | L/DER,CHI |
|---|
| 182.1 | D06BA | sulfathiazin stříbrný (do 50 g v jednom balení včetně) | lok. | 1 | GM | 1,08 | L/DER,CHI |
|
| 182.2 | D06BA | sulfathiazin stříbrný (nad 50 g v jednom balení) | lok. | 1 | GM | 0,98 | L/DER,CHI |
|
| 182.3 | D06BA01 | sulfadiazin stříbrný (do 50 g v jednom balení včetně) | lok. | 1 | GM | 1,32 | L/DER,CHI |
| 62229 | DERMAZIN | crm 1x50gm 1% | LEK | SLO |
| 182.4 | D06BA01 | suifadiazin stříbrný (nad 50 g v jednom balení) | lok. | 1 | GM | 1,12 | L/DER,CHI |
|
| 182.5 | D06BA02 | sulfathiazol | lok. | 1 | GM | 1,03 | |
|
| 182.6 | D06BA03 | mafenid | lok. | 1 | GM | 0,98 | L/DER,CHI |
|
| 182.7 | D06BA51 | sulfadiazin stříbrný v kombinaci (léková forma náplasti) | lok. | 100 | CM2 | 13,49 | L/DER,CHI |
|
| 182.8 | D06BA51 | sulfadiazin stříbrný v kombinaci (léková forma krému) | lok. | 1 | GM | 2,25 | L/DER,CHI |
| 183 | D07AA | kortikosteroidy třídy I, slabě účinné | lok. | |
|---|
| 183.1 | D07AA02 | hydrokortison | lok. | 1 | GM | 2,69 | |
| 00858 | HYDROCORTISON LECIVA | ung 1x10gm 1% | LEX | CZ |
| 183.2 | D07AA03 | prednisolon | lok. | 1 | GM | 3,32 | |
| 184 | D07AB | kortikosteroidy třídy II, středně účinné | lok. | |
|---|
| 184.1 | D07AB01 | klobetazon | lok. | 1 | GM | 3,32 | |
|
| 184.2 | D07AB02 | hydrokortison butyrát | lok. | 1 | GM | 3,32 | |
| 09310 | LOCOID 0.1% | ung 1x30gm 0.1% | YEU | NL |
| 09305 | LOCOID 0.1% | crm 1x30gm 0.1% | YEU | NL |
| 09307 | LOCOID 0.1% LOTION | lot 1x30ml | YEU | NL |
| 62047 | LOCOID LIPOCREAM | crm 1x30gm 0.1% | YEU | NL |
| 184.3 | D07AB03 | flumetason | lok. | 1 | GM | 3,32 | |
|
| 184.4 | D07AB07 | flupredniden | lok. | 1 | GM | 3,32 | |
|
| 184.5 | D07AB09 | triamcinolon (lékové formy mastí a krémů) | lok. | 1 | GM | 2,44 | |
| 02828 | TRIAMCINOLON LECIVA | crm 1x10gm 0.1% | LEX | CZ |
| 02829 | TRIAMCINOLON LECIVA | ung 1x10gm 0.1% | LEX | CZ |
| 184.6 | D07AB09 | triamcinolon (lékové formy lotia) | lok. | 1 | ML | 2,83 | |
| 02826 | TRIAMCINOLON | lot 1x15gm | GNO | CZ |
| 184.7 | D07AB09 | triamcinolon (lékové formy spreje) | lok. | 1 | GM | 0,73 | |
|
| 184.8 | D07AB09 | triamcinolon (lékové formy tinktury) | lok. | 1 | ML | 0,98 | |
|
| 184.9 | D07AB19 | dexamethason acetát | lok. | 1 | GM | 2,49 | |
| 02415 | DEXAMETHAZON LECIVA | crm 10gm 0.01% | LEX | CZ |
| 01965 | DEXAMETHAZON LECIVA | ung 1x10gm 0.025% | LEX | CZ |
| 185 | D07AC | kortikosteroidy třídy III, účinné (fluorované) | lok. | |
|---|
| 185.1 | D07AC01 | betamethason dipropionát | lok. | 1 | GM | 2,49 | |
| 98034 | DIPROSONE | crm 1x30gm | SCH | B |
| 98032 | DIPROSONE | ung 1x30gm | SCH | B |
| 88489 | KUTERID | crm 20gm | LEK | SLO |
| 80204 | BELODERM | ung 1x30gm 0.05% | BLU | CHO |
| 80206 | BELODERM | crm 1x30gm 0.05% | BLU | CHO |
| 185.2 | D07AC01 | betamethason valerát | lok. | 1 | GM | 3,32 | |
| 88489 | KUTERID | crm 20gm | LEK | SLO |
| 185.3 | D07AC02 | fluklorolon | lok. | 1 | GM | 3,32 | |
|
| 185.4 | D07AC04 | fluocinolon gel | lok. | 1 | GM | 2,44 | |
| 04156 | GELARGIN | gel 1x25gm | LEX | CZ |
| 185.5 | D07AC04 | fluocinolon mast a krém (koncentrace do 0,025% včetně) | lok. | 1 | GM | 2,93 | |
| 97901 | SYNALAR | ung 1x30gm | ICI | GB |
| 97902 | SYNALAR | crm 1x30gm | ICI | GB |
| 185.6 | D07AC04 | fluocinolon mast a krém (koncentrace nad 0,025%) | lok. | 1 | GM | 3,91 | |
|
| 185.7 | D07AC04 | fluocinolon lotio (koncentrace do 0,025% včetně) | lok. | 1 | ML | 2,91 | |
|
| 185.8 | D07AC04 | fluocinolon lotio (koncentrace nad 0,025%) | lok. | 1 | ML | 3,91 | |
|
| 185.9 | D07AC06 | diflukortolon | lok. | 1 | GM | 3,42 | |
|
| 185.10 | D07AC08 | fluocinonid | lok. | 1 | GM | 2,93 | |
|
| 185.11 | D07AC09 | budesonid | lok. | 1 | GM | 3,18 | |
|
| 185.12 | D07AC12 | halometason | lok. | 1 | GM | 3,27 | |
|
| 185.13 | D07AC17 | flutikason | lok. | 1 | GM | 3,42 | |
| 186 | D07AC | kortikosteroidy třídy III, účinné (nefluorované) | lok. | L/DER,ALG,PDD |
|---|
| 186.1 | D07AC13 | mometazon | lok. | 1 | GM | 6,70 | L/DER,ALG,PDD |
|
| 186.2 | D07AC18 | prednikarbat (do 10 g v 1 balení včetně) | lok. | 1 | GM | 6,70 | L/DER,ALG,PDD |
| 83154 | DERMATOP | crm 1x10gm 2.5mg/gm | HBS | SK |
| 83156 | DERMATOP | ung 1x10gm 2.5mg/gm | HBS | SK |
| 186.3 | D07AC18 | prednikarbat (nad 10 g v 1 balení) | lok. | 1 | GM | 5,87 | L/DER,ALG,PDD |
| 187 | D07AD | kortikosteroidy třídy IV, vysoce účinné | lok. | L/DER |
|---|
| 187.1 | D07AD01 | klobetasol | lok. | 1 | GM | 4,40 | L/DER |
|
| 187.2 | D07AD02 | halcinonid | lok. | 1 | ML | 4,64 | L/DER |
| 97019 | BETACORTON | liq 1x25ml | SEG | CH |
| 188 | D07BB | kortikosteroidy, středně účinné, kombinace s antiseptiky | lok. | |
|---|
| 188.1 | D07BA01 | prednisolon/ cloroxin | lok. | 1 | GM | 1,96 | |
|
| 188.2 | D07BB | flumethason pivalat/kyselina salicylová | lok. | 1 | GM | 2,93 | |
|
| 188.3 | D07BB01 | flumetason a antiseptika | lok. | 1 | GM | 3,32 | |
| 03405 | LORINDEN C | ung 15gm | POL | PL |
| 188.4 | D07BB03 | triamcinolon a antiseptika (lékové formy pěny) | lok. | 1 | GM | 1,42 | |
| 02975 | TRIAMCINOLON | spm 40gm | GNO | CZ |
| 188.5 | D07BB03 | triamcinolon a antiseptika (lékové formy spreje) | lok. | 1 | GM | 0,59 | |
|
| 188.6 | D07BB03 | triamcinolon a antiseptika (lékové formy tinktury) | lok. | 1 | ML | 1,47 | |
| 02827 | TRIAMCINOLON | tct 1x10ml | GNO | CZ |
| 188.7 | D07BB03 | triamcinolon a antiseptika (lékové formy mastí a krémů) | lok. | 1 | GM | 1,81 | |
| 04178 | TRIAMCINOLON E LECIVA | ung 1x20gm | LEX | CZ |
| 188.8 | D07BA01 | prednisolon/ hexamidin diisothionát | lok. | 1 | GM | 1,96 | |
| 189 | D07X | kortikosteroidy, jiné kombinace | lok. | |
|---|
| 189.1 | D07XA01 | hydrokortison | lok. | 1 | ML | 1,96 | |
|
| 189.2 | D07XA02 | prednisolon/ kyselina salicylová | lok. | 1 | ML | 1,47 | |
| 92411 | ALPICORT | sol 1x100ml | WOL | D |
| 189.3 | D07XB01 | flumetason | lok. | 1 | GM | 4,40 | |
| 09297 | LOCACORTEN TAR | ung 1x60gm | CGC | CH |
| 189.4 | D07XB02 | triamcinolon | lok. | 1 | GM | 1,81 | |
| 04160 | TRIAMCINOLON S LECIVA | ung 1x30gm | LEX | CZ |
| 189.5 | D07XC | diflucortolon/ isoconasol | lok. | 1 | GM | 2,69 | |
|
| 189.6 | D07XC01 | betamethason (lékové formy mastí a krémů) | lok. | 1 | GM | 2,69 | |
| 85864 | BELOSALIC | ung 1x30gm | BLU | CHO |
| 189.7 | D07XC01 | betamethason (lékové formy tinktur) | lok. | 1 | ML | 2,69 | |
|
| 189.8 | D07XD | halcinonid/ kyselina salicylová | lok. | 1 | ML | 3,57 | |
|
| 189.9 | D07XD | halcinonid/ močovina | lok. | 1 | GM | 3,57 | |
|
| 189.10 | D07CA01 | hydrocortison a antibiotika (lékové formy mastí a krémů) | lok. | 1 | GM | 1,96 | |
|
| 189.11 | D07CA01 | hydrocortison a antibiotika (tekuté lékové formy) | lok. | 1 | ML | 1,96 | |
| 190 | D08A | antiseptika a desinficiencia | lok. | |
|---|
| 190.1 | D08AC02 | chlorhexidin | lok. | 1000 | ML | 178,70 | |
|
| 190.2 | D08AD | kyselina boritá (lékové formy mastí) | lok. | 1 | GM | 0,68 | |
| 00905 | UNGUENTUM ACIDI BORICI SLOVAK. | ung 1x20gm 3% | SLO | SK |
| 190.3 | D08AD | kyselina boritá (lékové formy roztoků) | lok. | 10 | GM | 1,32 | |
|
| 190.4 | D08AG02 | polyvidon-jód (do 200 ml včetně roztoku v jednom balení) | lok. | 1 | ML | 0,98 | |
| 62318 | BETADINE (CHIRURG.) | liq 1x120ml | EGI | H |
| 02981 | JODISOL ROZTOK | liq 1x80gm | LDN | CZ |
| 96605 | JODISOL SPRAY S MECH.ROZPRASOV. | spr 1x75gm | LDN | CZ |
| 46054 | BRAUNOL 2000 | liq 1x100ml | BMB | CH |
| 190.5 | D08AG02 | polyvidon-jód (nad 200 ml roztoku v jednom balení) | lok. | 1 | ML | 0,49 | |
| 02983 | JODISOL ROZTOK | liq 1x760gm | LDN | CZ |
| 80553 | BRAUNOL 2000 | liq 1x1000ml | BMB | CH |
| 46056 | BRAUNOL 2000 | liq 1x500ml | BMB | CH |
| 62319 | BETADINE (CHIRURG.) | liq 1x1000ml | EGI | H |
| 62317 | BETADINE | liq 1x1000ml | EGI | H |
| 190.6 | D08AG02 | polyvidon-jód (do 200 g masti v jednom balení včetně) | lok. | 1 | GM | 1,96 | |
| 84421 | BRAUNOVIDON MAST | ung 100gm (pe tuba) | BMB | CH |
| 190.7 | D08AG02 | polyvidon-jód nad 200 g masti v jednom balení) | lok. | 1 | GM | 0,98 | |
| 46052 | BRAUNOVIDON MAST | ung 250gm (pe nad.) | BMB | CH |
| 84422 | BRAUNOVIDON MAST | ung 250gm (pe tuba) | BMB | CH |
| 190.8 | D08AH | kloroxin | lok. | 1 | GM | 0,78 | |
|
| 190.9 | D08AJ | bromid benzododecinia (vodný roztok do 50 ml v jednom balení včetně) | lok. | 1 | ML | 0,29 | |
|
| 190.10 | D08AJ | bromid benzododecinia (tinktura do 50 ml v jednom balení včetně) | lok. | 1 | ML | 0,29 | |
| 00739 | AJATIN TINCTURA | tct 1x50ml 1% | SLO | SK |
| 190.11 | D08AJ | chlorid karbetopendecinia (tinktura do 50 ml v jednom balení včetně) | lok. | 1 | ML | 0,29 | |
| 191 | D08AX | jiná antiseptika a desinficiencia | lok. | H |
|---|
| 191.1 | D08AX | hexamidin/ chlorhexidin | lok. | 1 | ML | 121,37 | H |
|
| 191.2 | D08AX | noxytiolin | lok. | 2.5 | GM | 492,11 | H |
|
| 191.3 | D08AX | noxytiolin/ tetrakain | lok. | 2.5 | GM | 492,11 | H |
|
| 191.4 | D08AX | taurolidin | lok. | 1 | GM | 94,48 | H |
| 93242 | TAUROLIN | gel 1x50gm/1.75gm | GSO | CH |
| 192 | D10A | lokálně podávaná léčiva k léčbě akne | lok. | |
|---|
| 192.1 | D10AD01 | tretinoin (lékové formy krémů a gelů do koncentrace 0,05% včetně) | lok. | 1 | GM | 3,96 | |
| 98205 | LOCACID | crm 1x30gm 0.05% | PFB | F |
| 97573 | RETIN A | crm 1x30gm 0.025% | CIL | CH |
| 03740 | RETIN A | crm 1x30gm 0.05% | CIL | CH |
| 192.2 | D10AD01 | tretinoin (lékové formy krémů a gelů koncentrace nad 0,05%) | lok. | 1 | GM | 4,40 | |
|
| 192.3 | D10AD01 | tretinoin (lékové formy roztoků do koncentrace 0,05% včetně) | lok. | 1 | ML | 4,11 | |
|
| 192.4 | D10AD01 | tretinoin (lékové formy roztoků koncentrace nad 0,05%) | lok. | 1 | ML | 4,40 | |
|
| 192.5 | D10AE01 | benzoyl peroxid (lékové formy krémů a gelů) | lok. | 1 | GM | 1,42 | |
| 86754 | ANTOPAR | gel 30gm 5% | LEK | SLO |
| 192.6 | D10AE01 | benzoyl peroxid (lékové formy roztoků a lotií) | lok. | 1 | ML | 0,39 | |
| 91816 | INOXITAN | lot 100ml 50mg/ml | GNO | CZ |
| 192.7 | D10AE01 | benzoyl peroxid (koncentrace 20%) | lok. | 1 | ML | 2,54 | |
|
| 192.8 | D10AF01 | klindamycin | lok. | 1 | ML | 1,96 | |
|
| 192.9 | D10AF02 | erythromycin (lékové formy krémů a mastí) | lok. | 1 | GM | 2,93 | |
| 192.10 | D10AF02 | erythromycin (lékové formy roztoků) do 60 ml včetně v jednom balení | lok. | 1 | ML | 2,25 | |
| 98204 | ERYFLUID | sol 1x30ml | PFB | F |
| 192.11 | D10AF52 | erythromycin v kombinaci | lok. | 1 | ML | 2,93 | |
|
| 192.12 | D10AX03 | kyselina azelaová | lok. | 1 | GM | 1,96 | |
|
| 192.13 | D10AF02 | erythromycin (lékové formy roztoků) nad 60 ml v jednom balení | lok. | 1 | ML | 1,81 | |
| 75285 | ERYFLUID | sol 1x100ml | PFB | F |
| 193 | D10B | celkově podávaná léčiva k léčbě akné | p.o. | X |
|---|
| 193.1 | D10BA01 | isotretinoin (do 10 MG včetně v jedné kapsli ) | p.o. | 30 | MG | 92,82 | X |
| 11685 | ROACCUTANE ROCHE | cps 30x10mg | HLR | CH |
| 193.2 | D10BA01 | isotretinoin (nad 10 MG v jedné kapsli) | p.o. | 30 | MG | 88,18 | X |
| 91843 | ROACCUTANE ROCHE | cps 30x20mg | HLR | CH |
| 194 | D11AX | jiná dermatologika | lok. | L/DER |
|---|
| 194.1 | D11AX | celulóza (lékové formy zásypů) | lok. | 1 | GM | 9,78 | L/DER |
|
| 194.2 | D11AX | fluorouracil (lékové formy roztoků) | lok. | 1 | ML | 17,25 | L/DER |
| 60890 | VERRUMAL | liq 1x13ml | HEM | D |
| 194.3 | D11AX | fluorouracil (lékové formy mastí) | lok. | 1 | GM | 13,15 | L/DER,ONK |
| 195 | G01AA | vaginálně podávaná antimykotika a antibiotika | vag. | |
|---|
Treatment with vaginal clindamycin is performed by a gynaecologist:
(a) the treatment of bacterial vaginosis during pregnancy,
(b) vaginitis with evidence of bacterial strains sensitivity to clindamycin.
| 195.1 | G01AA01 | nystatin | vag. | 100 | KU | 0,98 | |
|
| 195.2 | G01AA02 | natamycin (lékové formy s obsahem méně než 100 mg) | vag. | 25 | MG | 4,11 | |
|
| 195.3 | G01AA02 | natamycin (lékové formy s obsahem 100 mg) | vag. | 25 | MG | 7,14 | |
| 78213 | PIMAFUCIN | glo vag 3x100mg | YEU | NL |
| 195.4 | G01AA10 | klindamycin | vag. | 1 | GM | 12,81 | P |
|
| 195.5 | G01AA | neomycin/polymyxin/nystatin | vag. | 1 | DF | 10,90 | |
| 196 | G01AF | vaginálně podávané imidazolové deriváty | vag. | |
|---|
| 196.1 | G01AF | deriváty imidazolu | vag. | 0.1 | GM | 6,35 | |
|
| 196.2 | G01AF01 | metronidazol | vag. | 0.5 | GM | 3,71 | |
| 02430 | ENTIZOL | tbl vag 10x500mg | POL | PL |
| 66787 | MEDAZOL | tbl vag 10 | BLU | CHO |
| 196.3 | G01AF02 | klotrimazol (lékové formy vaginálních tablet) | vag. | 0.1 | GM | 8,70 | |
| 66549 | CLOTRIMAZOL AL 200 | tbl vag 3x200mg + apl. | HHC | D |
| 196.4 | G01AF02 | klotrimazol (lékové formy vaginálních krémů) | vag. | 0.1 | GM | 13,39 | |
| 68917 | JENAMAZOL 2% | crm vag 20gm+aplik. | VJP | D |
| 196.5 | G01AF04 | mikonazol | vag. | 0.1 | GM | 8,70 | |
|
| 196.6 | G01AF05 | ekonazol (lékové formy vaginálních krémů) | vag. | 0.1 | GM | 13,39 | |
|
| 196.7 | G01AF05 | ekonazol (lékové formy vaginálních tablet, globulí a čípků) | vag. | 0.1 | GM | 31,58 | |
|
| 196.8 | G01AF11 | ketoconazol | vag. | 0.4 | GM | 13,44 | |
|
| 196.9 | G01AF12 | fenticonazol | vag. | 0.1 | GM | 13,44 | |
|
| 196.10 | G01AF17 | oxikonazol | vag. | 0.6 | GM | 81,04 | |
| 99250 | GYNO-MYFUNGAR | tbl vag 1x600mg | LEX | CZ |
| 196.11 | G01AG02 | terkonazol (lékové formy vaginálních krémů) | vag. | 80 | MG | 13,49 | |
|
| 196.12 | G01AG02 | terkonazol (lékové formy vaginálních tablet) | vag. | 80 | MG | 31,28 | |
| 197 | G01AX | vaginálně podávaná jiná antiinfektiva a antiseptika | vag. | |
|---|
| 197.1 | G01AX | laktobacillus | vag. | 1 | DF | 10,26 | |
|
| 197.2 | G01AX | nifuratel/nystatin (lékové formy vaginálních čípků) | vag. | 1 | DF | 17,60 | |
|
| 197.3 | G01AX | nifuratel/nystatin (lékové formy vaginálních krémů) | vag. | 5 | GM | 35,19 | |
|
| 197.4 | G01AX | nitrofurantoin | vag. | 0.2 | GM | 2,64 | |
| 03629 | FURANTOIN LECIVA | tbl vag 30x100mg | LEX | CZ |
| 197.5 | G01AX | polykresol | vag. | 1 | GM | 1,42 | |
| 41965 | VAGOTHYL | sol 1x50gm | POL | PL |
| 197.6 | G01AX05 | nifuratel | p.o. | 0.6 | GM | 15,64 | L/GYN,URN |
|
| 197.7 | G01AX11 | polyvidon-jód (vaginální čípky) | vag. | 0.2 | GM | 8,94 | |
| 62321 | BETADINE | sup vag 14 | EGI | H |
| 197.8 | G01AX11 | polyvidon-jód (vaginální gel) | vag. | 0.2 | GM | 6,16 | |
| 94623 | BETADINE | gel vag 1x100gm+apl | MUP | CH |
| 197.9 | G01AX12 | ciklopirox (vaginální krém - do 40 GM včetně v jednom balení) | vag. | 1 | GM | 4,69 | |
|
| 197.10 | G01A | sulfathiazol | vag. | 1 | DF | 6,60 | |
|
| 197.11 | G01AX | jiná antiinfektiva a antiseptika (tetraboritan sodný) | vag. | 1 | DF | 6,40 | |
|
| 197.12 | G01AX12 | ciclopirox (vaginální roztok) | vag. | 1 | DF | 17,60 | |
|
| 197.13 | G01AX12 | ciclopirox (vaginální čípky) | vag. | 1 | DF | 31,28 | |
|
| 197.14 | G01AX12 | ciklopirox (vaginální krém - nad 40 GM v jednom balení) | vag. | 1 | GM | 3,52 | |
| 198 | G02AB | uterotonika ze skupiny námelových alkaloidů | p.o. | |
|---|
| 198.1 | G02AB02 | ergotové alkaloidy | p.o. | 0.2 | MG | 1,12 | |
|
| 198.2 | G02AB03 | ergometrin | p.o. | 0.2 | MG | 1,12 | |
| 199 | G02AB | uterotonika ze skupiny námelových alkaloidů | parent. | |
|---|
| 199.1 | G02AB01 | methylergometrin | parent. | 0.2 | MG | 17,21 | |
| 00509 | METHYLERGOMETRIN SPOFA | inj 5x1ml/0.2mg | SPX | CZ |
| 199.2 | G02AB03 | ergometrin | parent. | 0.2 | MG | 9,38 | |
| 200 | G02AD | uterotonika ze skupiny prostaglandinů | p.o. | H |
|---|
| 200.1 | G02AD02 | dinoproston | p.o. | 0.5 | MG | 95,31 | H |
| 86287 | PROSTIN E2 | tbl 10x0.5mg | UPJ | GB |
| 201 | G02AD | uterotonika ze skupiny prostaglandinů | vag. | K/P |
|---|
Treatment is administered by a gynecologist:
(a) preinduction of childbirth upon termination of pregnancy,
(b) induction of abortion within 24 weeks of pregnancy for genetic reasons;
(c) induction of childbirth (including stillbirth) after 24 weeks of pregnancy,
(d) in the postpartum period in the case of severe metrorhagia.
| 201.1 | G02AD02 | dinoproston (do 0,5 mg v jedné dávce včetně) | vag. | 1 | DF | 974,55 | K/P |
| 91643 | PREPIDIL | gel vag 3gm/0.5mg | UPJ | B |
| 201.2 | G02AD02 | dinoproston (nad 2 mg v jedné dávce) | vag. | 1 | DF | 416,94 | K/P |
|
| 201.3 | G02AD02 | dinoproston (nad 0,5 do 2 mg v jedné dávce včetně) | vag. | 1 | DF | 1111,90 | K/P |
| 202 | G02AD | uterotonika ze skupiny prostaglandinů | parent. | K/P |
|---|
Treatment is administered by a gynecologist:
(a) preinduction of childbirth upon termination of pregnancy,
(b) induction of abortion within 24 weeks of pregnancy for genetic reasons;
(c) induction of childbirth (including stillbirth) after 24 weeks of pregnancy,
(d) in the postpartum period in the case of severe metrorhagia.
| 202.1 | G02AD01 | dinoprost | parent. | 25 | MG | 651,85 | K/P |
|
| 202.2 | G02AD02 | dinoproston | parent. | 0.5 | MG | 389,86 | K/P |
| 67188 | PROSTIN E2 SS 1MG/ML | inj 1x0.75ml | UPJ | B |
| 67189 | PROSTIN E2 SS 10MG/ML | inj 1x0.5ml | UPJ | B |
| 202.3 | G02AD04 | karboprost | parent. | 0.25 | MG | 675,61 | K/P |
|
| 202.4 | G02AD05 | sulproston | parent. | 0.5 | MG | 651,85 | K/P |
| 203 | G02CA | tokolytika ze skupiny beta-sympatomimetik | p.o. | P |
|---|
Treatment is administered by a gynecologist:
only as a continuation of parenteral use of tocolytics.
| 203.1 | G02CA | hexoprenalin | p.o. | 1.5 | MG | 10,80 | P |
| 75173 | GYNIPRAL 0.5MG | tbl 20x0.5mg | HNP | A |
| 203.2 | G02CA01 | ritodrin | p.o. | 40 | MG | 23,66 | P |
|
| 203.3 | G02CA03 | fenoterol | p.o. | 20 | MG | 23,66 | P |
| 21391 | PARTUSISTEN | tbl 50x5mg | BOE | D |
| 204 | G02CA | tokolytika ze skupiny beta-sympatomimetik | parent. | U/P |
|---|
Treatment is administered by a gynecologist:
(a) initiation of tocolytic therapy after 20 weeks of pregnancy,
(b) the treatment of birth dystocia;
(c) intrapartic acute tocolysis.
| 204.1 | G02CA | hexoprenalin | parent. | 25 | RG | 45,36 | U/P |
| 75464 | GYNIPRAL 25RG KONCENTR.ZUR INF. | inf 5x5ml/25rg | HNP | A |
| 75463 | GYNIPRAL 10RG/2ML | inj 5x2ml/10rg | HNP | A |
| 75173 | GYNIPRAL 0.5MG | tbl 20x0.5mg | HNP | A |
| 204.2 | G02CA01 | ritodrin | parent. | 40 | MG | 45,36 | U/P |
|
| 204.3 | G02CA03 | fenoterol | parent. | 0.5 | MG | 45,36 | U/P |
| 03399 | PARTUSISTEN | inf 25x10ml/0.5mg | BOE | D |
| 205 | G02CB | inhibitory prolaktinu | p.o. | |
|---|
|
| 205.1 | G02CB | tergurid | p.o. | 1 | MG | 4,55 | |
| 91979 | MYSALFON | tbl obd 30x0.5mg | LEX | CZ |
| 205.2 | G02CB01 | bromokriptin | p.o. | 5 | MG | 14,66 | |
| 97673 | SEROCRYPTIN | tbl 30x2.5mg | SRO | I |
| 67515 | MEDOCRIPTINE | tbl 1000x2.5mg | MOE | CY |
| 67512 | MEDOCRIPTINE | tbl 30x2.5mg | MOE | CY |
| 205.3 | G02CB02 | lisurid | p.o. | 0.6 | MG | 2,49 | |
|
| 205.4 | G02CB03 | kabergolin | p.o. | 70 | RG | 27,08 | Z |
|
| 205.5 | G02CB04 | quinagolid | p.o. | 75 | RG | 27,08 | Z |
| 206 | G03B | androgeny | p.o. | L/END,ONK,GYN,SEX |
|---|
| 206.1 | G03BA03 | testosteron | p.o. | 0.12 | GM | 27,37 | L/END,ONK,GYN,SEX,URN |
|
| 206.2 | G03BB01 | mesterolon | p.o. | 50 | MG | 20,04 | L/END,ONK,GYN,SEX,URN |
| 09591 | PROVIRON 25 | tbl 20x25mg | SAG | D |
| 09592 | PROVIRON 25 | tbl 50x25mg | SAG | D |
| 207 | G03B | androgeny | parent. | L/END,ONK,GYN,SEX |
|---|
| 207.1 | G03BA03 | testosteron | parent. | 18 | MG | 8,11 | L/END,ONK,GYN,SEX,URN |
| 00373 | AGOVIRIN-DEPOT | inj 5x2ml/50mg | BTA | SK |
| 208 | G03CA | přirozené a semisyntetické estrogeny | p.o. | P |
|---|
Estradiol, treatment is performed by a gynaecologist, sexologist or endocrinologist:
(a) replacement treatment for women after premature menopause;
b) treatment of postmenopausal vegetative and estrogen-deficiency syndrome.
Estriol, treatment is performed by a gynaecologist, urologist, sexologist or endocrinologist: treatment of postmenopausal vegetative and estrogen-deficiency syndrome.
| 208.1 | G03CA | přírozené a semisyntetické estrogeny prosté, mestranol | p.o. | 0.15 | MG | 3,76 | P |
|
| 208.2 | G03CA57 | přírodní konj. estrogeny (do 625 RG včetně v jedné tabletě nebo tobolce) | p.o. | 625 | RG | 6,65 | P |
| 56299 | OESTROFEMINAL 0.3 | cps 21x0.3mg | MAC | D |
| 83387 | OESTROFEMINAL 0.6 | cps 21x0.6mg | MAC | D |
| 42200 | PREMARIN 0.625MG | tbl obd 1x28 | WYM | IRL |
| 53298 | PREMARIN 0.625MG | tbl obd 3x28 | WYM | IRL |
| 208.3 | G03CA03 | estradiol (do 2 mg v jedné tabletě včetně) | p.o. | 2 | MG | 6,65 | P |
|
| 208.4 | G03CA03 | estradiol (nad 2 mg v jedné tabletě) | p.o. | 2 | MG | 4,89 | P |
|
| 208.5 | G03CA03 | estradiol (s uvolněním méně než 50 RG/den, v rámci 28. denního cyklu) | transd. | 50 | RG | 4,89 | P |
|
| 208.6 | G03CA03 | estradiol (s uvolněním od 50 do 99 RG včetně /den, v rámci 28. denního cyklu) | transd. | 50 | RG | 6,65 | P |
|
| 208.7 | G03CA03 | estradiol (s uvolněním 100 a více RG/den, v rámci 28. denního cyklu) | transd. | 50 | RG | 9,97 | P |
|
| 208.8 | G03CA03 | estradiol (lékové formy gelů) | transd. | 1,5 | MG | 5,87 | P |
| 76922 | OESTROGEL | gel 1x80gm | LBE | F |
| 208.9 | G03CA03 | estradiol | vag. | 25 | RG | 5,87 | P |
|
| 208.10 | G03CA04 | estriol | p.o. | 2 | MG | 6,65 | P |
| 31315 | OVESTIN | tbl 30x2mg | ORG | NL |
| 208.11 | G03CA04 | estriol (lékové formy vaginálních krémů) | vag. | 0.2 | MG | 3,08 | P |
| 97170 | OVESTIN | crm 15gm+aplikator | ORG | NL |
| 98182 | OVESTIN | crm vag 1x 15gm+aplikator | ORG | IRL |
| 208.12 | G03CA04 | estriol (lékové formy vaginálních tablet, do 0,5 mg včetně) | vag. | 0.2 | MG | 5,87 | P |
|
| 208.13 | G03CA04 | estriol (lékové formy vaginálních tablet, nad 0,5 mg) | vag. | 0.2 | MG | 1,22 | P |
| 97590 | ORTHO-GYNEST D | sup vag 6 | CIL | CH |
| 208.14 | G03CA57 | přírodní konj. estrogeny (nad 625 RG v jedné tabletě nebo tobolce) | p.o. | 625 | RG | 4,89 | P |
| 09467 | OESTROFEMINAL 1.25 | cps 21x1.25mg | MAC | D |
| 53300 | PREMARIN 1.25MG | tbl obd 3x28 | WYM | IRL |
| 208.15 | G03CA03 | estradiol (lékové formy vaginálních krémů) | vag. | 0.2 | MG | 3,08 | P |
| 209 | G03CA | přirozené a semisyntetické estrogeny | parent. | |
|---|
| 209.1 | G03CA03 | estradiol | parent. | 1 | MG | 4,35 | |
| 00364 | AGOFOLLIN | inj 5x1ml/5mg | BTA | SK |
| 00365 | AGOFOLLIN-DEPOT | inj 1x2ml/10mg | BTA | SK |
| 209.2 | G03CA03 | estradiol valerat | parent. | 1 | MG | 2,40 | |
| 00529 | NEOFOLLIN | inj 5x1ml/5mg | BTA | SK |
| 209.3 | G03CA04 | estriol | parent. | 2 | MG | 4,30 | |
| 210 | G03D | progestiny | p.o. | L/GYN,URN,END,INT, SEX |
| 210.1 | G03DA02 | medroxy-progesteron | p.o. | 5 | MG | 3,81 | L/GYN,URN,END, INT,SEX |
| 91231 | PROVERA | tbl 24x5mg | UPJ | B |
| 210.2 | G03DA04 | progesteron | p.o. | 0.3 | GM | 17,40 | L/GYN,URN,END, INT,SEX |
|
| 210.3 | G03DB01 | dydrogesteron | p.o. | 10 | MG | 3,81 | L/GYN,URN,END, INT,SEX |
|
| 210.4 | G03DC02 | norethisteron | p.o. | 5 | MG | 2,88 | L/GYN,URN,END, INT,SEX |
| 01939 | NORETHISTERON SLOVAKOFARMA | tbl 30x5mg | SLO | SK |
| 210.5 | G03DC03 | lynestrenol | p.o. | 5 | MG | 2,88 | L/GYN,URN,END, INT,SEX |
|
| 210.6 | G03DC05 | tibolon | p.o. | 2.5 | MG | 26,10 | Z |
| 211 | G03D | progestiny | parent. | L/GYN,URN,SEX |
|---|
|
| 211.1 | G03DA03 | hydroxy-progesteron | parent. | 10 | MG | 1,76 | L/GYN,URN,SEX |
| 00531 | NEOLUTIN FORTE | inj 5x1ml/125mg | SPX | CZ |
| 211.2 | G03DA04 | progesteron (depotní lékové formy) | parent. | 5 | MG | 4,01 | L/GYN,URN,SEX |
| 00367 | AGOLUTIN-DEPOT | inj 1x2ml/50mg | BTA | SK |
| 211.3 | G03DA04 | progesteron | parent. | 5 | MG | 1,08 | L/GYN,URN,SEX |
| 02094 | AGOLUTIN | inj 5x2ml/60mg | BTA | SK |
| 212 | G03E | androgeny a ženské pohlavní hormony | parent. | L/GYN,END,SEX |
|---|
| 212.1 | G03EA02 | testosteron a estrogen | parent. | 1 | DF | 22,34 | L/GYN,END,SEX |
| 00464 | FOLIVIRIN | inj 5x2ml | BTA | SK |
| 212.2 | G03EA03 | prasteron enantat/estradiol valerat | parent. | 1 | DF | 73,32 | L/GYN,END,SEX |
| 213 | G03F | progestiny a estrogeny | p.o. | P |
|---|
Treatment is administered by a gynaecologist, sexologist or endocrinologist:
treatment of postmenopausal vegetative and estrogen-deficiency syndrome.
| 213.1 | G03FA01 | norethisteron a estrogen | p.o. | 1 | DF | 7,33 | P |
|
| 213.2 | G03FA01 | norethisteron a estrogen | transd. | 50 | RG | 7,33 | P |
|
| 213.3 | G03FB | gestageny a estrogeny, sekvenční přípravky | p.o. | 0.75 | DF | 5,08 | P |
| 67425 | CYCLO-MENORETTE | tbl obd 3x21(=63) | WYE | D |
| 84582 | CYCLOOSTROGYNAL | drg 21 | ASH | D |
| 84583 | CYCLOOSTROGYNAL | drg 3x21(=63) | ASH | D |
| 213.4 | G03FB05 | norethisteron a estrogen | p.o. | 1 | DF | 6,84 | P |
|
| 213.5 | G03FB06 | medroxy-progesteron a estrogen | p.o. | 0.75 | DF | 5,08 | P |
| 54310 | DIVINA | tbl 3x21 (=63) | ORN | DK |
| 54309 | DIVINA | tbl 1x21 | ORN | DK |
| 213.6 | G03HB01 | cyproteron/ estradiol | p.o. | 0.75 | DF | 6,84 | P |
| 214 | G03GA | gonadotrofin (choriový) | parent. | L/GYN,END,PDD,SEX |
|---|
| 214.1 | G03GA01 | choriový gonadotrofin (do 500 U v 1 ampuli včetně) | parent. | 250 | U | 24,59 | L/GYN,END,PDD, SEX |
| 10809 | PREGNYL | inj 3x500ut+solv. | ORG | NL |
| 214.2 | G03GA01 | choriový gonadotrofin (nad 500 U do 1500 U v 1 ampuli včetně) | parent. | 250 | U | 15,45 | L/GYN,END,PDD, SEX |
| 11951 | PREGNYL | inj 3x1500ut+solv. | ORG | NL |
| 214.3 | G03GA01 | choriový gonadotrofin (nad 1500 U v 1 ampuli) | parent. | 250 | U | 11,05 | L/GYN,END,PDD, SEX |
| 96314 | PREGNYL | inj 3x5000ut+solv. | ORG | NL |
| 99905 | PROFASI 5000 | inj sic 1x5ku+solv. | SRO | I |
| 99906 | PROFASI 5000 | inj 1x5ku+1x1ml | SRO | CH |
| 09571 | PROFASI 5000 | inj sic 3x5ku+solv. | SRO | I |
| 97855 | PROFASI 5000 | inj sic 3x5ku+solv. | SRO | CH |
| 99316 | PREGNYL | inj 50x5000ut+solv. | ORG | NL |
| 215 | G03GA | gonadotrofin (lidský) | parent. | Z |
|---|
| 215.1 | G03GA02 | gonadotrofin lidský | parent. | 75 | U | 329,64 | Z |
| 12979 | MENOGON | inj sic 10+10xsolv. | FEI | D |
| 43727 | MERIONAL 75 M.J. | inj sic 1x75ut+solv | IBS | CH |
| 215.2 | G03GA04 | urofollitrofin | parent. | 75 | U | 400,81 | Z |
| 99629 | METRODIN 75 | inj sic 1x75ut+solv | LSE | CH |
| 56473 | METRODIN 75 | inj sic 1x75ut+solv | SRO | I |
| 94394 | METRODIN 75 | inj sic 10x75ut+sol | LSE | CH |
| 56474 | METRODIN 75 | inj sic 10x75ut+sol | SRO | I |
| 43723 | FOSTIMON 75 M.J. | inj sic 1x75ut+solv | IBS | CH |
| 43724 | FOSTIMON 75 M.J | inj sic 10x75ut+sol | IBS | CH |
| 215.3 | G03GA06 | folitrofin beta | parent. | 75 | U | 733,19 | Z |
|
| 215.4 | G03GA04 | urofollitrofin vysoce čištěný | parent. | 75 | U | 488,79 | Z |
|
| 215.5 | G03GA05 | folitrofin alfa | parent. | 75 | U | 733,19 | Z |
| 216 | G03GB | syntetické stimulátory ovulace | p.o. | L/GYN,END,SEX |
|---|
| 216.1 | G03GB02 | klomifen | p.o. | 9 | MG | 1,32 | L/GYN,END,SEX, URN |
| 83672 | CLOMHEXAL 50 | tbl 10x50mg | HEX | D |
| 02628 | GRAVOSAN | tbl 30x50mg | LEX | CZ |
| 217 | G03HA | antiandrogeny | p.o. | L/PSY,END,URN,GYN, SEX |
|---|
| 217.1 | G03HA01 | cyproteron (do 10 mg v jedné tabletě včetně) | p.o. | 0.1 | GM | 195,52 | L/PSY,END,URN GYN,SEX |
|
| 217.2 | G03HA01 | cyproteron (nad 10 mg v jedné tabletě) | p.o. | 0.1 | GM | 71,51 | L/PSY,END,URN GYN,SEX |
| 97862 | ANDROCUR | tbl 20x50mg | SAG | D |
| 03783 | ANDROCUR | tbl 50x50mg | SAG | D |
| 218 | G03HA | antiandrogeny | parent. | L/PSY,SEX |
|---|
| 218.1 | G03HA01 | cyproteron | parent. | 0.1 | GM | 128,06 | L/PSY,SEX, URN |
| 23342 | ANDROCUR-DEPOT | inj 3x3ml/300mg | SAG | D |
| 219 | G03XA | antigonadotrofiny a podobná léčiva | p.o. | L/GYN,END,HEM,ALG, SEX |
|---|
| 219.1 | G03XA01 | danazol | p.o. | 0.6 | GM | 83,68 | L/GYN,END,HEM, ALG,SEX |
| 67525 | ANARGIL 100MG | cps 100x100mg | MOE | CY |
| 67526 | ANARGIL 100MG | cps 200x100mg | MOE | CY |
| 67527 | ANARGIL 100MG | cps 500x100mg | MOE | CY |
| 67528 | ANARGIL 200MG | cps 100x200mg | MOE | CY |
| 67529 | ANARGIL 200MG | cps 200x200mg | MOE | CY |
| 67530 | ANARGIL 200MG | cps 500x200mg | MOE | CY |
| 219.2 | G03XA02 | gestrinon | p.o. | 0.7 | MG | 47,36 | L/GYN,END,HEM, ALG,SEX |
| 220 | G04AB | chinolonová chemoterapeutika močových infekcí | p.o. | |
|---|
| 220.1 | G04AB01 | kyselina nalidixová | p.o. | 4 | GM | 8,55 | |
|
| 220.2 | G04AB03 | kyselina pipemidová | p.o. | 0.8 | GM | 19,55 | |
|
| 220.3 | G04AB04 | kyselina oxolinová | p.o. | 1 | GM | 8,55 | |
| 91101 | DESUROL | tbl 50x250mg | LEX | CZ |
| 221 | G04AC | nitrofuranová chemoterapeutika močových infekcí | p.o. | |
|---|
| 221.1 | G04AC01 | nitrofurantoin | p.o. | 0.2 | GM | 2,44 | |
| 90510 | FURANTOIN LECIVA | tbl ent 20x100mg | LEX | CZ |
| 221.2 | G04AC02 | nifurtinol | p.o. | 0.16 | GM | 2,44 | |
| 222 | G04BC | rozpouštědla močových kamenů | p.o. | |
|---|
| 222.1 | G04BC | rozpouštědla močových kamenů (ve formě prášku) | p.o. | 10 | GM | 6,01 | |
| 02150 | ALKALIT | gra 1x200gm | IHO | CZ |
| 222.2 | G04BC | rozpouštědla močových kamenů (ve formě eff. tablet) | p.o. | 4 | DF | 6,01 | |
| 223 | G04BD | spasmolytika močových cest | p.o. | L/URN,GYN,SEX, GER |
| 223.1 | G04BD02 | flavoxat | p.o. | 0.8 | GM | 13,69 | L/URN,GYN,SEX GER |
|
| 223.2 | G04BD04 | oxybutynin | p.o. | 15 | MG | 13,69 | L/URN,GYN,SEX GER |
| 66791 | DITROPAN | tbl 30x5mg | MDD | F |
| 13102 | UROXAL 5MG | tbl 60x5mg | DEB | F |
| 223.3 | G04BD06 | propiverin (do 5 mg v jedné tabletě včetně) | p.o. | 15 | MG | 12,32 | L/URN,GYN,SEX PDD, GER |
| 66819 | MICTONETTEN | drg 50x5mg | APG | D |
| 92255 | MICTONETTEN | drg 30x5mg | APG | D |
| 66820 | MICTONETTEN | drg 100x5mg | APG | D |
| 223.4 | G04BD06 | propiverin (nad 5 mg v jedné tabletě) | p.o. | 15 | MG | 6,35 | L/URN,GYN,SEX, GER |
| 92254 | MICTONORM | drg 30x15mg | APG | D |
| 66817 | MICTONORM | drg 50x15mg | APG | D |
| 66818 | MICTONORM | drg 100x15mg | APG | D |
| 224 | G04BX | jiná urologika, k léčbě benigní hyperplasie prostaty | p.o. | L/URN |
|---|
| 224.1 | G04CA01 | alfuzosin | p.o. | 7.5 | MG | 22,00 | L/URN |
|
| 224.2 | G04CA01 | alfuzosin (SR nebo retardované forny) | p.o. | 10 | MG | 22,00 | L/URN |
|
| 224.3 | G04CA02 | tamsulosin | p.o. | 0.4 | MG | 22,00 | L/URN |
|
| 224.4 | G04CA03 | terazosin | p.o. | 5 | MG | 20,33 | L/URN |
|
| 224.5 | G04CB01 | finasterid | p.o. | 5 | MG | 22,00 | L/URN |
|
| 224.6 | G04CX01 | extrakt Pyg. africanum | p.o. | 2 | DF | 20,14 | L/URN |
| 42212 | TADENAN 50MG | cps 30 | DEB | F |
| 224.7 | G04CX02 | extrakt Serenoa repens | p.o. | 320 | MG | 20,14 | L/URN |
|
| 224.8 | G04CX03 | mepartricin | p.o. | 150 | KU | 22,00 | L/URN |
|
| 224.9 | G04CX91 | extrakt Pyg. africanum v kombinaci. | p.o. | 2 | DF | 20,14 | L/URN |
| 225 | H01A | hormony předního laloku hypofýzy | parent. | |
|---|
| 225.1 | H01AA02 | tetrakosaktid (nedepotní lékové formy) | parent. | 0.25 | MG | 59,93 | L/END |
|
| 225.2 | H01AC01 | somatropin | parent. | 2 | U | 765,20 | L/J5 |
| 86419 | SAIZEN | inj sic 1x4ut+1ml | SRO | MEX |
| 56362 | ZOMACTON 12 | inj sic 5x12ut+solv | FEI | D |
| 96132 | NORDITROPIN PENSET 12UT | inj sic 1x12ut+solv | NOO | DK |
| 96133 | NORDITROPIN PENSET 24UT | inj sic 1x24ut+solv | NOO | DK |
| 56033 | NORDITROPIN12I.U. | inj sic 1x12ut+solv | NOO | DK |
| 226 | H01BA | vasopresin a jeho deriváty | parent. | H |
|---|
| 226.1 | H01BA02 | desmopresin | parent. | 4 | RG | 82,41 | H |
|
| 226.2 | H01BA04 | terlipresin (do 0,5 mg včetně v jedné ampuli) | parent. | 1 | MG | 301,88 | H |
| 44356 | REMESTYP 0.5 | inj 5x5ml/0.5mg | FRL | CZ |
| 226.3 | H01BA05 | ornipresin | parent. | 5 | U | 27,57 | H |
|
| 226.4 | H01BA04 | terlipresin (nad 0,5 mg v jedné ampuli) | parent. | 1 | MG | 245,27 | H |
| 227 | H01BA | vasopresin a jeho deriváty | lok. | |
|---|
| 227.1 | H01BA02 | desmopresin (nosní kapky) | lok. | 25 | RG | 20,63 | |
| 02634 | ADIURETIN SD | gtt nas 1x5ml/0.5mg | FRL | CZ |
| 227.2 | H01BA02 | desmopresin (nosní spray) | lok. | 25 | RG | 31,72 | P |
Treatment with desmopressin as a nasal spray is prescribed by an endocrine or pediatrician in the indication of diabetes insipidus centralis in patients under 15 years of age.
| 227.3 | H01BA02 | desmopresin (pevné lékové formy) | p.o. | 400 | RG | 20,63 | |
| 228 | H01BB | oxytocin a jeho deriváty | parent. | H |
|---|
| 228.1 | H01BB02 | oxytocin (do 2 U v jedné ampuli včetně) | parent. | 15 | U | 44,28 | H |
| 00543 | OXYTOCIN FERRING-LECIVA | inj 5x2ml/2ut | FRL | CZ |
| 228.2 | H01BB02 | oxytocin (nad 2 U v jedné ampuli) | parent. | 15 | U | 19,80 | H |
| 00544 | OXYTOCIN FERRING-LECIVA | inj 5x1ml/5ut | FRL | CZ |
| 229 | H01CA | hormon uvolňující gonadotrofin | lok. | Z |
|---|
| 229.1 | H01CA01 | gonadorelin (nasálně) | lok. | 1.2 | MG | 203,34 | Z |
| 86238 | KRYPTOCUR | inh sol 1x10gm+pump | HOE | D |
| 229.2 | H01CA02 | nafarelin do 4 ml včetně v jednom balení (nasálně) | lok. | 0,4 | MG | 147,61 | Z |
|
| 229.3 | H01CA02 | nafarelin nad 4 ml v jednom balení (nasálně) | lok. | 0,4 | MG | 116,04 | Z |
| 230 | H01CB | somatostatin a jeho deriváty | parent. | X |
|---|
| 230.1 | H01CB01 | somatostatin | parent. | 6 | MG | 8052,52 | X |
| 92109 | SOMATOSTATIN | inj sic 1x250rg+1ml | UCB | B |
| 66824 | SOMATOSTATIN | inj sic 1x3mg+solv. | UCB | B |
| 83084 | SOMATOSTATIN 6MG | inj sic 1x6mg+solv. | UCB | B |
| 230.2 | H01CB02 | oktreotid | parent. | 1 | MG | 5050,76 | X |
| 93866 | SANDOSTATIN | inj 5x1ml/0.5mg | SAN | CH |
| 230.3 | H01CB03 | lantreotid | parent. | 2,14 | MG | 2206,74 | X |
| 84701 | SOMATULINE P.R. | inj sic 1x30mg+solv | IPE | F |
| 231 | H02AA | mineralokortikoidy | p.o. | |
|---|
| 231.1 | H02AA02 | fludrokortison | p.o. | 0.1 | MG | 4,79 | |
| 23865 | FLUDROCORTISON | tbl 100x0.1mg | SQH | D |
| 232 | H02AB | glukokortikoidy | p.o. | |
|---|
|
| 232.1 | H02AB01 | betamethason | p.o. | 1.5 | MG | 3,42 | |
|
| 232.2 | H02AB02 | dexamethason (4 mg v jedné tabletě a více) | p.o. | 1.5 | MG | 10,22 | |
| 83994 | FORTECORTIN 4 | tbl 20x4mg | MEC | D |
| 232.3 | H02AB02 | dexamethason (méně než 4 mg v jedné tabletě) | p.o. | 1.5 | MG | 3,42 | |
| 86698 | DEXAMETHAZON LECIVA | tbl 20x0.5mg-blistr | LEX | CZ |
| 70508 | DEXONA | tbl 100x0.5mg | CAD | IND |
| 232.4 | H02AB04 | methylprednisolon (do 8 mg v jedné tabletě včetně) | p.o. | 7.5 | MG | 3,42 | |
|
| 232.5 | H02AB04 | methylprednisolon (nad 8 mg v jedné tabletě) | p.o. | 7.5 | MG | 5,43 | |
| 86606 | MEDROL | tbl 50x16mg(blistr) | UPJ | B |
| 93617 | MEDROL | tbl 50x16mg(lekov.) | UPJ | B |
| 232.6 | H02AB07 | prednison | p.o. | 10 | MG | 2,49 | |
| 02963 | PREDNISON 20 LECIVA | tbl 20x20mg(blistr) | LEX | CZ |
| 00269 | PREDNISON 5 LECIVA | tbl 20x5mg | LEX | CZ |
| 232.7 | H02AB08 | triamcinolon | p.o. | 7.5 | MG | 2,74 | |
| 00332 | TRIAMCINOLON LECIVA | tbl 20x4mg | LEX | CZ |
| 232.8 | H02AB09 | hydrokortison | p.o. | 30 | MG | 7,33 | |
| 76205 | HYDROCORTISON 10MG JENAPHARM | tbl 20x10mg | VJP | D |
| 232.9 | H02AB10 | kortison | p.o. | 37.5 | MG | 5,72 | |
| 80588 | CORTISON CIBA 25MG | tbl 100x25mg | CGC | CH |
| 232.10 | H02AB07 | prednison (do 10 mg včetně) | p.rect. | 10 | MG | 17,30 | |
| 84000 | RECTODELT | sup 6x5mg | TRM | D |
| 84001 | RECTODELT | sup 6x10mg | TRM | D |
| 232.11 | H02AB07 | prednison (nad 30 mg) | p.rect. | 10 | MG | 4,59 | |
| 84003 | RECTODELT | sup 6x100mg | TRM | D |
| 232.12 | H02AB07 | prednison (nad 10 do 30 mg včetně) | p.rect. | 10 | MG | 8,16 | |
| 84002 | RECTODELT | sup 6x30mg | TRM | D |
| 233 | H02AB | glukokortikoidy | parent. | O |
|---|
| 233.1 | H02AB | mazipredon | parent. | 30 | MG | 17,79 | O |
| 02125 | DEPERSOLON | inj 3x1ml/30mg | GED | H |
| 233.2 | H02AB01 | betamethason (depotní lékové formy) | parent. | 0.4 | MG | 4,01 | O |
| 89870 | DIPROPHOS | inj 1x1ml | SCH | B |
| 78257 | DIPROPHOS | inj 5x1ml | SCH | F |
| 233.3 | H02AB02 | dexamethason (40 mg v jedné ampuli) | parent. | 1.5 | MG | 26,54 | O |
| 99479 | FORTECORTIN MONO 40(AMPULE) | inj 1x5ml/40mg | MEC | D |
| 233.4 | H02AB02 | dexamethason (do 8 mg v jedné ampuli včetně) | parent. | 1.5 | MG | 2,54 | O |
| 84090 | DEXAMED | inj 10x2ml/8mg | MOE | CY |
| 96108 | DEXONA | inj 6x2ml 4mg/ml | CAD | IND |
| 96109 | DEXONA | inj 8x6x2ml | CAD | IND |
| 233.5 | H02AB04 | methylprednisolon (do 80 mg v jedné ampuli včetně) | parent. | 20 | MG | 36.20 | O |
| 09709 | SOLU-MEDROL | inj sic 1x40mg+1ml | UPJ | B |
| 233.6 | H02AB04 | methylprednisolon (nad 500 mg v jedné ampuli) | parent. | 20 | MG | 15,25 | O |
|
| 233.7 | H02AB04 | methylprednisolon (nad 80 do 500 mg v jedné ampuli včetně) | parent. | 20 | MG | 22,44 | O |
| 09711 | SOLU-MEDROL | inj sic 1x500mg+8ml | UPJ | B |
| 233.8 | H02AB06 | prednisolon (do 50 mg v jedné ampuli včetně) | parent. | 10 | MG | 17,84 | O |
| 09705 | SOLU-DECORTIN H 50 | inj sic 1x50mg+1ml | MEC | D |
| 233.9 | H02AB06 | prednisolon (nad 50 mg v jedné ampuli) | parent. | 10 | MG | 12,51 | O |
| 09707 | SOLU-DECORTIN H 250 | inj sic 1x250mg+2ml | MEC | D |
| 233.10 | H02AB08 | triamcinolon | parent. | 7.5 | MG | 13,64 | O |
| 08006 | KENALOG 10 | inj 1x5ml/50mg | LEX | CZ |
| 02126 | KENALOG 40 | inj 1x5ml/200mg | LEX | CZ |
| 233.11 | H02AB09 | hydrokortison | parent. | 30 | MG | 11,19 | O |
| 03950 | SOLU-CORTEF | inj sic 1x100mg | UPJ | B |
| 06199 | SOLU-CORTEF | inj sic 25x100mg | UPJ | B |
| 00484 | HYDROCORTISON SOLUBILE VUAB | inj 1x100mg | VUA | CZ |
| 234 | H03AA | hormony štítné žlázy | p.o. | |
|---|
| 234.1 | H03AA | hormony štítné žlázy | p.o. | 1 | DF | 2,15 | |
| 61161 | JODTHYROX | tbl 100 | MEC | D |
| 234.2 | H03AA01 | levothyroxin sodný (do 50 RG v 1 tabletě včetně) | p.o. | 0.15 | MG | 1,96 | |
| 77584 | L-THYROXIN 50 BERLIN-CHEMIE | tbl 100x50rg | BCE | D |
| 62190 | EUTHYROX 50 | tbl 100x50rg | MEC | D |
| 47141 | LETROX 50 | tbl 100x50rg | BCE | D |
| 96142 | L-THYROXINE 50 HENNING | tbl 100x50rg | HNB | D |
| 234.3 | H03AA01 | levothyroxin sodný (nad 50 RG do 100 RG včetně v 1 tabletě) | p.o. | 0.15 | MG | 1,37 | |
| 96146 | L-THYROXINE 100 HENNING | tbl 100x100rg | HNB | D |
| 47133 | LETROX 150 | tbl 100x150rg | BCE | D |
| 234.4 | H03AA01 | levothyroxin sodný (nad 100 RG v 1 tabletě) | p.o. | 0.15 | MG | 1,12 | |
| 96150 | L-THYROXINE 150 HENNING | tbl 100x150rg | HNB | D |
| 234.5 | H03AA02 | liothyronin sodný | p.o. | 0.06 | MG | 4,89 | |
| 09805 | TERTROXIN | tbl 100x0.02mg | GLA | GB |
| 234.6 | H03AA03 | kombinace levothyroxinu a liothyroninu | p.o. | 1 | DF | 1,81 | |
| 03875 | THYREOTOM | tbl 60x50rg | BCE | D |
| 234.7 | H03CA | jódová terapie | p.o. | 200 | RG | 1,82 | |
| 61158 | JODID 100 | tbl 100 | MEC | D |
| 61159 | JODID 200 | tbl 100 | MEC | D |
| 235.1 | H03BA02 | propylthiouracil | p.o. | 0.1 | GM | 7,92 | |
| 09577 | PROPYCIL 50 | tbl 100x50mg | KCH | D |
| 09576 | PROPYCIL 50 | tbl 20x50mg | SVP | D |
| 235.2 | H03BB01 | karbimazol | p.o. | 15 | MG | 2,83 | |
| 00066 | CARBIMAZOL SLOVAKOFARMA | tbl 100x5mg | SLO | SK |
| 235.3 | H03BB02 | thiamazol | p.o. | 10 | MG | 2,10 | |
|
| 235.4 | H03BC01 | perchlorát draselný | p.o. | 0.2 | GM | 1,66 | |
| 236 | H03B | thyreostatika | parent. | H |
|---|
| 236.1 | H03BB02 | thiamazol | parent. | 10 | MG | 4,50 | H |
| 20617 | FAVISTAN | inj 10x1ml/40mg | ASD | D |
| 237 | H04AA | glukagon a jeho deriváty | parent. | L/DIA |
|---|
| 237.1 | H04AA01 | glukagon | parent. | 1 | MG | 404,62 | L/DIA |
| 90511 | GLUCAGON | inj sic 1x10mg+sol | LIL | USA |
| 02392 | GLUCAGON | inj sic 1x1mg+sol | LIL | USA |
| 237.2 | H04AA01 | glukagon (ve formě hypokit) | parent. | 1 | MG | 811,39 | L/DIA |
| 83741 | GLUCAGEN 1MG HYPOKIT | inj sic 1mg+strik. | NOO | DK |
| 238 | H05BA | kalcitonin | inhal. | L/INT,GYN,ORT,END |
|---|
| 238.1 | H05BA01 | kalcitonin (lososí, do 100 U včetně v jedné dávce) | inhal. | 200 | U | 115,70 | L/INT,GYN,ORT, END |
|
| 238.2 | H05BA01 | kalcitonin (lososí, nad 100 U v jedné dávce) | inhal. | 200 | U | 115,70 | L/INT,GYN,ORT, END |
| 56091 | MIACALCIC NASAL 200 | spr nas 1x2 ml | NPA | CH |
| 239 | H05BA | kalcitonin | parent. | L/INT,GYN,ORT,END |
|---|
| 239.1 | H05BA01 | kalcitonin (lososí) | parent. | 100 | U | 118,09 | L/INT,GYN,ORT, END |
| 89017 | UCECAL 50 I.U. | inj 5x1ml/50ut | UCB | B |
| 239.2 | H05BA03 | kalcitonin (lidský, do 50 U v jedné ampuli včetně) | parent. | 100 | U | 125,37 | L/INT,GYN,ORT, END |
|
| 239.3 | H05BA03 | kalcitonin (lidský, nad 50 U v jedné ampuli) | parent. | 100 | U | 157,39 | L/INT,GYN,ORT, END |
| 240 | J01AA | tetracyklinová antibiotika | p.o. | |
|---|
| 240.1 | J01AA02 | doxycyklin | p.o. | 0.1 | GM | 4,01 | |
| 90986 | DEOXYMYKOIN | tbl 10x100mg | LEX | CZ |
| 12735 | DOXYHEXAL 200 TABS | tbl 10x200mg | HEX | D |
| 12736 | DOXYHEXAL 200 TABS | tbl 20x200mg | HEX | D |
| 12741 | DOXYHEXAL TABS | tbl 10x100mg | HEX | D |
| 12742 | DOXYHEXAL TABS | tbl 20x100mg | HEX | D |
| 240.2 | J01AA04 | lymecyklin | p.o. | 0.6 | GM | 4,01 | |
|
| 240.3 | J01AA06 | oxytetracyklin | p.o. | 1 | GM | 4,01 | |
|
| 240.4 | J01AA07 | tetracyklin | p.o. | 1 | GM | 4,01 | |
|
| 240.5 | J01AA08 | minocyklin | p.o. | 0.2 | GM | 4,01 | |
| 241 | J01AA | tetracyklinová antibiotika | parent. | K |
|---|
| 241.1 | J01AA02 | doxycyklin | parent. | 0.1 | GM | 94,63 | K |
| 94790 | VIBRAMYCIN | inj sic 1x200mg | PFI | B |
| 12705 | DOXYHEXAL SF | inj 2x5ml/100mg | HEX | D |
| 12706 | DOXYHEXAL SF | inj 5x5ml/100mg | HEX | D |
| 241.2 | J01AA09 | rolitetracyklin | parent. | 0.35 | GM | 94,63 | K |
| 242 | J01BA | amfenikolová antibiotika | p.o. | |
|---|
| 242.1 | J01BA01 | chloramfenikol | p.o. | 3 | GM | 24,73 | |
| 71951 | CHLORAMPHENICOL LECIVA | cps 30x250mg | LEX | CZ |
| 243 | J01BA | amfenikolová antibiotika | parent. | K |
|---|
|
| 243.1 | J01BA01 | chloramfenikol | parent. | 3 | GM | 241,12 | K |
| 97390 | CHLORAMPHENICOL SOLUBILE VUAB | inj sic 1x1gm | VUA | CZ |
| 243.2 | J01BA02 | thiamphenikol | parent. | 1.5 | GM | 176,31 | K |
| 244 | J01CA | aminopenicilinová antibiotika | p.o. | |
|---|
| 244.1 | J01CA01 | ampicilin (pevné lékové formy) | p.o. | 2 | GM | 16,62 | |
| 60916 | AMPICILIN 250 LECIVA | cps 20x250mg | LEX | CZ |
| 60917 | AMPICILIN 250 LECIVA | cps 30x250mg | LEX | CZ |
| 60920 | AMPICILIN 500 LECIVA | cps 20x500mg | LEX | CZ |
| 60921 | AMPICILIN 500 LECIVA | cps 30x500mg | LEX | CZ |
| 244.2 | J01CA01 | ampicilin (tekuté lékové formy) | p.o. | 2 | GM | 20,24 | |
| 84508 | AMPICILIN 250 LECIVA | sir sic 1x5gm/100ml | LEX | CZ |
| 244.3 | J01CA04 | amoxicilin (pevné lékové formy) | p.o. | 1 | GM | 10,12 | |
| 66370 | OSPAMOX 1000MG | tbl obd 12x1000mg | BCA | A |
| 66828 | AMOCLEN 250 | cps 30x250mg | LEX | CZ |
| 66829 | AMOCLEN 500 | cps 30x500mg | LEX | CZ |
| 53681 | AMOXICILLIN 250-SLOVAKOFARMA | cps 30x250mg | SLO | SK |
| 53682 | AMOXICILLIN 500-SLOVAKOFARMA | cps 30x500mg | SLO | SK |
| 244.4 | J01CA04 | amoxicilin (tekuté lékové formy do 0,5 GM včetně v 5 mililitrech) | p.o. | 1 | GM | 13,05 | |
| 84510 | AMOCLEN 250 | sir sic 1x5gm/100ml | LEX | CZ |
| 244.5 | J01CA04 | amoxicilin (tekuté lékové formy nad 0,5 GM v 5 mililitrech) | p.o. | 1 | GM | 10,75 | |
|
| 244.6 | J01CA06 | bakampicilin | p.o. | 1.2 | GM | 16,62 | |
| 245 | J01CA | aminopenicilinová antibiotika | parent. | K |
|---|
| 245.1 | J01CA01 | ampicilin | parent. | 2 | GM | 27,08 | K |
| 60248 | PENTREXYL | inj sic 50x250mg | BMS | I |
| 246 | J01CA | acylureidová antibiotika | parent. | U/ATB |
|---|
| 246.1 | J01CA09 | azlocilin | parent. | 12 | GM | 637,48 | U/ATB |
| 04035 | SECUROPEN | inj sic 5x2gm+20ml | BAY | D |
| 97002 | SECUROPEN | inf 5x5gm | BAY | D |
| 246.2 | J01CA12 | piperacilin | parent. | 14 | GM | 1297,98 | U/ATB |
| 12336 | PIPRAKS | inj sic 1x2gm+10ml | ECZ | TR |
| 246.3 | J01CA13 | tikarcilin | parent. | 15 | GM | 1980,92 | U/ATB |
| 247 | J01CE | na beta-laktamázu citlivé peniciliny | p.o. | |
|---|
| 247.1 | J01CE02 | fenoxymethylpenicilin (nad 900 ku v jedné tabletě) | p.o. | 2 | GM | 19,65 | |
| 66359 | OSPEN 1000 | tbl obd 12x1000ku | BCA | A |
| 66360 | OSPEN 1500 | tbl obd 12x1500ku | BCA | A |
| 69468 | PENBENE | tbl obd 30x1mu | MCK | D |
| 69467 | PENICILLIN V 1 MEGA VON CT | tbl obd 10x1mu | CTA | D |
| 64936 | PENCID 1500 | tbl obd 20x1.5mu | LEX | CZ |
| 64937 | PENCID 1000 | tbl obd 20x1mu | LEX | CZ |
| 247.2 | J01CE02 | fenoxymethylpenicilin (méně než 500 ku v jedné tabletě) | p.o. | 2 | GM | 21,02 | |
| 84626 | V-PENICILIN 250MG SLOVAKOFARMA | tbl 30x250mg-lekov. | SLO | SK |
| 92805 | V-PENICILIN 250MG SLOVAKOFARMA | tbl 30x250mg-blistr | SLO | SK |
| 247.3 | J01CE02 | fenoxymethylpenicilin ( od 500 ku včetně do 900 ku včetně v jedné tabletě) | p.o. | 2 | GM | 19,11 | |
| 84627 | V-PENICILIN 500MG SLOVAKOFARMA | tbl 30x500mg-lekov. | SLO | SK |
| 92806 | V-PENICILIN 500MG SLOVAKOFARMA | tbl 30x500mg-blistr | SLO | SK |
| 247.4 | J01CE06 | penamecilin | p.o. | 1.05 | GM | 14,52 | |
| 56442 | PENCLEN | tbl 30x350mg-blistr | SLO | SK |
| 247.5 | J01CE10 | benzathin fenoxymethylpenicilin | p.o. | 2 | GM | 29,43 | |
| 76213 | OSPEN 750 | sir 60ml 750mg/5ml | KRK | SLO |
| 247.6 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy do 250 kIU v 5 ml včetně) | p.o. | 2 | GM | 69.99 | |
| 98281 | INFECTOCILLIN 250 SIRUP | gra sus 1x75ml | INF | D |
| 247.7 | J01CE02 | fenoxymethylpenicilin (tekuté lékové formy nad 250 kIU v 5 ml) | p.o. | 2 | GM | 26,30 | |
| 248 | J01CE | na beta-laktamázu citlivé peniciliny | parent. | K |
|---|
| 248.1 | J01CE01 | benzylpenicilin (do 1 MU v jedné ampuli včetně) | parent. | 3.6 | GM | 123,86 | K |
| 01093 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x1mu | BTA | SK |
| 248.2 | J01CE01 | benzylpenicilin (nad 1 MU v jedné ampuli) | parent. | 3.6 | GM | 49,32 | K |
| 93405 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x5mu | BTA | SK |
| 248.3 | J01CE08 | benzathin benzylpenicilin (do 0,6 MU v jedné ampuli včetně) | parent. | 2.0 | MU | 70,63 | K |
| 01089 | PENDEPON | inj 10x600ku | BTA | SK |
| 248.4 | J01CE08 | benzathin benzylpenicilin (nad 0,6 MU v jedné ampuli) | parent. | 2.0 | MU | 32,94 | K |
| 50160 | RETARPEN 2.4 M.U.I. | inj sic 50x2.4mu | BCW | A |
| 248.5 | J01CE09 | prokain penicilin (do 0,6 MU v jedné dávce včetně) | parent. | 2 | MU | 79,58 | K |
| 01101 | PROKAIN PENICILIN G BIOTIKA | inj 10x600ku | BTA | SK |
| 248.6 | J01CE09 | prokain penicilin (nad 0,6 MU v jedné dávce) | parent. | 2 | MU | 39,05 | K |
| 01102 | PROKAIN PENICILIN G BIOTIKA | inj 10x1.5mu | BTA | SK |
| 248.7 | J01CE30 | kombinace | parent. | 0.5 | DF | 10,36 | K |
| 02723 | PENDEPON COMPOSITUM | inj 10x1.5mu | BTA | SK |
| 249 | J01CF | vůči beta-laktamáze stabilní peniciliny | p.o. | |
|---|
| 249.1 | J01CF02 | cloxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | |
|
| 249.2 | J01CF02 | cloxacilin (tekuté lékové formy) | p.o. | 2 | GM | 39,98 | |
|
| 249.3 | J01CF04 | oxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | |
| 02677 | OXACILIN 250 LECIVA | cps 60x250mg | LEX | CZ |
| 60247 | PROSTAPHLIN 500MG | cps 100x500mg | BMS | I |
| 60437 | PROSTAPHLIN 500MG | cps 100x500mg | BMS | USA |
| 249.4 | J01CF04 | oxacilin (tekuté lékové formy) | p.o. | 2 | GM | 39,98 | |
| 250 | J01CF | vůči beta-laktamáze stabilní peniciliny | parent. | K |
|---|
| 250.1 | J01CF04 | oxacilin | parent. | 2 | GM | 98,74 | K |
| 92359 | PROSTAPHLIN 1000MG | inj sic 1x1000mg | BMS | I |
| 92357 | PROSTAPHLIN 250MG | inj sic 50x250mg | BMS | I |
| 60243 | PROSTAPHLIN 250MG | inj sic 50x250mg | BMS | USA |
| 92358 | PROSTAPHLIN 500MG | inj sic 50x500mg | BMS | I |
| 60245 | PROSTAPHLIN 500MG | inj sic 50x500mg | BMS | USA |
| 251 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny | p.o. | |
|---|
| 251.1 | J01CR01 | ampicilin a inhibitor beta-laktamázy (pevné lékové formy) | p.o. | 1.5 | GM | 92,87 | |
|
| 251.2 | J01CR01 | ampicilin a inhibitor beta-laktamázy (tekuté lékové formy) | p.o. | 1.5 | GM | 112,42 | |
|
| 251.3 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, do 375 mg v 1 tabletě včetně) | p.o. | 1 | GM | 40,81 | |
|
| 251.4 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 375 mg do 625 mg včetně v 1 tabletě) | p.o. | 1 | GM | 37,15 | |
|
| 251.5 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 625 mg v 1 tabletě) | p.o. | 1 | GM | 34,85 | |
|
| 251.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy do 156 mg v 5 ml včetně) | p.o. | 1 | GM | 50,74 | |
|
| 251.7 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy, nad 156 mg v 5 ml) | p.o. | 1 | GM | 39,89 | |
| 96416 | AMOKSIKLAV FORTE | plv sus 1x100ml | LEK | SLO |
| 252 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny, nebo kombinace penicilinů | parent. | U/ATB |
|---|
| 252.1 | J01CR01 | ampicilin a enzymový inhibitor | parent. | 1,5 | GM | 158,37 | U/ATB |
|
| 252.2 | J01CR02 | amoxicilin a inhibitor beta-laktamázy | parent. | 1 | GM | 110,42 | U/ATB |
| 97659 | AUGMENTIN I.V. | inj 10x600mg | LEX | CZ |
| 97660 | AUGMENTIN I.V. | inj 5x1.2gm | LEX | CZ |
| 72972 | AMOKSIKLAV 1.2GM | inj sic 5x1.2gm | LEK | SLO |
| 72973 | AMOKSIKLAV 600MG | inj sic 5x600mg | LEK | SLO |
| 252.3 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15 | GM | 1820,84 | U/ATB |
|
| 252.4 | J01CR05 | piperacilin a inhibitor beta-laktamázy | parent. | 14 | GM | 1980,92 | U/ATB |
|
| 252.5 | J01CR50 | kombinace penicilinů | parent. | 3 | DF | 71,80 | U |
|
| 252.6 | J01DA | cefoperazon a inhibitor beta-laktamázy | parent. | 2 | GM | 397,00 | U/ATB |
| 253 | J01DA | cefalosporinová antibiotika | p.o. | |
|---|
| 253.1 | J01DA01 | cefalexin (pevné lékové formy) | p.o. | 2 | GM | 38,13 | |
| 66357 | OSPEXIN 1000MG | tbl obd 12x1000mg | BCA | A |
| 67212 | CEPHABENE 1000MG | tbl obd 20x1000mg | MCK | D |
| 67211 | CEPHABENE 1000MG | tbl obd 10x1000mg | MCK | D |
| 67208 | CEPHABENE 500MG | tbl obd 10x500mg | MCK | D |
| 67209 | CEPHABENE 500MG | tbl obd 20x500mg | MCK | D |
| 55779 | CEFACLEN 250 | cps 30x250mg | SLO | SK |
| 55782 | CEFACLEN 500 | cps 30x500mg | SLO | SK |
| 253.2 | J01DA01 | cefalexin (tekuté lékové formy) | p.o. | 2 | GM | 44,33 | |
| 66354 | OSPEXIN 250MG/5ML | gra sus 1x60ml | BCA | A |
| 66355 | OSPEXIN 375MG/5ML | gra sus 1x60ml | BCA | A |
| 253.3 | J01DA06 | cefuroxim axetil (pevné lékové formy) | p.o. | 1 | GM | 114,38 | |
|
| 253.4 | J01DA06 | cefuroxim axetil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | |
|
| 253.5 | J01DA08 | cefaklor (pevné lékové formy do 375 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 95,80 | |
| 56962 | CECLOR | cps 21x250mg | LIL | CH |
| 99231 | CECLOR | cps 15x250mg | LIL | CH |
| 69474 | CECLOR RETARD 375MG | tbl obd 10x375mg | LIL | I |
| 53153 | VERCEF 250 MG | cps 7x3 (blistr) | RXY | IND |
| 253.6 | J01DA08 | cefaklor (tekuté lékové formy, do 125 mg/5 ml včetně) | p.o. | 1.5 | GM | 129,04 | |
| 99217 | CECLOR | sus 75ml 125mg/5ml | LIL | CH |
| 99221 | CECLOR | sus 75ml 125mg/5ml | LIL | I |
| 53151 | VERCEF125 MG/5ML | plv sus 1x100 ml | RXY | IND |
| 253.7 | J01DA08 | cefaklor (tekuté lékové formy, nad 125 mg/5 ml) | p.o. | 1.5 | GM | 118,29 | |
| 99222 | CECLOR | sus 75ml 250mg/5ml | LIL | CH |
| 99226 | CECLOR | sus 75ml 250mg/5ml | LIL | I |
| 53152 | VERCEF250 MG/5ML | plv sus 1x100 ml | RXY | IND |
| 253.8 | J01DA09 | cefadroxil (pevné lékové formy) | p.o. | 2 | GM | 50,25 | |
| 93905 | DURACEF | cps 12x500mg | BRI | I |
| 253.9 | J01DA09 | cefadroxil (tekuté lékové formy) | p.o. | 2 | GM | 73,86 | |
|
| 253.10 | J01DA23 | cefixim | p.o. | 0.4 | GM | 113,01 | ATB |
| 76235 | SUPRAX | plv sus 1x50ml/1gm | GED | H |
| 76233 | SUPRAX | tbl obd 10x200mg | GED | H |
| 253.11 | J01DA26 | cefetamet | p.o. | 1 | GM | 107,53 | ATB |
|
| 253.12 | J01DA33 | cefpodoxim | p.o. | 0.4 | GM | 114,38 | ATB |
|
| 253.13 | J01DA39 | ceftibuten | p.o. | 0.4 | GM | 114,38 | ATB |
|
| 253.14 | J01DA08 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. | 1.5 | GM | 92,87 | |
| 56963 | CECLOR | cps 21x500mg | LIL | CH |
| 99240 | CECLOR | cps 15x500mg | LIL | CH |
| 53157 | VERCEF 500 MG | cps 7x3 (blistr) | RXY | IND |
| 254 | J01DA | cefalosporinová antibiotika | parent. | U/ATB P |
|---|
Treatment with ceftriaxone in outpatient care is performed by a neurologist, an infectionist, a dermatologist, a pediatrician or a rheumatist:
(a) the oral treatment of bacterial meningitis in children under 18 years of age;
(b) treatment for Lyme disease stage II and III (documented by laboratory examination),
(c) treatment of uncomplicated acute gonorrhea (single intravenous administration of 250 mg ceftriaxone).
| 254.1 | J01DA03 | cefalotin | parent. | 4 | GM | 188,18 | U |
| 85512 | CEFALOTIN BIOTIKA | inj sic 50x1gm | BTA | SK |
| 254.2 | J01DA04 | cefazolin | parent. | 3 | GM | 180,07 | U |
| 83111 | ORIZOLIN | inj sic 1x1000mg | CAD | IND |
| 85510 | VULMIZOLIN | inj sic 50x1gm | BTA | SK |
| 91148 | VULMIZOLIN | inj sic 10x1gm | BTA | SK |
| 254.3 | J01DA05 | cefoxitin | parent. | 6 | GM | 937,79 | U/ATB |
|
| 254.4 | J01DA06 | cefuroxim | parent. | 4 | GM | 497,69 | U/ATB |
| 76360 | ZINACEF AD INJ. | inj sic 1x1.5gm | GLA | I |
| 254.5 | J01DA07 | cefamandol | parent. | 6 | GM | 615,68 | U/ATB |
|
| 254.6 | J01DA10 | cefotaxim do 1 g včetně v jedné ampuli | parent. | 6 | GM | 663,29 | U/ATB |
| 94176 | CEFOTAXIME | inj 1x1gm | LEK | SLO |
| 254.7 | J01DA11 | ceftazidim do 500 mg včetně v jedné ampuli | parent. | 6 | GM | 1736,18 | U/ATB |
|
| 254.8 | J01DA12 | cefsulodin | parent. | 6 | GM | 615,68 | U/ATB |
|
| 254.9 | J01DA13 | ceftriaxon | parent. | 2 | GM | 769,55 | ambulantně: K/P ústavně: U/ATB |
| 80662 | LENDACIN 1GM | inj sic 5x1gm | LEK | SLO |
| 80663 | LENDACIN 250MG | inj sic 5x250mg | LEK | SLO |
| 254.10 | J01DA22 | ceftizoxim | parent. | 4 | GM | 615,68 | U/ATB |
|
| 254.11 | J01DA30 | cefapirin | parent. | 4 | GM | 194,73 | U |
|
| 254.12 | J01DA32 | cefoperazon | parent. | 6 | GM | 1795,57 | U/ATB |
| 75039 | CEFOBID | inj sic 1x1gm | PFI | TR |
| 254.13 | J01DA37 | cefpirom | parent. | 4 | GM | 1679,48 | U/ATB |
| 86598 | CEFROM 2GM | inj sic 1x2gm | ROU | F |
| 254.14 | J01DA24 | cefepim | parent. | 4 | GM | 1690,43 | U/ATB |
|
| 254.15 | J01DA10 | cefotaxim nad 1 g v jedné ampuli | parent. | 6 | GM | 593,68 | U/ATB |
|
| 254.16 | J01DA11 | ceftazidim nad 500 mg v jedné ampuli | parent. | 6 | GM | 1739,99 | U/ATB |
| 255 | J01DF | monobaktámová antibiotika | parent. | U/ATB |
|---|
| 255.1 | J01DF01 | aztreonam | parent. | 4 | GM | 1694,73 | U/ATB |
| 86412 | AZACTAM | inj sic 1x1gm | BMS | I |
| 256 | J01DH | karbapenemová antibiotika | parent. | U/ATB |
|---|
| 256.1 | J01DH02 | meropenem | parent. | 2 | GM | 2259,20 | U/ATB |
| 83488 | MERONEM 500MG I.M. | inj sic 1x500mg+sol | ZNC | GB |
| 256.2 | J01DH51 | imipenem a inhibitor enzymu | parent. | 2 | GM | 2258,99 | U/ATB |
| 257 | J01EB | krátkodobě působící sulfonamidy | p.o. | |
|---|
| 257.1 | J01EA01 | trimethoprim (do 100 mg v jedné tabletě včetně) | p.o. | 0.4 | GM | 12,32 | |
| 62325 | TRIPRIM 100MG | tbl 10x100mg | MCK | A |
| 76513 | TRIPRIM 100MG | tbl 20x100mg | MCK | A |
| 257.2 | J01EA01 | trimethoprim (nad 100 mg v jedné tabletě) | p.o. | 0.4 | GM | 9,29 | |
| 62324 | TRIPRIM 200MG | tbl 10x200mg | MCK | A |
| 76510 | TRIPRIM 200MG | tbl 20x200mg | MCK | A |
| 257.3 | J01EB05 | sulfafurazol | p.o. | 4 | GM | 13,64 | |
| 00313 | SULFISOXAZOL LECIVA | tbl 20x500mg-blistr | LEX | CZ |
| 258 | J01EE | sulfonamidy kombinované s trimetoprimem | p.o. | |
|---|
| 258.1 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy, do 120 mg v jedné tabletě včetně) | p.o. | 1.92 | GM | 17,06 | |
|
| 258.2 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy nad 120 mg v jedné tabletě) | p.o. | 1.92 | GM | 6,84 | |
| 97868 | ORIPRIM | tbl 2x10x480mg | CAD | IND |
| 87758 | ORIPRIM | tbl 10x10x480mg | CAD | IND |
| 06264 | SUMETROLIM | tbl 20x480mg | EGI | H |
| 258.3 | J01EE01 | sulfamethoxazol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 22,39 | |
| 75459 | PRIMOTREN | sus 1x100ml | LEK | SLO |
| 87757 | ORIPRIM PRO INFANT. | sus 50ml 240mg/5ml | CAD | IND |
| 258.4 | J01EE03 | sulfametrol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | |
|
| 258.5 | J01EE03 | sulfametrol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,07 | |
|
| 258.6 | J01EE04 | sulfamonoxol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | |
|
| 258.7 | J01EE04 | sulfamonoxol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,07 | |
|
| 258.8 | J01EE05 | sulfadimidin a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | |
| 259 | J01EE | sulfonamidy kombinované s trimetoprimem | parent. | K |
|---|
| 259.1 | J01EE01 | sulfamethoxazol a trimethoprim | parent. | 1.92 | GM | 113,40 | K |
| 91281 | PRIMOTREN I.V. | inj 10x5ml | LEK | SLO |
| 260 | J01FA | makrolidová antibiotika | p.o. | |
|---|
|
| 260.1 | J01FA01 | erythromycin (pevné lékové formy) | p.o. | 1 | GM | 20,09 | |
| 260.2 | J01FA01 | erythromycin (tekuté lékové formy) | p.o. | 1 | GM | 47,31 | |
| 97507 | ERYTHROMYCIN-RATIO.TS 200MG/5ML | plv sus 1x60ml | MCK | D |
| 55585 | MEROMYCIN 200MG/5ML | plv sus 1x100ml | MCK | D |
| 97508 | ERYTHROMYCIN-RATIO.TS 200MG/5ML | plv sus 1x100ml | MCK | D |
| 55584 | MEROMYCIN 200MG/5ML | plv sus 1x60ml | MCK | D |
| 260.3 | J01FA02 | spiramycin | p.o. | 3 | GM | 67,26 | |
|
| 260.4 | J01FA05 | oleandomycin | p.o. | 1 | GM | 19,21 | |
|
| 260.5 | J01FA06 | roxithromycin (do 100 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 48,63 | |
| 65367 | RULID 100MG | tbl obd 10x100mg | LEX | CZ |
| 65366 | RULID 50MG | tbl obd 10x50mg | LEX | CZ |
| 260.6 | J01FA06 | roxithromycin (nad 100 mg v jedné tabletě) | p.o. | 0.3 | GM | 42,04 | |
| 96452 | RULID 150MG | tbl obd 20x150mg | LEX | CZ |
| 55467 | RULID 300MG | tbl obd 10x300mg | LEX | CZ |
| 96731 | RULID 150MG | tbl obd 10x150mg | LEX | CZ |
| 260.7 | J01FA07 | josamycin (pevné lékové formy) | p.o. | 2 | GM | 42,04 | |
|
| 260.8 | J01FA07 | josamycin (tekuté lékové formy) | p.o. | 1 | GM | 47,31 | |
|
| 260.9 | J01FA09 | klarithromycin (pevné lékové formy) | p.o. | 0.5 | GM | 67,26 | |
| 83613 | KLACID 250MG | tbl obd 14x250mg | ABB | CH |
| 83614 | KLACID 250MG | tbl obd 10x250mg | ABB | CH |
| 83615 | KLACID 250MG | tbl obd 10x250mg | ABB | I |
| 260.10 | J01FA09 | klarithromycin (tekuté lékové formy) | p.o. | 0.5 | GM | 77,82 | |
| 80481 | KLACID 125MG/5ML | gra sus 1x100ml | ABB | I |
| 53800 | KLACID 250MG/5ML | gra sus 1x100ml | ABB | I |
| 260.11 | J01FA10 | azithromycin (pevné lékové formy do 125 mg v 1 tabletě nebo tobolce včetně) | p.o. | 0.25 | GM | 88,57 | |
| 96819 | SUMAMED | tbl 6x125mg | PLI | CHO |
| 260.12 | J01FA10 | azithromycin (tekuté lékové formy) | p.o. | 0.25 | GM | 96,24 | |
| 96812 | SUMAMED FORTE | sir 20ml 200mg/5ml | PLI | CHO |
| 96811 | SUMAMED | sir 20ml 100mg/5ml | PLI | CHO |
| 260.13 | J01FA13 | dirythromycin | p.o. | 0.5 | GM | 67,26 | |
|
| 260.14 | J01FA10 | azithromycin (pevné lékové formy nad 125 mg v 1 tabletě nebo tobolce) | p.o. | 0.25 | GM | 87,88 | |
| 93590 | SUMAMED | cps 6x250mg | PLI | CHO |
| 96813 | SUMAMED | tbl 3x500mg | PLI | CHO |
| 260.15 | J01RA | kombinace antibakteriálních léčiv (spiramycin/metronidazol) | p.o. | 5 | DF | 32,16 | |
| 261 | J01FA | makrolidová antibiotika | parent. | K |
|---|
| 261.1 | J01FA01 | erythromycin | parent. | 1 | GM | 910,47 | K |
| 88108 | ERYTHROCIN I.V. | inj 1x300mg | ABB | GB |
| 261.2 | J01FA02 | spiramycin | parent. | 3 | GM | 1249,88 | K |
| 262 | J01FF | linkosamidová antibiotika | p.o. | ATB |
|---|
| 262.1 | J01FF01 | klindamycin (pevné lékové formy) | p.o. | 1.2 | GM | 65,25 | |
| 91193 | DALACIN C | cps 100x150mg | UPJ | B |
| 56867 | KLIMICIN 300MG | cps 16x300mg | LEK | SLO |
| 03365 | DALACIN C | cps 16x150mg | UPJ | B |
| 94574 | KLIMICIN | cps 16x150mg | LEK | SLO |
| 83458 | DALACIN C | cps 16x300mg | UPJ | B |
| 262.2 | J01FF01 | klindamycin (tekuté lékové formy) | p.o. | 1.2 | GM | 160,62 | |
|
| 262.3 | J01FF02 | linkomycin (pevné lékové formy) | p.o. | 1.8 | GM | 29,08 | ATB |
| 91997 | NELOREN | cps 16x500mg | LEK | SLO |
| 262.4 | J01FF02 | linkomycin (tekuté lékové formy) | p.o. | 1.8 | GM | 160,62 | ATB |
| 263 | J01FF | linkosamidová antibiotika | parent. | U/ATB |
|---|
| 263.1 | J01FF01 | klindamycin (do 0,3 GM včetně v jedné ampuli) | parent. | 1.8 | GM | 665,19 | U/ATB |
| 97878 | KLIMICIN I.V. A I.M. | inj 10x2ml/300mg | LEK | SLO |
| 263.2 | J01FF01 | klindamycin (nad 0,3 GM v jedné ampuli) | parent. | 1.8 | GM | 645,79 | U/ATB |
|
| 263.3 | J01FF02 | linkomycin | parent. | 1.8 | GM | 49,17 | U/ATB |
| 83593 | MEDOGLYCIN 600MG | inj 100x2ml/600mg | MOE | CY |
| 67029 | MEDOGLYCIN 600MG | inj 10x2ml/600mg | MOE | CY |
| 264 | J01GA | streptomycin a jeho deriváty | parent. | |
|---|
| 264.1 | J01GA01 | streptomycin | parent. | 1 | GM | 85,05 | |
| 265 | J01GB | aminoglykosidová antibiotika | parent. | U/ATB |
|---|
|
| 265.1 | J01GB01 | tobramycin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 43,84 | U |
|
| 265.2 | J01GB01 | tobramycin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23,02 | U |
|
| 265.3 | J01GB03 | gentamicin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 45,18 | U |
| 96413 | GENTAMICIN 40MG LEK | inj 10x2ml/40mg | LEK | SLO |
| 265.4 | J01GB03 | gentamicin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23,61 | U |
| 96414 | GENTAMICIN 80MG LEK | inj 10x2ml/80mg | LEK | SLO |
| 265.5 | J01GB03 | gentamicin (lékové formy pěny) | lok. | 130 | MG | 2411,98 | U/ATB |
|
| 265.6 | J01GB03 | gentamicin (lékové formy kuliček k implantaci) | imp. | 1 | DF | 152,06 | U/ATB |
|
| 265.7 | J01GB05 | neomycin | parent. | 1 | GM | 122,34 | U/ATB |
|
| 265.8 | J01GB06 | amikacin (do 100 mg v jedné ampuli včetně) | parent. | 1 | GM | 741,01 | U/ATB |
| 12334 | AMIKOZIT 100MG | inj 1x2ml | ECZ | TR |
| 265.9 | J01GB06 | amikacin (nad 100 mg v jedné ampuli) | parent. | 1 | GM | 398,66 | U/ATB |
| 12335 | AMIKOZIT 500MG | inj 1x2ml | ECZ | TR |
| 265.10 | J01GB07 | netilmicin (do 50 mg v jedné ampuli včetně) | parent. | 0.35 | GM | 519,93 | U/ATB |
|
| 265.11 | J01GB07 | netilmicin (nad 50 mg v jedné ampuli) | parent. | 0.35 | GM | 304,57 | U/ATB |
|
| 265.12 | J01GB11 | isepamicin (nad 250 mg v jedné ampuli) | parent. | 1 | GM | 516,90 | U/ATB |
|
| 265.13 | J01GB11 | isepamicin (do 250 mg včetně v jedné ampuli) | parent. | 1 | GM | 620,27 | U/ATB |
| 266 | J01MA | fluorované chinolony | p.o. | |
|---|
For the treatment of sparfloxacin and trovafloxacin, consultation and approval of an antibiotic centre are required.
| 266.1 | J01MA01 | ofloxacin | p.o. | 0.4 | GM | 29,33 | |
| 54391 | TAROFLOX 200 | tbl obd 10x200mg | HBS | SK |
| 55636 | OFLOXIN 200 | tbl obd 10x200mg | LEX | CZ |
| 266.2 | J01MA02 | ciprofloxacin | p.o. | 1 | GM | 29,33 | |
| 53715 | CIFLOXINAL | tbl obd 200x250mg | PMP | CZ |
| 87104 | CIFLOXINAL | tbl obd 10x250mg | PMP | CZ |
| 87105 | CIFLOXINAL | tbl obd 20x250mg | PMP | CZ |
| 53201 | CIPHIN 250 | tbl obd 10x250mg | SLO | SK |
| 53202 | CIPHIN 500 | tbl obd 10x500mg | SLO | SK |
| 53203 | CIPHIN 750 | tbl obd 10x750mg | SLO | SK |
| 56830 | CIPLOX 200MG/100ML | inf 1x100ml(plast) | CIA | IND |
| 44988 | CIPLOX 250 | tbl obd 10x250mg | CIA | IND |
| 44989 | CIPLOX 250 | tbl obd 50x250mg | CIA | IND |
| 44985 | CIPLOX 500 | tbl obd 10x500mg | CIA | IND |
| 44986 | CIPLOX 500 | tbl obd 50x500mg | CIA | IND |
| 96040 | CIPRINOL | inj 5x10ml/100mg | KRK | SLO |
| 94453 | CIPRINOL 250 | tbl obd 10x250mg | KRK | SLO |
| 96039 | CIPRINOL 500 | tbl obd 10x500mg | KRK | SLO |
| 91559 | CIPROBAY 100 | inf 1x50ml/100mg | BAY | D |
| 91560 | CIPROBAY 200 | inf 1x100ml/200mg | BAY | D |
| 91155 | CIPROBAY 250 | tbl obd 10x250mg | BAY | D |
| 91156 | CIPROBAY 500 | tbl obd 10x500mg | BAY | D |
| 266.3 | J01MA03 | pefloxacin | p.o. | 0.8 | GM | 29,33 | |
| 94156 | ABAKTAL | tbl obd 10x400mg | LEK | SLO |
| 266.4 | J01MA04 | enoxacin | p.o. | 0.8 | GM | 22,48 | |
|
| 266.5 | J01MA06 | norfloxacin | p.o. | 0.8 | GM | 22,48 | |
| 44089 | GYRABLOCK 400 | tbl obd 100x400mg | MOE | CY |
| 44087 | GYRABLOCK 400 | tbl obd 30x400mg | MOE | CY |
| 44088 | GYRABLOCK 400 | tbl obd 50x400mg | MOE | CY |
| 93465 | NOLICIN | tbl 20x400mg | KRK | SLO |
| 266.6 | J01MA07 | lomefloxacin | p.o. | 0.8 | GM | 29,33 | |
|
| 266.7 | J01MA08 | fleroxacin | p.o. | 0.4 | GM | 29,33 | |
|
| 266.8 | J01MA09 | sparfloxacin | p.o. | 0.2 | GM | 29,33 | P |
|
| 266.9 | J01MA | trovafloxacin | p.o. | 0,2 | GM | 29,33 | P |
| 267 | J01MA | fluorované chinolony | parent. | U/ATB |
| 267.1 | J01MA01 | ofloxacin | parent. | 0.4 | GM | 212,23 | U/ATB |
|
| 267.2 | J01MA02 | ciprofloxacin | parent. | 0.5 | GM | 212,23 | U/ATB |
|
| 267.3 | J01MA03 | pefloxacin | parent. | 0.8 | GM | 93,26 | U/ATB |
| 94155 | ABAKTAL | inj 10x5ml/400mg | LEK | SLO |
| 267.4 | J01MA08 | fleroxacin | parent. | 0.4 | GM | 212,23 | U/ATB |
|
| 267.5 | J01MA | trovafloxacin | parent. | 0,2 | GM | 212,23 | U/ATB |
| 268 | J01XA | ostatní antibiotika | parent. | U/ATB |
| 268.1 | J01XA01 | vankomycin | parent. | 2 | GM | 1618,09 | U/ATB |
| 92289 | EDICIN 0,5GM | inj.sicc.1x500mg | LEK | SLO |
| 92290 | EDICIN 1GM | inj.sicc.1x1gm | LEK | SLO |
| 268.2 | J01XA02 | teikoplanin | parent. | 0.4 | GM | 2932,74 | U/ATB |
| 71992 | TARGOCID | inj 1x400mg | MDD | GB |
| 268.3 | J01XB01 | kolistin | parent. | 3 | MU | 116,92 | U/ATB |
| 61178 | COLIMYCINE | inj sic 50x1mu | RBE | F |
| 268.4 | J01XB02 | polymyxin | parent. | 0.15 | GM | 103,09 | U/ATB |
| 269 | J01XB | polymyxinová antibiotika | p.o. | U/ATB |
| 269.1 | J01XB01 | kolistin | p.o. | 3 | MU | 42,82 | U/ATB |
| 86794 | COLIMYCINE | tbl 50x1.5mu | RRO | F |
| 270 | J01XD | imidazolová chemoterapeutika | parent. | U |
| 270.1 | J01XD01 | metronidazol | parent. | 1.5 | GM | 176,89 | U |
|
| 270.2 | J01XD03 | ornidazol | parent. | 1 | GM | 50,44 | U |
| 96404 | AVRAZOR | inj 5x3ml/500mg | LEX | CZ |
| 271 | J02AA | antimykotická antibiotika | parent. | U |
| 2 | J02AA01 | amfotericin | parent. | 35 | MG | 292,49 | U |
| 71969 | AMPHOTERICIN B | inj sic 1x50mg | SQH | D |
| 57548 | AMPHOTERICIN B SQUIBB | inj sic 1x50mg | BMJ | F |
| 272 | J02AB | imidazolová antimykotika | p.o. | |
| 272.1 | J02AB02 | ketokonazol | p.o. | 0.2 | GM | 27,37 | |
| 04243 | NIZORAL | tbl 10x200mg | JAN | B |
| 88192 | NIZORAL | tbl 30x200mg | JAN | B |
| 91739 | ORONAZOL | tbl 20x200mg | KRK | SLO |
| 273 | J02AB | imidazolová antimykotika | parent. | U |
| 273.1 | J02AB01 | mikonazol | parent. | 1 | GM | 469,63 | U |
| 274 | J02AC | triazolová antimykotika | p.o. | P |
1. A short-term treatment is performed by a gynaecologist or dermatologist based on culture or microscopic examination:
a) vaginal mycosis not responding to locally administered antifungals
(b) recurrence of vaginal mycosis
2. Multiday treatment is performed by an infectious, haematologist, oncologist, transplant unit specialist or dermatologist:
a) systemic mycosis in immunocompromised patients
(b) severe forms of mucosal and skin mycoses caused by candidates or dermatophytes based on culture or microscopic examination
(c) severe forms of nail mycosis (itraconazole) if at least one of the following conditions applies:
Disability of the whole nail plate
Disability of at least four nail plates such that each has a disability affecting more than 30% for the free edge of the nail in a axial direction
Influenza of the fingernail of the lower limb
A positive microscopic finding and mycological culture sampling are a condition for initiating treatment ad c).
(d) prophylactic in immunocompromised patients or pre-transplant patients
e) itraconazole liquid formulations - treatment of oral and oesophageal candidiasis and prophylaxis in immunocompromised patients
| 274.1 | J02AC01 | flukonazol (do 50 mg v 1 tabletě nebo 5 ml sirupu včetně) | p.o. | 0.2 | GM | 479,01 | P |
|
| 274.2 | J02AC01 | flukonazol ( nad 50 mg do 100 mg v 1 tabletě nebo 5 ml sirupu včetně) | p.o. | 0.2 | GM | 436,59 | P |
| 94381 | DIFLUCAN | cps 28x100mg | PFI | F |
| 274.3 | J02AC01 | flukonazol (nad 100 mg v 1 tabletě nebo 5 ml sirupu) | p.o. | 0.2 | GM | 436,59 | P |
|
| 274.4 | J02AC01 | flukonazol (do 150 mg v jednom balení včetně) | p.o. | 0.15 | GM | 372,16 | P |
| 53917 | FLUCONAZOL 150-SLOVAKOFARMA | cps 1x150mg | SLO |
| 274.5 | J02AC02 | itrakonazol (pevné lékové formy) nad 400 mg v jednom balení | p.o. | 0.2 | GM | 111,93 | P |
| 94897 | SPORANOX | cps 15x100mg | JAN | B |
| 274.6 | J02AC02 | itrakonazol (pevné lékové formy do 400 mg včetně v jednom balení) | p.o. | 0.2 | GM | 144,10 | P |
| 33921 | SPORANOX | cps 4x100mg | JAN | B |
| 274.7 | J02AX01 | flucytosin | p.o. | 10 | GM | 858,22 | P |
|
| 274.8 | J02AC02 | itrakonazol (tekuté lékové formy) | p.o. | 0.2 | GM | 402,81 | P |
| 56067 | SPORANOX | sol 1x150ml/1.5gm | JAN |
| 275 | J02AC | triazolová antimykotika | parent. | U/P |
Therapeutic: severe, life-threatening systemic mycosis.
Prophylactic: in immunocompressed or transplant patients.
| 275.1 | J02AC01 | flukonazol | parent. | 0.2 | GM | 1129,01 | U/P |
| 96548 | DIFLUCAN I.V. | inf 1x100ml 2mg/ml | PFI | F |
| 275.2 | J02AX01 | flucytosin | parent. | 10 | GM | 2710,83 | U/P |
| 276 | J04AB | antibiotika k léčbě tuberkulózy | p.o. | |
Treatment with rifabutin is performed by a pneumologist or infectionist: treatment of tuberculosis caused by atypical mycobacteria.
| 276.1 | J04AB02 | rifampicin | p.o. | 0.6 | GM | 12,76 | |
| 11038 | TUBOCIN | cps 100x150mg | PMM | BG |
| 11039 | TUBOCIN | cps 100x300mg | PMM | BG |
| 96735 | ARFICIN | cps 100x150mg | BLU | CHO |
| 96780 | ARFICIN | cps 100x300mg | BLU | CHO |
| 276.2 | J04AB04 | rifabutin | p.o. | 0.15 | GM | 125,72 | P |
| 277 | J04AB | antibiotika k léčbě tuberkulózy | parent. | |
| 277.1 | J04AB03 | rifamycin | parent. | 0.6 | GM | 244,40 | |
|
| 277.2 | J04AB30 | kapreomycin | parent. | 1 | GM | 553,11 | |
| 278 | J04AC | hydrazidy k léčbě tuberkulózy | p.o. | |
| 278.1 | J04AC01 | isoniazid | p.o. | 0.3 | GM | 2,00 | |
| 03303 | NIDRAZID | tbl 250x100mg | LEX | CZ |
| 279 | J04AK | další léčiva k léčbě tuberkulózy | p.o. | |
| 279.1 | J04AK01 | pyrazinamid | p.o. | 1.5 | GM | 9,19 | |
| 75508 | TISAMID | tbl 100x500mg | ORN | SF |
| 279.2 | J04AK02 | ethambutol | p.o. | 1.2 | GM | 12,42 | |
| 03023 | SURAL | tbl 100x400mg | CHN | H |
| 280 | J04BA | chemoterapeutika k léčbě lepry | p.o. | |
| 280.1 | J04BA02 | dapson | p.o. | 50 | MG | 1,37 | |
| 93821 | DISULONE 100 AU PROTOXAL.DE FER | tbl 100x100mg | SPC | F |
Treatment with brivudine, aciclovir, famcyclovir and valaciclovir is performed by an infectionist, oncologist, hematologist, gynecologist, dermatologist, clinical immunologist, neurologist and transplant specialist:
(a) treatment of the initial phase of herpes genitalis in pregnant women after 20 weeks of pregnancy,
(b) treatment of herpes zoster and herpes genitalis in immunocompromised patients (in cytostatic therapy, immunosuppressive therapy, corticosteroid treatment, or in subjects with evidence of immunodeficiency, and in atopic patients, respectively),
c) treatment of herpes zoster at facial location,
(d) prophylaxis after allogeneic bone marrow transplantation.
Treatment with inosine pranobex is performed by an allergologist or an immunologist in patients with established immune impairment.
Treatment of antiretroviral agents (zidovudine, didanosine, zalcitabine, saquinavir, ritonavir, indavir, stavudine, efavirenz, nevirapine,
nelfinavir and lamivudine) is indicated by an infectious agent working in AIDS centers.
Treatment with ganciclovir is performed by an infectious, oncologist, hematologist and transplant centre specialist:
(a) treatment and secondary prophylaxis of severe CMV infections in HIV / AIDS patients;
(b) prophylaxis and treatment of CMV infections in patients with allogeneic and autologous bone marrow transplantation;
(c) prophylaxis and treatment of CMV infections in patients with organ transplantation.
| 281.1 | J05AB | brivudin | p.o. | 0.5 | GM | 458,88 | P |
|
| 281.2 | J05AB01 | acyklovir | p.o. | 4 | GM | 435,95 | P |
| 84128 | HERPESIN 400 | tbl 25x400mg | LCM | CZ |
| 84127 | HERPESIN 200 | tbl 25x200mg | LCM | CZ |
| 88303 | ZOVIRAX | tbl 25x200mg | BWE | GB |
| 67323 | ZOVIRAX | tbl 35x800mg | BWE | GB |
| 96448 | ZOVIRAX | tbl 70x400mg | BWE | GB |
| 281.3 | J05AB06 | gancyklovir | p.o. | 3 | GM | 2002,96 | P |
| 53102 | CYMEVENE 250MG | cps 84x250mg | SYN | POR |
| 281.4 | J05AB09 | famcyklovir | p.o. | 0.75 | GM | 458,88 | P |
|
| 281.5 | J05AB11 | valacyklovir | p.o. | 3 | GM | 458,88 | P |
|
| 281.6 | J05AE01 | saquinavir | p.o. | 1,8 | GM | 504,14 | P |
|
| 281.7 | J05AE02 | indinavir | p.o. | 2,4 | GM | 504,14 | P |
|
| 281.8 | J05AE03 | ritonavir | p.o. | 1,2 | GM | 504,14 | P |
|
| 281.9 | J05AE04 | nelfinavir | p.o. | 2,25 | GM | 504,14 | P |
|
| 281.10 | J05AF01 | zidovudin | p.o. | 1.5 | GM | 685,28 | P |
| 96179 | AZITIDIN 100 | tbl 50x100mg | LCM | CZ |
| 281.11 | J05AF02 | didanosin | p.o. | 0.4 | GM | 236,43 | P |
|
| 281.12 | J05AF03 | zalcitabin | p.o. | 2.25 | MG | 241,76 | P |
| 66734 | HIVID 0.75MG | tbl obd 100x0.75mg | HLR | CH |
| 281.13 | J05AF04 | stavudin | p.o. | 80 | MG | 302,07 | P |
| 53210 | ZERIT 40MG | cps 60x40mg | BMS | F |
| 53209 | ZERIT 40MG | cps 56x40mg | BMS | F |
| 281.14 | J05AF05 | lamivudin | p.o. | 0,3 | GM | 248,01 | P |
| 281.15 | J05AF30 | kombinace antiretrovirových virostatik | p.o. | 2 | DF | 522,13 | P |
|
| 281.16 | J05AG01 | nevirapin | p.o. | 0,4 | GM | 353,49 | P |
|
| 281.17 | J05AG03 | efavirenz | p.o. | 0,6 | GM | 423,29 | P |
|
| 281.18 | J05AX05 | inosin pranobex | p.o. | 1 | GM | 30,55 | P |
| 88174 | ISOPRINOSINE | tbl 5x10(=50)x500mg | EWO | CH |
| 282 | J05AB | antivirotika ze skupiny nukloeosidů | parent. | U/P |
Treatment with brivudine, aciclovir, famcyclovir and valaciclovir is performed by an infectionist, oncologist, hematologist, gynecologist, dermatologist, clinical immunologist, neurologist and transplant specialist:
(a) treatment of the initial phase of herpes genitalis in pregnant women after 20 weeks of pregnancy,
(b) treatment of herpes zoster and herpes genitalis in immunocompromised patients (in cytostatic therapy, immunosuppressive therapy, corticosteroid treatment, or in subjects with evidence of immunodeficiency, and in atopic patients, respectively),
c) treatment of herpes zoster at facial location,
(d) prophylaxis after allogeneic bone marrow transplantation.
Treatment with inosine pranobex is performed by an allergologist or an immunologist in patients with established immune impairment.
Treatment of antiretroviral medicinal products (zidovudine, didanosine, zalcitabine, saquinavir, ritonavir, indavir, stavudine, efavirenz, nevirapine, nelfinavir, and lamivudine) is indicated by an AIDS centre infectious agent.
Treatment with ganciclovir is performed by an infectious, oncologist, hematologist and transplant centre specialist:
(a) treatment and secondary prophylaxis of severe CMV infections in HIV / AIDS patients;
(b) prophylaxis and treatment of CMV infections in patients with allogeneic and autologous bone marrow transplantation;
(c) prophylaxis and treatment of CMV infections in patients with organ transplantation.
| 282.1 | J05AB01 | acyklovir | parent. | 4 | GM | 1551,47 | U/P |
| 93260 | HERPESIN 250 | inj sic 10x250mg | LCM | CZ |
| 282.2 | J05AB06 | gancyklovir | parent. | 0.5 | GM | 1960,83 | U/P |
|
| 282.3 | J05AB12 | cidofovir | parent. | 375 | MG | 33556,50 | U/P |
| 44745 | VISTIDE | inf 1x5ml 75mg/ml | PAU | B |
| 282.4 | J05AD01 | foskarnet | parent. | 6.5 | GM | 3006,25 | U/P |
|
| 282.5 | J05AF01 | zidovudin | parent. | 1 | GM | 2748,47 | U/P |
| 283 | J06AA | imunitní séra | parent. | K/P |
The serum against staphylococcal infections is used by the doctor to treat severe staphylococcal infections.
Diphtheria serum is used by an infectious or pediatrician to treat diphtheria.
Serum against snake venom is administered by the doctor to treat the bite of the viper.
A serum against botulism is used by the doctor to treat botulism in a comprehensive way.
The gas-tar serum is administered by an infectious or surgical specialist to prophylaxis and treatment of clostridium infections.
The rabies serum is administered by an infectionist to prophylaxis or treatment of rabies.
| 283.1 | J06AA | sérum proti stafylokokovým infekcím | parent. | | | plně | K/P |
| 01194 | STASEA SEVAC | inj. 1x5000ut | SEV | CZ |
| 283.2 | J06AA01 | sérum proti záškrtu | parent. | | | plně K/P |
|
| 283.3 | J06AA03 | sérum proti hadímu jedu | parent. | | | plně | K/P |
| 83330 | IPSER EUROPE PASTEUR | inj. 1x5ml | PMX | F |
| 01206 | VENISE SEVAC | inj. 1x10ml/10ku | SEV | CZ |
| 283.4 | J06AA04 | sérum proti botulinu | parent. | | | plně | K/P |
| 01190 | BOSEA SEVAC | inj. 1x35ml | SEV | CZ |
| 283.5 | J06AA05 | sérum proti plynaté sněti | parent. | | | plně | K/P |
| 01195 | GASEA SEVAC | inj. 1x20ml/25ku | SEV | CZ |
| 283.6 | J06AA06 | sérum proti vzteklině | parent. | | | plně | K/P |
| 94015 | SERUM ANTIRAB.1000 U.I.PASTEUR | inj 1x5ml 200ut/ml | PMX | F |
| 284 | J06BA | imunoglobuliny, normální lidské | parent. | |
| 284.1 | J06BA01 | imunoglobuliny, norm. lidské, k extravasální aplikaci | parent. | 1 | DF | 57,68 | O |
| 01263 | NORGA I.M.SEVAC | inj 10x1.9ml | SEV | CZ |
| 01262 | NORGA I.M.SEVAC | inj 1x1.9ml | SEV | CZ |
| 284.2 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci (z tuzemské plazmy zakázkovou frakcionací) | parent. | 1 | GM | 991,90 | B |
| 284.3 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci | parent. | 1 | GM | 991,90 | B |
| 62553 | INTRAGLOBIN F PRO INFUS. | inf 1x50ml | BTP | D |
| 62554 | INTRAGLOBIN F PRO INFUS. | inf 1x100ml | BTP | D |
| 62555 | INTRAGLOBIN F PRO INFUS. | inf 1x200ml | BTP | D |
| 03833 | IVEGA (IMUNOGLOBUL.LIDSKY I.V.) | inj sic 500mg bilk. | IMA | SK |
| 284.4 | J06BA02 | imunoglobuliny normální lidské pro i.v. aplikaci (s obsahem IgM) | parent. | 1 | GM | 1955,16 | U |
| 45372 | OCTAGAM | inj 1x20ml | OPU | A |
| 12691 | OCTAGAM | inj 1x50ml | OPU | A |
| 12693 | OCTAGAM | inj 1x200ml | OPU | A |
| 12692 | OCTAGAM | inj 1x100ml | OPU | A |
| 285 | J06BB | specifické imunoglobuliny | parent. | K |
Infectionist, oncologist, haematologist and pediatrician are responsible for the treatment of immunoglobulin against non-inflammatory and shingles:
(a) unvaccinated pregnant women,
(b) newborn after contact with varicella,
(c) immunocompressed patients after contact with varicella,
(d) varicelous primary pneumonitis.
Treatment with immunoglobulin against cytomegalovirus infection is performed by an infectious, oncologist, hematologist or pediatrician:
(a) a newborn with evidence of cytomegalovirus infection;
(b) generalised cytomegalovirus infection in immunocompromised patients;
(c) prophylaxis of cytomegalovirus infections in transplanted patients with donor or recipient positivity. The immunoglobulin against cytomegalovirus infection is covered by the U symbol.
Tetanus immunoglobulin is paid according to symbol B.
Comments 0